101
|
Liu J, Zhang H, Qiao X, Wu M, Wang H, Ran K, Luo H, Chen Y, Sun J, Tang B. The feasibility and safety of laparoscopic inguinal hernia repair as a 24-h day surgery for patients aged 80 years and older: a retrospective cohort study. Hernia 2023; 27:1533-1541. [PMID: 37898974 DOI: 10.1007/s10029-023-02912-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Accepted: 10/08/2023] [Indexed: 10/31/2023]
Abstract
INTRODUCTION As the proportion of aging adults increases and inguinal hernia repair becomes increasingly popular as a day surgery, the demand for laparoscopic inguinal hernia repair as a day surgery is increasing among patients aged 80 years and older. Relevant research needs to be completed, so we aimed to evaluate laparoscopic inguinal hernia repair as a 24-h day surgery for this group of patients. METHODS In this retrospective cohort study, we utilized propensity score matching to analyze the data of patients who underwent laparoscopic inguinal hernia repair at a day surgery center between January 1, 2019, and March 1, 2022. Patients were divided into ≥ 80 years old and < 80 years old groups. We compared the perioperative laboratory results, perioperative outcomes, and 1-year complications between the two groups. RESULT A total of 554 patients were included in the study. After propensity score matching, 292 patients were included in the matched cohort (98 patients in the ≥ 80 years old group and 194 patients in the < 80 years old group). During hospitalization, there were significant differences in ASA classification, Caprini score, length of hospital stays, risk of thrombosis, and delayed discharge rate. No significant difference was found in the incidence of total postoperative complications between the two groups at the 1-year follow-up (HR: 0.96, 95% CI 0.36-2.54, P = 0.96). CONCLUSION In our study, LIHR as a 24-h day surgery was safe and effective for patients over 80 years old. However, to reduce the rate of delayed discharge, cautious perioperative evaluation is necessary.
Collapse
Affiliation(s)
- J Liu
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - H Zhang
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - X Qiao
- The Second Clinical Medical College of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - M Wu
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - H Wang
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - K Ran
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - H Luo
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - Y Chen
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - J Sun
- Vascular, Hernia and Abdominal Wall Surgery, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, China
| | - B Tang
- The Fourth Clinical College of Chongqing Medical University, 55 University-Town Middle Road, Shapingba District, Chongqing, China.
| |
Collapse
|
102
|
Li XJ, Yu S, Liu J, Wu SJ, Tian W, Tian Y. Correlation of serum levels of HIF-1α, SMAD3, and HDAC3 with the disease severity in stroke patients. Eur Rev Med Pharmacol Sci 2023; 27:11840-11846. [PMID: 38164847 DOI: 10.26355/eurrev_202312_34782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2024]
Abstract
OBJECTIVE Explore serum levels of hypoxia-inducible factor-1α (HIF-1α), signal transduction molecule 3 (SMAD3), and histone deacetylase (HDAC) and their correlation with the severity of the condition of stroke patients. PATIENTS AND METHODS Clinical records of 93 stroke patients and 93 healthy individuals were retrospectively analyzed. Serum levels of HIF-1α, SMAD3, and HDAC3 in patients with different disease degrees and lesion areas were compared between the two groups. Correlation between serum levels of HIF-1α, SMAD3, and HDAC3 and the severity and lesion area of the observation group were analyzed. RESULTS Serum levels of HIF-1α, SMAD3, and HDAC3 in the observation group were higher than those in the control group (p<0.05). Serum levels of HIF-1α, SMAD3, and HDAC3 in patients with moderate and severe disease were significantly higher than those in patients with mild disease and were the highest in patients with severe disease (p<0.05). Serum levels of HIF-1α, SMAD3, and HDAC3 in patients with moderate and large areas of cerebral infarction were significantly higher than those in patients with small areas of cerebral infarction and the highest in patients with large areas of cerebral infarction (p<0.05). Spearman correlation analysis showed that serum levels of HIF-1α, SMAD3, and HDAC3 significantly positively correlated with the severity of stroke and lesion area (p<0.05). CONCLUSIONS Serum levels of HIF-1α, SMAD3, and HDAC3 in stroke patients are highly expressed, and the increase positively correlates with the severity of the disease and the area of the lesion.
Collapse
Affiliation(s)
- X-J Li
- Department of Clinical Laboratory, Hengyang Medical School, The Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, China.
| | | | | | | | | | | |
Collapse
|
103
|
Liao X, Han Y, Shen C, Liu J, Wang Y. Targeting the NLRP3 inflammasome for the treatment of hypertensive target organ damage: Role of natural products and formulations. Phytother Res 2023; 37:5622-5638. [PMID: 37690983 DOI: 10.1002/ptr.8009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 08/10/2023] [Accepted: 08/25/2023] [Indexed: 09/12/2023]
Abstract
BACKGROUND AND AIM Hypertension is a major global health problem that causes target organ damage (TOD) in the heart, brain, kidney, and blood vessels. The mechanisms of hypertensive TOD are not fully understood, and its treatment is challenging. This review provides an overview of the current knowledge on the role of Nod-like receptor pyrin domain containing 3 (NLRP3) inflammasome in hypertensive TOD and the natural products and formulations that inhibit it. METHODS We searched PubMed, Web of Science, Google Scholar, and CNKI for relevant articles using the keywords "hypertension," "target organ damage," "NLRP3 inflammasome," "natural products," and "formulations." We reviewed the effects of the NLRP3 inflammasome on hypertensive TOD in different organs and discussed the natural products and formulations that modulate it. KEY RESULTS In hypertensive TOD, the NLRP3 inflammasome is activated by various stimuli such as oxidative stress and inflammation. Activation of NLRP3 inflammasome leads to the production of pro-inflammatory cytokines that exacerbate tissue damage and dysfunction. Natural products and formulations, including curcumin, resveratrol, triptolide, and allicin, have shown protective effects against hypertensive TOD by inhibiting the NLRP3 inflammasome. CONCLUSIONS AND IMPLICATIONS The NLRP3 inflammasome is a promising therapeutic target in hypertensive TOD. Natural products and formulations that inhibit the NLRP3 inflammasome may provide novel drug candidates or therapies for hypertensive TOD. Further studies are needed to elucidate the molecular mechanisms and optimize the dosages of these natural products and formulations and evaluate their clinical efficacy and safety.
Collapse
Affiliation(s)
- Xiaolin Liao
- Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China
| | - Yuanshan Han
- Scientific Research Department, The First Hospital of Hunan University of Chinese Medicine, Changsha, China
| | - Chuanpu Shen
- Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China
- The Key laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Institute for Liver Diseases of Anhui Medical University Hefei, Hefei, China
| | - Jianjun Liu
- Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China
| | - Yuhong Wang
- Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China
| |
Collapse
|
104
|
Jiao J, Liu J, Luo F, Shang M, Pan C, Qi B, Zhao L, Yin P, Shang D. Qingyi granules ameliorate severe acute pancreatitis in rats by modulating the gut microbiota and serum metabolic aberrations. Pharm Biol 2023; 61:927-937. [PMID: 37323024 DOI: 10.1080/13880209.2023.2222755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
CONTEXT Qingyi granules can be used to effectively treat patients with severe acute pancreatitis (SAP). OBJECTIVE To elucidate the role of gut microbiota-mediated metabolism in the therapeutic effects of Qingyi granules. MATERIALS AND METHODS Sprague-Dawley rats were grouped into the sham operation, SAP model, Qingyi granule intervention (Q, 1.8 g/kg) and emodin intervention (E, 50 mg/kg) groups and observed for 24 h. H&E staining and ELISA were used for histopathological analysis and serum enzyme and cytokine assays. 16S rDNA sequencing and UHPLC-HRMS were used for gut microbiota analysis and untargeted metabolomics. RESULTS In SAP rats, Qingyi granules decreased the pancreatic pathological score (Q, 7.4 ± 1.14; SAP, 11.6 ± 1.14, p < 0.01); serum amylase (Q, 121.2 ± 6.7; SAP, 144.3 ± 8.86, p < 0.05), lipase (Q, 566 ± 20.34; SAP, 656.7 ± 29.32, p < 0.01), and diamineoxidase (Q, 492.8 ± 26.08; SAP, 566.1 ± 26.83, p < 0.05) activities; and IL-1β (Q, 29.48 ± 0.88; SAP, 36.17 ± 1.88, p < 0.01), IL-6 (Q, 112.2 ± 3.57; SAP, 128.9 ± 9.09, p < 0.05) and TNF-α (Q, 215.3 ± 8.67; SAP, 266.4 ± 28.03, p < 0.05) levels. SAP induced Helicobacter and Lactobacillus overgrowth and suppressed Romboutsia and Allobaculum growth and caused aberrations in bacterial metabolites, which were partly reversed by Qingyi granules. DISCUSSION AND CONCLUSIONS Qingyi granules can modulate the gut microbiota and metabolic abnormalities to ameliorate SAP. Multi-omics approaches allow systematic study of the pharmacological mechanisms of compound prescriptions for critical illnesses.
Collapse
Affiliation(s)
- Juying Jiao
- Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China
- College of Integrative Medicine, Dalian Medical University, Dalian, China
- Shanghai Medical College, Fudan University, Shanghai, China
| | - Jianjun Liu
- Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China
- College of Integrative Medicine, Dalian Medical University, Dalian, China
| | - Fei Luo
- Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China
- College of Integrative Medicine, Dalian Medical University, Dalian, China
| | - Mengxue Shang
- Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China
- College of Integrative Medicine, Dalian Medical University, Dalian, China
| | - Chen Pan
- Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China
- College of Integrative Medicine, Dalian Medical University, Dalian, China
| | - Bing Qi
- Pancreaticobiliary Center, Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China
| | - Liang Zhao
- Pancreaticobiliary Center, Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China
| | - Peiyuan Yin
- Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China
- College of Integrative Medicine, Dalian Medical University, Dalian, China
| | - Dong Shang
- Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China
- College of Integrative Medicine, Dalian Medical University, Dalian, China
- Pancreaticobiliary Center, Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China
| |
Collapse
|
105
|
Wang Z, Liu T, Li W, Yu G, Mi Z, Wang C, Liao X, Huai P, Chu T, Liu D, Sun L, Fu X, Sun Y, Wang H, Wang N, Liu J, Liu H, Zhang F. Genome-wide meta-analysis and fine-mapping prioritize potential causal variants and genes related to leprosy. MedComm (Beijing) 2023; 4:e415. [PMID: 38020709 PMCID: PMC10674079 DOI: 10.1002/mco2.415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Revised: 09/05/2023] [Accepted: 09/22/2023] [Indexed: 12/01/2023] Open
Abstract
To date, genome-wide association studies (GWASs) have discovered 35 susceptible loci of leprosy; however, the cumulative effects of these loci can only partially explain the overall risk of leprosy, and the causal variants and genes within these loci remain unknown. Here, we conducted out new GWASs in two independent cohorts of 5007 cases and 4579 controls and then a meta-analysis in these newly generated and multiple previously published (2277 cases and 3159 controls) datasets were performed. Three novel and 15 previously reported risk loci were identified from these datasets, increasing the known leprosy risk loci of explained genetic heritability from 23.0 to 38.5%. A comprehensive fine-mapping analysis was conducted, and 19 causal variants and 14 causal genes were identified. Specifically, manual checking of epigenomic information from the Epimap database revealed that the causal variants were mainly located within the immune-relevant or immune-specific regulatory elements. Furthermore, by using gene-set, tissue, and cell-type enrichment analyses, we highlighted the key roles of immune-related tissues and cells and implicated the PD-1 signaling pathways in the pathogenetic mechanism of leprosy. Collectively, our study identified candidate causal variants and elucidated the potential regulatory and coding mechanisms for genes associated with leprosy.
Collapse
Affiliation(s)
- Zhenzhen Wang
- Department of BiostatisticsSchool of Public HealthCheeloo College of MedicineShandong UniversityJinanShandongChina
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Tingting Liu
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Wenchao Li
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Gongqi Yu
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Zihao Mi
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Chuan Wang
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Xiaojie Liao
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Pengcheng Huai
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Tongsheng Chu
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Dianchang Liu
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Lele Sun
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Xi'an Fu
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Yonghu Sun
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Honglei Wang
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Na Wang
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Jianjun Liu
- Department of Human Genetics, Genome Institute of SingaporeSingaporeSingapore
| | - Hong Liu
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| | - Furen Zhang
- Shandong Provincial Key Lab for Dermatovenereology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical SciencesJinanShandongChina
| |
Collapse
|
106
|
Sheng JD, Liu J, Du JW, Wang YP. Withaferin A alleviates inflammation and joint injury in arthritic rats via elevating microRNA-1297 to target karyopherin alpha2. J Physiol Pharmacol 2023; 74. [PMID: 38345447 DOI: 10.26402/jpp.2023.6.08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/11/2023] [Accepted: 12/31/2023] [Indexed: 02/15/2024]
Abstract
Withaferin A (WFA) is a natural compound separated from the medicinal plant Withania somnifera. As reported, it has the potential to safely cure rheumatoid arthritis (RA) in animal models. Nevertheless, the action mechanism of WFA in treating RA has not been completely illuminated. The study was to explore the action and mechanism of WFA on arthritic rats. First, a collagen-induced arthritis rat model was established. WFA administration alleviated inflammation and injury in arthritic rats. Subsequently, fibroblast synovial cells (FLS) of arthritic rats were separated and cell proliferation and apoptosis abilities were tested. It was found that WFA was available to repress FLS cell proliferation and accelerate apoptosis. MicroRNA-1297 was downregulated in RA patients. Clinical correlation analysis suggested that miR-1297 in the serum of RA patients was negatively associated with pro-inflammatory factors interleukin (IL)-6, IL-17, tumor necrosis factor (TNF)-α, and RA diagnostic indexes (RF, DAS28). In the meantime, miR-1297 had superior diagnostic value in differentiating RA patients from healthy people. Karyopherin α2 (KPNA2) was the downstream target of miR-1297, while miR-1297 negatively modulated KPNA2 expression. Importantly, WFA further restrained KPNA2 expression via elevating miR-1297 in functional rescue experiments, thereby treating inflammation and injury in arthritic rats and repressing FLS cell proliferation and activation. In short, WFA alleviated inflammation and joint damage in arthritic rats via elevating miR-1297 to target KPNA2.
Collapse
Affiliation(s)
- J D Sheng
- Department of Orthopedics, Tianshui First People's Hospital, Tianshui City, Gansu Province, China
| | - J Liu
- Department of Orthopedics, Tianshui First People's Hospital, Tianshui City, Gansu Province, China
| | - J W Du
- Department of Anesthesiology, Tianshui First People's Hospital, Tianshui City, Gansu Province, China
| | - Y P Wang
- Department of Orthopedics, The First Affiliated Hospital of Lanzhou University, Lanzhou City, Gansu Province, China.
| |
Collapse
|
107
|
Lai JL, Liu SP, Jiang XX, Liu J, Li A, Li B, Li XK, Ye XJ, Lei KJ, Zhou L. Can Optical Surface Imaging Replace Non-coplanar Cone-beam Computed Tomography for Non-coplanar Set-up Verification in Single-isocentre Non-coplanar Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Single and Multiple Brain Metastases? Clin Oncol (R Coll Radiol) 2023; 35:e657-e665. [PMID: 37778972 DOI: 10.1016/j.clon.2023.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 08/03/2023] [Accepted: 09/18/2023] [Indexed: 10/03/2023]
Abstract
AIMS To conduct a direct comparison regarding the non-coplanar positioning accuracy between the optical surface imaging system Catalyst HDTM and non-coplanar cone-beam computed tomography (NC-CBCT) in intracranial single-isocentre non-coplanar stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HSRT). MATERIALS AND METHODS Twenty patients with between one and five brain metastases who underwent single-isocentre non-coplanar volumetric modulated arc therapy (NC-VMAT) SRS or HSRT were enrolled in this study. For each non-zero couch angle, both Catalyst HDTM and NC-CBCT were used for set-up verification prior to beam delivery. The set-up error reported by Catalyst HDTM was compared with the set-up error derived from NC-CBCT, which was defined as the gold standard. Additionally, the dose delivery accuracy of each non-coplanar field after using Catalyst HDTM and NC-CBCT for set-up correction was measured with SRS MapCHECKTM. RESULTS The median set-up error differences (absolute values) between the two positioning methods were 0.30 mm, 0.40 mm, 0.50 mm, 0.15°, 0.10° and 0.10° in the vertical, longitudinal, lateral, yaw, pitch and roll directions, respectively. The largest absolute set-up error differences regarding translation and rotation were 1.5 mm and 1.1°, which occurred in the longitudinal and yaw directions, respectively. Only 35.71% of the pairs of measurements were within the tolerance of 0.5 mm and 0.5° simultaneously. In addition, the non-coplanar field with NC-CBCT correction yielded a higher gamma passing rate than that with Catalyst HDTM correction (P < 0.05), especially for evaluation criteria of 1%/1 mm with a median increase of 12.8%. CONCLUSIONS Catalyst HDTM may not replace NC-CBCT for non-coplanar set-up corrections in single-isocentre NC-VMAT SRS and HSRT for single and multiple brain metastases. The potential role of Catalyst HDTM in intracranial SRS/HSRT needs to be further studied in the future.
Collapse
Affiliation(s)
- J L Lai
- Radiotherapy Physics & Technology Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - S P Liu
- Radiotherapy Physics & Technology Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - X X Jiang
- Radiotherapy Physics & Technology Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - J Liu
- Department of Oncology, Chengdu First People's Hospital, Chengdu, Sichuan, China
| | - A Li
- Radiotherapy Physics & Technology Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - B Li
- Radiotherapy Physics & Technology Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - X K Li
- West China Clinical Medical College of Sichuan University, Chengdu, Sichuan, China
| | - X J Ye
- Department of Oncology, Yibin Second People's Hospital, Yibin, Sichuan, China
| | - K J Lei
- Department of Oncology, Yibin Second People's Hospital, Yibin, Sichuan, China
| | - L Zhou
- Thoracic Oncology Ward, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
| |
Collapse
|
108
|
An P, Awe C, Barbeau PS, Becker B, Belov V, Bernardi I, Bock C, Bolozdynya A, Bouabid R, Brown A, Browning J, Cabrera-Palmer B, Cervantes M, Conley E, Daughhetee J, Detwiler J, Ding K, Durand MR, Efremenko Y, Elliott SR, Fabris L, Febbraro M, Gallo Rosso A, Galindo-Uribarri A, Germer AC, Green MP, Hakenmüller J, Heath MR, Hedges S, Hughes M, Johnson BA, Johnson T, Khromov A, Konovalov A, Kozlova E, Kumpan A, Kyzylova O, Li L, Link JM, Liu J, Mahoney M, Major A, Mann K, Markoff DM, Mastroberti J, Mattingly J, Mueller PE, Newby J, Parno DS, Penttila SI, Pershey D, Prior CG, Rapp R, Ray H, Raybern J, Razuvaeva O, Reyna D, Rich GC, Ross J, Rudik D, Runge J, Salvat DJ, Sander J, Scholberg K, Shakirov A, Simakov G, Sinev G, Skuse C, Snow WM, Sosnovtsev V, Subedi T, Suh B, Tayloe R, Tellez-Giron-Flores K, Tsai YT, Ujah E, Vanderwerp J, van Nieuwenhuizen EE, Varner RL, Virtue CJ, Visser G, Walkup K, Ward EM, Wongjirad T, Yoo J, Yu CH, Zawada A, Zettlemoyer J, Zderic A. Measurement of Electron-Neutrino Charged-Current Cross Sections on ^{127}I with the COHERENT NaIνE Detector. Phys Rev Lett 2023; 131:221801. [PMID: 38101357 DOI: 10.1103/physrevlett.131.221801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Revised: 10/02/2023] [Accepted: 11/08/2023] [Indexed: 12/17/2023]
Abstract
Using an 185-kg NaI[Tl] array, COHERENT has measured the inclusive electron-neutrino charged-current cross section on ^{127}I with pion decay-at-rest neutrinos produced by the Spallation Neutron Source at Oak Ridge National Laboratory. Iodine is one the heaviest targets for which low-energy (≤50 MeV) inelastic neutrino-nucleus processes have been measured, and this is the first measurement of its inclusive cross section. After a five-year detector exposure, COHERENT reports a flux-averaged cross section for electron neutrinos of 9.2_{-1.8}^{+2.1}×10^{-40} cm^{2}. This corresponds to a value that is ∼41% lower than predicted using the MARLEY event generator with a measured Gamow-Teller strength distribution. In addition, the observed visible spectrum from charged-current scattering on ^{127}I has been measured between 10 and 55 MeV, and the exclusive zero-neutron and one-or-more-neutron emission cross sections are measured to be 5.2_{-3.1}^{+3.4}×10^{-40} and 2.2_{-0.5}^{+0.4}×10^{-40} cm^{2}, respectively.
Collapse
Affiliation(s)
- P An
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C Awe
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - P S Barbeau
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - B Becker
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - V Belov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
- National Research Center "Kurchatov Institute," Moscow, 123182, Russian Federation
| | - I Bernardi
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - C Bock
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - A Bolozdynya
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - R Bouabid
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - A Brown
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Mathematics and Physics, North Carolina Central University, Durham, North Carolina 27707, USA
| | - J Browning
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | | | - M Cervantes
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - E Conley
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - J Daughhetee
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - J Detwiler
- Center for Experimental Nuclear Physics and Astrophysics and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - K Ding
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - M R Durand
- Center for Experimental Nuclear Physics and Astrophysics and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - Y Efremenko
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - S R Elliott
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - L Fabris
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - M Febbraro
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - A Gallo Rosso
- Department of Physics, Laurentian University, Sudbury, Ontario P3E 2C6, Canada
| | - A Galindo-Uribarri
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - A C Germer
- Department of Physics, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - M P Green
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - J Hakenmüller
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - M R Heath
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - S Hedges
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - M Hughes
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - B A Johnson
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - T Johnson
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - A Khromov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - A Konovalov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - E Kozlova
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - A Kumpan
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - O Kyzylova
- Center for Neutrino Physics, Virginia Tech, Blacksburg, Virginia 24061, USA
| | - L Li
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - J M Link
- Center for Neutrino Physics, Virginia Tech, Blacksburg, Virginia 24061, USA
| | - J Liu
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - M Mahoney
- Department of Physics, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - A Major
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - K Mann
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - D M Markoff
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Mathematics and Physics, North Carolina Central University, Durham, North Carolina 27707, USA
| | - J Mastroberti
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - J Mattingly
- Department of Nuclear Engineering, North Carolina State University, Raleigh, North Carolina 27695, USA
| | - P E Mueller
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - J Newby
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - D S Parno
- Department of Physics, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - S I Penttila
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - D Pershey
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - C G Prior
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R Rapp
- Washington & Jefferson College, Washington, Pennsylvania 15301, USA
| | - H Ray
- Department of Physics, University of Florida, Gainesville, Florida 32611, USA
| | - J Raybern
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - O Razuvaeva
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
- National Research Center "Kurchatov Institute," Moscow, 123182, Russian Federation
| | - D Reyna
- Sandia National Laboratories, Livermore, California 94550, USA
| | - G C Rich
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - J Ross
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Mathematics and Physics, North Carolina Central University, Durham, North Carolina 27707, USA
| | - D Rudik
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - J Runge
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - D J Salvat
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - J Sander
- Department of Physics, University of South Dakota, Vermillion, South Dakota 57069, USA
| | - K Scholberg
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - A Shakirov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - G Simakov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
- National Research Center "Kurchatov Institute," Moscow, 123182, Russian Federation
| | - G Sinev
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
| | - C Skuse
- Department of Physics, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - W M Snow
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - V Sosnovtsev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow 115409, Russian Federation
| | - T Subedi
- Center for Neutrino Physics, Virginia Tech, Blacksburg, Virginia 24061, USA
- Department of Physical and Environmental Sciences, Concord University, Athens, West Virginia 24712, USA
| | - B Suh
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - R Tayloe
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | | | - Y-T Tsai
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - E Ujah
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
- Department of Mathematics and Physics, North Carolina Central University, Durham, North Carolina 27707, USA
| | - J Vanderwerp
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - E E van Nieuwenhuizen
- Department of Physics, Duke University, Durham, North Carolina 27708, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - R L Varner
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - C J Virtue
- Department of Physics, Laurentian University, Sudbury, Ontario P3E 2C6, Canada
| | - G Visser
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - K Walkup
- Center for Neutrino Physics, Virginia Tech, Blacksburg, Virginia 24061, USA
| | - E M Ward
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - T Wongjirad
- Department of Physics and Astronomy, Tufts University, Medford, Massachusetts 02155, USA
| | - J Yoo
- Department of Physics and Astronomy, Seoul National University, Seoul, 08826, Korea
| | - C-H Yu
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - A Zawada
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - J Zettlemoyer
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
| | - A Zderic
- Center for Experimental Nuclear Physics and Astrophysics and Department of Physics, University of Washington, Seattle, Washington 98195, USA
| |
Collapse
|
109
|
Ren F, Miao J, Liu J, Xia B, Chen Z, Xu Y, Zhang R, Fan J, Lin W. Willingness to receive and recommend hypothetical mpox vaccination and associated factors in Chinese adults: a community-based survey in Shenzhen, China. Public Health 2023; 225:267-276. [PMID: 37952343 DOI: 10.1016/j.puhe.2023.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2023] [Revised: 08/02/2023] [Accepted: 10/09/2023] [Indexed: 11/14/2023]
Abstract
OBJECTIVES China may face new threats to public health due to the increased risk of imported mpox (monkeypox) cases. However, research gaps exist in the acceptance of mpox vaccination and potential associated factors in the Chinese population. STUDY DESIGN We conducted a cross-sectional study targeting community residents in Shenzhen, China, from August 5 to September 7 2022. METHODS A self-administered questionnaire was used to collect information about demographic and health characteristics, mpox-related perceptions, and attitudes towards mpox vaccination. Multivariable logistic regression models were applied to detect the factors associated with willingness to receive and recommend mpox vaccination. RESULTS A total of 2293 community residents were included in the analyses (average age: 34.03, female: 72.6%). Among the participants, 76.9% were aware of mpox, 62.1% were aware of the global mpox outbreak, but only 53.6% had a high knowledge level of mpox. Males had a higher proportion of high knowledge (56.9% vs 52.3%, P<0.05) and a lower proportion of high worry (30.2% vs 45.4%, P<0.05) than females. Approximately 69.1% of the participants were willing to vaccinate against mpox, and 69.6% were willing to recommend mpox vaccination to people around them, in which no gender difference was found. The obstacle reported most among people hesitant to receive vaccination was concerning the safety and side-effects, whereas it changed to be concerning the suitability due to individual health differences among people hesitant to recommend mpox vaccines. Factors associated with the willingness to receive and recommend mpox vaccination included having a history of influenza vaccination, having a history of COVID-19 vaccination, being aware of the global mpox outbreak, having a high knowledge level of mpox, and having a high level of mpox-related worry. CONCLUSIONS This study identified a moderate willingness to receive and recommend mpox vaccination among Chinese adults. Without gender differences, willingness to receive and recommend mpox vaccination was significantly associated with mpox-related perceptions, such as awareness, knowledge, and worry. Authoritative and up-to-date information is needed to help the general population improve public confidence in mpox vaccines in China.
Collapse
Affiliation(s)
- F Ren
- Gushu Community Health Service Center, Baoan Central Hospital of Shenzhen, Shenzhen 518102, China
| | - J Miao
- Gushu Community Health Service Center, Baoan Central Hospital of Shenzhen, Shenzhen 518102, China
| | - J Liu
- Haicheng Community Health Service Center, Baoan Central Hospital of Shenzhen, Shenzhen 518102, China
| | - B Xia
- Gushu Community Health Service Center, Baoan Central Hospital of Shenzhen, Shenzhen 518102, China
| | - Z Chen
- Gushu Community Health Service Center, Baoan Central Hospital of Shenzhen, Shenzhen 518102, China
| | - Y Xu
- Emergency Office, Futian District Center for Disease Control and Prevention, Shenzhen 518040, China
| | - R Zhang
- Department of Programme Immunization, Futian District Center for Disease Control and Prevention, Shenzhen 518040, China
| | - J Fan
- Department of Preventive Healthcare, Affiliated Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen 518028, China.
| | - W Lin
- Department of Healthcare, Affiliated Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen 518048, China.
| |
Collapse
|
110
|
Huang Y, Jiang L, Liu J, Xu Y, Mo F, Su J, Tao R. Investigating a Causal Relationship Between Diabetes Mellitus and Oropharyngeal Cancer: A Mendelian Randomization Study. Community Dent Health 2023; 40:212-220. [PMID: 37988677 DOI: 10.1922/cdh_00025huang09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 05/01/2023] [Indexed: 11/23/2023]
Abstract
OBJECTIVE Previous observational studies reported an association of diabetes mellitus (DM) with oropharyngeal cancer (OPC), however, the potential causality of the association between them remains unclear. METHODS To explore this causal relationship in individuals of European descent, a two-sample Mendelian randomization (MR) study was conducted. A genome-wide association study (GWAS) of DM was used to represent the exposure factor (T1DM: n = 24,840; T2DM: n = 215,654), and GWAS of OPC represented the outcome (n = 3,448). RESULTS Forty-one single nucleotide polymorphisms (SNPs) related to T1DM and fifty-four SNPs related to T2DM were identified as effective instrumental variables (IVs) in the two-sample MR analyses. In IVW estimates, neither T1DM nor T2DM significantly contributed to an increased risk of OPC [T1DM: OR 1.0322 (95% CI 0.9718, 1.0963), P = 0.3033; T2DM: OR 0.9998 (95% CI 0.9995, 1.0002), P = 0.2858]. Four other regression models produced similar results. MR-Egger regression results [Cochran's Q statistic was 47.1544 (P = 0.1466) in T1DM, and 35.5084 (P = 0.9512) in T2DM] suggested no horizontal pleiotropy between IVs and outcomes. CONCLUSION Our findings suggest little evidence to support the genetic role of diabetes mellitus in OPC development in the European population.
Collapse
Affiliation(s)
- Y Huang
- Department of Periodontics and Oral medicine, College of Stomatology, Guangxi Medical University, China
| | - L Jiang
- Department of Periodontics and Oral medicine, College of Stomatology, Guangxi Medical University, China
| | - J Liu
- Department of Periodontics and Oral medicine, College of Stomatology, Guangxi Medical University, China
| | - Y Xu
- Department of Periodontics and Oral medicine, College of Stomatology, Guangxi Medical University, China
| | - F Mo
- Department of Periodontics and Oral medicine, College of Stomatology, Guangxi Medical University, China
| | - J Su
- Department of Periodontics and Oral medicine, College of Stomatology, Guangxi Medical University, China
| | - R Tao
- Department of Periodontics and Oral medicine, College of Stomatology, Guangxi Medical University, China
| |
Collapse
|
111
|
Chen B, Tan L, Chen D, Wang X, Liu J, Huang X, Wang Y, Huang S, Mao F, Lian J. KCNH2A561V Heterozygous Mutation Inhibits KCNH2 Protein Expression via The Activation of UPR Mediated by ATF6. Physiol Res 2023; 72:621-631. [PMID: 38015761 PMCID: PMC10751050 DOI: 10.33549/physiolres.935095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Accepted: 05/26/2023] [Indexed: 01/05/2024] Open
Abstract
The potassium channel protein KCNH2 is encoded by KCNH2 gene, and there are more than 300 mutations of KCNH2. Unfolded protein response (UPR) is typically initiated in response to an accumulation of unfolded and/or misfolded proteins in the endoplasmic reticulum (ER). The present study aimed to explore the UPR process and the role of activating transcription factor 6 (ATF6) in the abnormal expression of potassium voltage-gated channel subfamily H member 2 (KCNH2)A561V. The wild-type (wt) KCNH2 and A561V mutant KCNH2 was constructed with his-tag. The 293 cells were used and divided into KCNH2wt+KCNH2A561V, KCNH2wt and KCNH2A561V groups. The expression levels of ATF6 and KCNH2 in different groups were detected by Western blotting, reverse transcription-quantitative PCR, immunofluorescence and immuno-coprecipitation assays. The protein types and abundance of immuno-coprecipitation samples were analyzed by mass spectrometry. The proteomic analysis of the mass spectrometry results was carried out by using the reactome database and GO (Gene Ontology) tool. The mRNA expression levels of KCNH2 and ATF6 in the KCNH2wt+KCNH2A561V group were higher compared with the KCNH2A561V group. However, the full-length protein expression of ATF6 was inhibited, indicating that ATF6 was highly activated and a substantial number of ATF6 was sheared in KCNH2wt+KCNH2A561V group compared with control group. Furthermore, A561V-KCNH2 mutation leading to the accumulation of the immature form of KCNH2 (135 kDa bands) in ER, resulting in the reduction of the ratio of 155 kDa/135 kDa. In addition, the abundance of UPR-related proteins in the KCNH2A561V group was higher compared with the KCNH2wt+KCNH2A561V group. The 'cysteine biosynthetic activity' of GO:0019344 process and the 'positive regulation of cytoplasmic translation activity' of GO:2000767 process in the KCNH2A561V group were higher compared with the KCNH2wt+KCNH2A561V group. Hence, co-expression of wild-type and A561V mutant KCNH2 in 293 cells activated the UPR process, which led to the inhibition of protein translation and synthesis, in turn inhibiting the expression of KCNH2. These results provided a theoretical basis for clinical treatment of Long QT syndrome.
Collapse
Affiliation(s)
- B Chen
- Emergency Medical Center, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China; Department of General Surgery, Ningbo No.2 Hospital, Ningbo, China. ; Department of Cardiology, Ningbo Medical Center LiHuiLi Hospital, Ningbo, China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
112
|
Duan X, Wang L, Wei W, Wang Z, Zhang X, Liu J, Ding D. Chronic kidney disease and functional impairment in a longitudinal study of older adults in China. BMJ Open 2023; 13:e074819. [PMID: 38011971 PMCID: PMC10685976 DOI: 10.1136/bmjopen-2023-074819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 08/07/2023] [Indexed: 11/29/2023] Open
Abstract
OBJECTIVES To examine the associations of chronic kidney disease (CKD) with dynamic functional impairment among older Chinese adults. DESIGN This was a prospective longitudinal study. SETTING Data were derived from the Chinese Longitudinal Healthy Longevity Study. PARTICIPANTS All adults aged ≥60 years were potentially eligible. This study included 2970 participants. PRIMARY OUTCOME MEASURES CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2. Functional performances included instrumental activities of daily living (IADL) and basic activities of daily living (BADL), which were measured using six daily activities, including eating, dressing, transferring, using the toilet, bathing and continence, and eight daily activities, including visiting neighbours, shopping, cooking, washing clothes, walking 1 km, lifting 5 kg, crouching and standing up three times and taking public transportation, respectively. RESULTS This study included 2970 participants, including 988 (33.60%) participants with CKD. Participants with CKD had higher IADL scores than those without CKD (β=0.895, 95% CI: 0.761 to 1.029). Furthermore, there was a significant linear trend in the association of CKD severity with the IADL score (p<0.001). Similarly, CKD was significantly associated with higher BADL scores (β=0.067, 95% CI: 0.017 to 0.118). However, only participants with moderate and advanced CKD had a higher BADL score (β=0.088 and 0.152, 95% CI: 0.006 to 0.171 and 0.019 to 0.286, respectively). CONCLUSIONS CKD was associated with worse functional impairment. Furthermore, there was a significant linear trend in the association of the severity of CKD with the IADL score. However, only participants with moderate and advanced CKD had higher BADL scores.
Collapse
Affiliation(s)
- Xiaoyu Duan
- Department of Urology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Lingdian Wang
- Department of Urology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Wei Wei
- Department of Urology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Zhifeng Wang
- Department of Urology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Xiaoli Zhang
- Department of Urology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Jianjun Liu
- Department of Urology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Degang Ding
- Department of Urology, Henan Provincial People's Hospital, Zhengzhou, China
| |
Collapse
|
113
|
Yan YJ, Zhang ZX, Wang X, Lu L, Zhao ZC, Li C, Liu J, Li WD, Liu T, Fu WH. [Short-term outcomes after robotic proximal gastrectomy with double-tract reconstruction]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:1071-1074. [PMID: 37974353 DOI: 10.3760/cma.j.cn441530-20230511-00164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
|
114
|
Zhao D, Liu J, Wu ZS. [Research of epidemiology of cardiovascular disease in China: 50 years' developments and achievements]. Zhonghua Xin Xue Guan Bing Za Zhi 2023; 51:1111-1117. [PMID: 37963742 DOI: 10.3760/cma.j.cn112148-20230720-00011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/16/2023]
Affiliation(s)
- D Zhao
- Center of Clinical and Epidemiology Researches, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
| | - J Liu
- Center of Clinical and Epidemiology Researches, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
| | - Z S Wu
- Center of Clinical and Epidemiology Researches, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
| |
Collapse
|
115
|
Zhou Y, Wang Y, Zhang Z, Yin X, Liu J, Zheng W. Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study. J Clin Endocrinol Metab 2023; 108:3330-3337. [PMID: 37267432 DOI: 10.1210/clinem/dgad314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Revised: 05/29/2023] [Accepted: 05/30/2023] [Indexed: 06/04/2023]
Abstract
PURPOSE To study whether male sex is a risk factor for prognosis in patients with differentiated thyroid cancer after 131I treatment using the propensity score matching (PSM) method. METHODS From April 2016 to October 2021, 1948 postoperative differentiated thyroid cancer patients aged 43 (interquartile range: 34, 54) years who received 131I treatment were retrospectively enrolled and divided into male (n = 645) and female groups (n = 1303). The PSM method was adopted to process all data to reduce the influence of data bias and confounding variables. The Mann-Whitney U test and χ2 test were used for data analysis. Multivariate logistic regression was used to analyze the risk factors affecting prognosis, and the receiver operating characteristic curve was used to analyze the relationship between stimulated thyroglobulin (sTg) level, 131I dose, and poor prognosis. RESULTS Before PSM, the proportion of male patients with poor prognosis was significantly higher than that of female patients. After PSM, there was no difference in the proportion of poor prognosis between male and female groups. Multivariate logistic regression analysis showed that male sex; high T stage, N1b stage, and M1 stage; high sTg level; and high 131I dose were risk factors for poor prognosis before PSM. After PSM, high T stage, M1 stage, high sTg level, and 131I dose were still risk factors but male sex was no longer a risk factor for poor prognosis. CONCLUSIONS After the reduction of selection bias by PSM, male sex was no longer a risk factor for prognosis after 131I treatment of differentiated thyroid cancer. In addition, high T stage (T3 + T4 stage), M1 stage, sTg ≥10.15 ng/mL, and 131I dose ≥260 mCi were risk factors for poor prognosis.
Collapse
Affiliation(s)
- Yaqian Zhou
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300041, China
- Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China
| | - Yan Wang
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300041, China
| | - Zhiting Zhang
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300041, China
| | - Xue Yin
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300041, China
| | - Jianjun Liu
- Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China
| | - Wei Zheng
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300041, China
| |
Collapse
|
116
|
Yan S, Tu CY, Du CY, Luo J, Liu JF, Liu TQ, Liu Q, Liu J, Li XH, Wang LC, Fang ZP, Yi WM, Chen YJ, Li QL, Ni Y, Wu JC, Qin CJ, Gu YL, Lu Z, Lun ZJ, Du LX, Chen G, Zheng QC, Sun KJ, Han WQ, Yu J. [Effect of recombinant human thrombin for hemostasis in liver resection: a randomized controlled phase Ⅲ clinical trial]. Zhonghua Yi Xue Za Zhi 2023; 103:3416-3423. [PMID: 37963740 DOI: 10.3760/cma.j.cn112137-20230911-00438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/16/2023]
Abstract
Objective: To evaluate the hemostatic efficacy, safety and immunogenicity of recombinant human thrombin in the treatment of liver wounds that still ooze after conventional surgical hemostasis. Methods: A multicenter, stratified randomized, double-blind, placebo-controlled phase Ⅲ trial with a planned enrollment of 510 subjects at 33 centers, with a 2∶1 randomization to the thrombin group versus the placebo group. An interim analysis will be conducted after approximately 70% of the subjects have completed the observation period. The primary efficacy endpoint was the rate of hemostasis within 6 minutes at the point of bleeding that could be evaluated. Safety analysis was performed one month after surgery, and the positive rates of anti-drug antibody (ADA) and neutralizing antibody were evaluated. Results: At the interim analysis, a total of 348 subjects had been randomized and received the study drug (215 were male and 133 were female). They were aged 19-69 (52.9±10.9)years. Among them, 232 were in the thrombin group and 116 were in the placebo group, with balanced and comparable demographics and baseline characteristics between the two groups. The hemostasis rate at 6 minutes was 71.6% (95%CI:65.75%-77.36%) in the thrombin group and 44.0% (95%CI: 34.93%-53.00%) in the placebo group, respectively (P<0.001). No grade≥3 drug-related adverse events and no drug-related deaths were reported from the study.No recombinant human thrombin-induced immunologically-enhanced ADA or immunologically-induced ADA was detected after topical use in subjects. Conclusion: Recombinant human thrombin has shown significant hemostatic efficacy and good safety in controlling bleeding during liver resection surgery, while also demonstrating low immunogenicity characteristics.
Collapse
Affiliation(s)
- S Yan
- Department of Hepatobiliary and Pancreatic Surgery, the Second Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
| | - C Y Tu
- Department of General Surgery, Lishui Central Hospital, Lishui 323020, China
| | - C Y Du
- Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China
| | - J Luo
- Department of Hepatobiliary and Intestinal Surgery, Hunan Cancer Hospital, Changsha 410031, China
| | - J F Liu
- Department of Hepatobiliary and Pancreatic Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China
| | - T Q Liu
- Department of General Surgery, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
| | - Q Liu
- Department of Hepatobiliary Surgery, Liuzhou People's Hospital, Liuzhou 545006, China
| | - J Liu
- Department of Hepatobiliary Surgery, Guizhou Provicial People's Hospital, Guiyang 550002, China
| | - X H Li
- Department of Hepatobiliary Surgery, Liaocheng People's Hospital, Liaocheng 252000, China
| | - L C Wang
- Department of General Surgery, the Third People's Hospital of Hainan Province, Sanya 572000, China
| | - Z P Fang
- Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Linhai 317099, China
| | - W M Yi
- Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
| | - Y J Chen
- Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China
| | - Q L Li
- Department of Hepatobiliary and Pancreatic Surgery, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - Y Ni
- Department of Hepatobiliary and Pancreatic Surgery, Shenzhen Second People's Hospital, Shenzhen 518035, China
| | - J C Wu
- Department of Hepatobiliary Surgery, Hainan Provincial People's Hospital, Haikou 570311, China
| | - C J Qin
- Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng 475000, China
| | - Y L Gu
- Department of Hepatobiliary Surgery, Affiliated Hospital of Jiangnan Univeisity, Wuxi 214122, China
| | - Z Lu
- Department of Hepatobiliary Surgery, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - Z J Lun
- Department of Hepatobiliary Vascular Surgery, Zaozhuang Municipal Hospital, Zaozhuang 277101, China
| | - L X Du
- Department of Hepatobiliary Surgery, Shanxi Provincial People's Hospital, Xi'an 710068, China
| | - G Chen
- Department of Hepatobiliary and Pancreatic Surgery, the First People's Hospital of Kunming, Kunming 650034, China
| | - Q C Zheng
- Department of Hepatobiliary Surgery, Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China
| | - K J Sun
- Department of Hepatobiliary Surgery, Zibo Central Hospital, Zibo 255036, China
| | - W Q Han
- Department of Urinary Surgery, Hunan Cancer Hospital, Changsha 410031, China
| | - J Yu
- Department of Hepatobiliary and Pancreatic Surgery, the First Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
| |
Collapse
|
117
|
Lin F, Sun H, Chen Y, Zhang YY, Liu J, He Y, Zheng FM, Xu ZL, Wang FR, Kong J, Wang ZD, Wan YY, Mo XD, Wang Y, Cheng YF, Zhang XH, Huang XJ, Xu LP. [Impact of SARS-CoV-2 infection on graft composition and early transplant outcomes following allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:890-899. [PMID: 38185517 PMCID: PMC10753252 DOI: 10.3760/cma.j.issn.0253-2727.2023.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Indexed: 01/09/2024]
Abstract
Objective: To assess the feasibility of using donors with novel coronavirus disease 2019 (COVID-19) for allogeneic hematopoietic stem cell transplantation (allo-HSCT) when there are no other available donors and allo-HSCT cannot be delayed or discontinued. Methods: Seventy-one patients with malignant hematological diseases undergoing allo-HSCT between December 8, 2022, and January 10, 2023, were included. Of these, 16 received grafts from donors with mild COVID-19 (D-COVID(+) group) and 55 received grafts from donors without COVID-19 (D-COVID(-) group). The graft compositions were compared between the two groups. Engraftment, acute graft-versus-host disease (aGVHD), overall survival (OS), and relapse were also evaluated. Results: There were no serious side effects or adverse events in the D-COVID(+) group. The mononuclear cell dose and CD34(+) cell dose were comparable between the two groups, and no additional apheresis was required. There were no significant differences in the lymphocyte, monocyte, and T-cell subset doses between the two groups. The median natural killer cell dose in the D-COVID(+) group was significantly higher than that in the D-COVID(-) group (0.69×10(8)/kg vs. 0.53×10(8)/kg, P=0.031). The median follow-up time was 72 (33-104) days. All patients achieved primary engraftment. The 60-day platelet engraftment rates in the D-COVID(+) and D-COVID(-) groups were 100% and (96.4±0.2) %, respectively (P=0.568). There were no significant differences in neutrophil (P=0.309) and platelet (P=0.544) engraftment times. The cumulative incidence of grade 2-4 aGVHD was (37.5±1.6) % vs. (16.4±0.3) % (P=0.062), and of grade 3-4 aGVHD was 25.0% ±1.3% vs. 9.1% ±0.2% (P=0.095) in the D-COVID(+) and D-COVID(-) groups, respectively. The probabilities of 60-day OS were 100% and 98.1% ±1.8% (P=0.522) in the D-COVID(+) and D-COVID(-) groups, respectively. There was no relapse of primary disease during the study period. Conclusion: When allo-HSCT cannot be delayed or discontinued and no other donor is available, a donor with mild COVID-19 should be considered if tolerable. Larger sample sizes and longer follow-up periods are required to validate these results.
Collapse
Affiliation(s)
- F Lin
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - H Sun
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Y Chen
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Y Y Zhang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - J Liu
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Y He
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - F M Zheng
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Z L Xu
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - F R Wang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - J Kong
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Z D Wang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Y Y Wan
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - X D Mo
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Y Wang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - Y F Cheng
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - X H Zhang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - X J Huang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| | - L P Xu
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing 100044, China
| |
Collapse
|
118
|
Zhang MZ, Zhang RY, Liu J, Wang W. [Advances in the role of autoimmune mechanisms in chronic obstructive pulmonary disease]. Zhonghua Jie He He Hu Xi Za Zhi 2023; 46:1131-1136. [PMID: 37914427 DOI: 10.3760/cma.j.cn112147-20230731-00037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/03/2023]
Abstract
Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease whose pathogenesis mainly involves airway remodelling and alveolar destruction caused by inflammation, protease-antiprotease imbalance, oxidative stress, and imbalance between apoptosis and compensatory repair of lung tissue structure cells. In recent years, the role of the autoimmune response in COPD has attracted widespread attention, but there is still some controversy. This article reviewed the role of autoimmunity in COPD from different perspectives, starting with the relationship between autoimmunity and the pathogenesis of COPD.
Collapse
Affiliation(s)
- M Z Zhang
- Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
| | - R Y Zhang
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China; National Center for Respiratory Medicine, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China
| | - J Liu
- Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
| | - W Wang
- Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
| |
Collapse
|
119
|
Guirette M, Lan J, McKeown N, Brown MR, Chen H, DE Vries PS, Kim H, Rebholz CM, Morrison AC, Bartz TM, Fretts AM, Guo X, Lemaitre RN, Liu CT, Noordam R, DE Mutsert R, Rosendaal FR, Wang CA, Beilin L, Mori TA, Oddy WH, Pennell CE, Chai JF, Whitton C, VAN Dam RM, Liu J, Tai ES, Sim X, Neuhouser ML, Kooperberg C, Tinker L, Franceschini N, Huan T, Winkler TW, Bentley AR, Gauderman WJ, Heerkens L, Tanaka T, van Rooij J, Munroe PB, Warren HR, Voortman T, Chen H, Rao DC, Levy D, Ma J. Genome-Wide Interaction Analysis with DASH Diet Score Identified Novel Loci for Systolic Blood Pressure. medRxiv 2023:2023.11.10.23298402. [PMID: 37986948 PMCID: PMC10659476 DOI: 10.1101/2023.11.10.23298402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2023]
Abstract
Objective We examined interactions between genotype and a Dietary Approaches to Stop Hypertension (DASH) diet score in relation to systolic blood pressure (SBP). Methods We analyzed up to 9,420,585 biallelic imputed single nucleotide polymorphisms (SNPs) in up to 127,282 individuals of six population groups (91% of European population) from the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (CHARGE; n=35,660) and UK Biobank (n=91,622) and performed European population-specific and cross-population meta-analyses. Results We identified three loci in European-specific analyses and an additional four loci in cross-population analyses at P for interaction < 5e-8. We observed a consistent interaction between rs117878928 at 15q25.1 (minor allele frequency = 0.03) and the DASH diet score (P for interaction = 4e-8; P for heterogeneity = 0.35) in European population, where the interaction effect size was 0.42±0.09 mm Hg (P for interaction = 9.4e-7) and 0.20±0.06 mm Hg (P for interaction = 0.001) in CHARGE and the UK Biobank, respectively. The 1 Mb region surrounding rs117878928 was enriched with cis-expression quantitative trait loci (eQTL) variants (P = 4e-273) and cis-DNA methylation quantitative trait loci (mQTL) variants (P = 1e-300). While the closest gene for rs117878928 is MTHFS, the highest narrow sense heritability accounted by SNPs potentially interacting with the DASH diet score in this locus was for gene ST20 at 15q25.1. Conclusion We demonstrated gene-DASH diet score interaction effects on SBP in several loci. Studies with larger diverse populations are needed to validate our findings.
Collapse
Affiliation(s)
- Mélanie Guirette
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA
| | - Jessie Lan
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA
| | - Nicola McKeown
- Programs of Nutrition, Department of Health Sciences, Sargent College of Health & Rehabilitation Sciences, Boston University, Boston, MA, USA
| | - Michael R Brown
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Han Chen
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Paul S DE Vries
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Hyunju Kim
- Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Seattle, WA, USA
| | - Casey M Rebholz
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Alanna C Morrison
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - Traci M Bartz
- Cardiovascular Health Research Unit, Departments of Biostatistics and Medicine, University of Washington, Seattle, WA, USA
| | - Amanda M Fretts
- Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Seattle, WA, USA
| | - Xiuqing Guo
- The Lundquist Institute at Harbor-UCLA, Torrance, CA, USA
| | - Rozenn N Lemaitre
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA
| | - Ching-Ti Liu
- Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Raymond Noordam
- Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands
| | - Renée DE Mutsert
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Frits R Rosendaal
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Carol A Wang
- School of Medicine and Public Health, University of Newcastle, NSW, Australia
- Hunter Medical Research Institute, NSW, Australia
| | - Lawrence Beilin
- Medical School, Royal Perth Hospital Unit, University of Western Australia, Crawley, Western Australia, Australia
| | - Trevor A Mori
- Medical School, Royal Perth Hospital Unit, University of Western Australia, Crawley, Western Australia, Australia
| | - Wendy H Oddy
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia Saw Swee Hock, School of Public Health, National University of Singapore and National University Health System, Singapore
| | - Craig E Pennell
- School of Medicine and Public Health, University of Newcastle, NSW, Australia
- Hunter Medical Research Institute, NSW, Australia
| | - Jin Fang Chai
- School of Population Health, Curtin University, Perth, Western Australia, Australia
| | - Clare Whitton
- School of Population Health, Curtin University, Perth, Western Australia, Australia
- Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore
| | - Rob M VAN Dam
- School of Population Health, Curtin University, Perth, Western Australia, Australia
| | - Jianjun Liu
- Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore
| | - E Shyong Tai
- School of Population Health, Curtin University, Perth, Western Australia, Australia
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Xueling Sim
- School of Population Health, Curtin University, Perth, Western Australia, Australia
| | - Marian L Neuhouser
- Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Charles Kooperberg
- Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Lesley Tinker
- Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Nora Franceschini
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA
| | - Tianxiao Huan
- Framingham Heart Study and Population Sciences Branch, NHLBI, Framingham, MA, USA
| | - Thomas W Winkler
- Department of Genetic Epidemiology, University of Regensburg; Regensburg, Germany
| | - Amy R Bentley
- Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - W James Gauderman
- Division of Biostatistics, Department of Population and Public Health Sciences, University of Southern California; CA, USA
| | - Luc Heerkens
- Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands
| | - Toshiko Tanaka
- Longitudinal Studies Section, National Institute on Aging, Baltimore, MD, USA
| | - Jeroen van Rooij
- Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
| | - Patricia B Munroe
- Centre of Clinical Pharmacology & Precision Medicine, William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - Helen R Warren
- Centre of Clinical Pharmacology & Precision Medicine, William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - Trudy Voortman
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
| | - Honglei Chen
- Department of Epidemiology and Biostatistics College of Human Medicine, Michigan State University, East Lansing, Michigan, USA
| | - D C Rao
- Center for Biostatistics and Data Science, Institute for Informatics, Data Science, and Biostatistics, Washington University School of Medicine, St. Louis, MO, USA
| | - Daniel Levy
- Framingham Heart Study and Population Sciences Branch, NHLBI, Framingham, MA, USA
| | - Jiantao Ma
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA
| |
Collapse
|
120
|
Acharya S, Adamová D, Adler A, Aglieri Rinella G, Agnello M, Agrawal N, Ahammed Z, Ahmad S, Ahn SU, Ahuja I, Akindinov A, Al-Turany M, Aleksandrov D, Alessandro B, Alfanda HM, Alfaro Molina R, Ali B, Ali Y, Alici A, Alizadehvandchali N, Alkin A, Alme J, Alocco G, Alt T, Altsybeev I, Anaam MN, Andrei C, Andronic A, Anguelov V, Antinori F, Antonioli P, Anuj C, Apadula N, Aphecetche L, Appelshäuser H, Arata C, Arcelli S, Aresti M, Arnaldi R, Arsene IC, Arslandok M, Augustinus A, Averbeck R, Azmi MD, Badalà A, Baek YW, Bai X, Bailhache R, Bailung Y, Bala R, Balbino A, Baldisseri A, Balis B, Banerjee D, Banoo Z, Barbera R, Barile F, Barioglio L, Barlou M, Barnaföldi GG, Barnby LS, Barret V, Barreto L, Bartels C, Barth K, Bartsch E, Baruffaldi F, Bastid N, Basu S, Batigne G, Battistini D, Batyunya B, Bauri D, Bazo Alba JL, Bearden IG, Beattie C, Becht P, Behera D, Belikov I, Bell Hechavarria ADC, Bellini F, Bellwied R, Belokurova S, Belyaev V, Bencedi G, Beole S, Bercuci A, Berdnikov Y, Berdnikova A, Bergmann L, Besoiu MG, Betev L, Bhaduri PP, Bhasin A, Bhat MA, Bhattacharjee B, Bianchi L, Bianchi N, Bielčík J, Bielčíková J, Biernat J, Bigot AP, Bilandzic A, Biro G, Biswas S, Bize N, Blair JT, Blau D, Blidaru MB, Bluhme N, Blume C, Boca G, Bock F, Bodova T, Bogdanov A, Boi S, Bok J, Boldizsár L, Bolozdynya A, Bombara M, Bond PM, Bonomi G, Borel H, Borissov A, Bossi H, Botta E, Bouziani YEM, Bratrud L, Braun-Munzinger P, Bregant M, Broz M, Bruno GE, Buckland MD, Budnikov D, Buesching H, Bufalino S, Bugnon O, Buhler P, Buthelezi Z, Butt JB, Bysiak SA, Cai M, Caines H, Caliva A, Calvo Villar E, Camacho JMM, Camerini P, Canedo FDM, Carabas M, Carnesecchi F, Caron R, Castillo Castellanos J, Catalano F, Ceballos Sanchez C, Chakaberia I, Chakraborty P, Chandra S, Chapeland S, Chartier M, Chattopadhyay S, Chattopadhyay S, Chavez TG, Cheng T, Cheshkov C, Cheynis B, Chibante Barroso V, Chinellato DD, Chizzali ES, Cho J, Cho S, Chochula P, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Ciacco M, Cicalo C, Cifarelli L, Cindolo F, Ciupek MR, Clai G, Colamaria F, Colburn JS, Colella D, Colocci M, Concas M, Conesa Balbastre G, Conesa Del Valle Z, Contin G, Contreras JG, Coquet ML, Cormier TM, Cortese P, Cosentino MR, Costa F, Costanza S, Crkovská J, Crochet P, Cruz-Torres R, Cuautle E, Cui P, Cunqueiro L, Dainese A, Danisch MC, Danu A, Das P, Das P, Das S, Dash AR, Dash S, David RMH, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Martin C, De Pasquale S, Deb S, Debski RJ, Deja KR, Del Grande R, Dello Stritto L, Deng W, Dhankher P, Di Bari D, Di Mauro A, Diaz RA, Dietel T, Ding Y, Divià R, Dixit DU, Djuvsland Ø, Dmitrieva U, Dobrin A, Dönigus B, Dubey AK, Dubinski JM, Dubla A, Dudi S, Dupieux P, Durkac M, Dzalaiova N, Eder TM, Ehlers RJ, Eikeland VN, Eisenhut F, Elia D, Erazmus B, Ercolessi F, Erhardt F, Ersdal MR, Espagnon B, Eulisse G, Evans D, Evdokimov S, Fabbietti L, Faggin M, Faivre J, Fan F, Fan W, Fantoni A, Fasel M, Fecchio P, Feliciello A, Feofilov G, Fernández Téllez A, Ferrer MB, Ferrero A, Ferrero C, Ferretti A, Feuillard VJG, Filova V, Finogeev D, Fionda FM, Flor F, Flores AN, Foertsch S, Fokin I, Fokin S, Fragiacomo E, Frajna E, Fuchs U, Funicello N, Furget C, Furs A, Fusayasu T, Gaardhøje JJ, Gagliardi M, Gago AM, Galvan CD, Gangadharan DR, Ganoti P, Garabatos C, Garcia JRA, Garcia-Solis E, Garg K, Gargiulo C, Garibli A, Garner K, Gautam A, Gay Ducati MB, Germain M, Ghosh C, Ghosh SK, Giacalone M, Gianotti P, Giubellino P, Giubilato P, Glaenzer AMC, Glässel P, Glimos E, Goh DJQ, Gonzalez V, González-Trueba LH, Gorgon M, Gotovac S, Grabski V, Graczykowski LK, Grecka E, Grelli A, Grigoras C, Grigoriev V, Grigoryan S, Grosa F, Grosse-Oetringhaus JF, Grosso R, Grund D, Guardiano GG, Guernane R, Guilbaud M, Gulbrandsen K, Gundem T, Gunji T, Guo W, Gupta A, Gupta R, Guzman SP, Gyulai L, Habib MK, Hadjidakis C, Hamagaki H, Hamid M, Han Y, Hannigan R, Haque MR, Harris JW, Harton A, Hassan H, Hatzifotiadou D, Hauer P, Havener LB, Heckel ST, Hellbär E, Helstrup H, Hemmer M, Herman T, Herrera Corral G, Herrmann F, Herrmann S, Hetland KF, Heybeck B, Hillemanns H, Hills C, Hippolyte B, Hofman B, Hohlweger B, Honermann J, Hong GH, Horzyk A, Hosokawa R, Hou Y, Hristov P, Hughes C, Huhn P, Huhta LM, Hulse CV, Humanic TJ, Hushnud H, Hutson A, Hutter D, Iddon JP, Ilkaev R, Ilyas H, Inaba M, Innocenti GM, Ippolitov M, Isakov A, Isidori T, Islam MS, Ivanov M, Ivanov M, Ivanov V, Izucheev V, Jablonski M, Jacak B, Jacazio N, Jacobs PM, Jadlovska S, Jadlovsky J, Jaelani S, Jaffe L, Jahnke C, Jakubowska MJ, Janik MA, Janson T, Jercic M, Jevons O, Jimenez AAP, Jonas F, Jones PG, Jowett JM, Jung J, Jung M, Junique A, Jusko A, Kabus MJ, Kaewjai J, Kalinak P, Kalteyer AS, Kalweit A, Kaplin V, Karasu Uysal A, Karatovic D, Karavichev O, Karavicheva T, Karczmarczyk P, Karpechev E, Kashyap V, Kebschull U, Keidel R, Keijdener DLD, Keil M, Ketzer B, Khan AM, Khan S, Khanzadeev A, Kharlov Y, Khatun A, Khuntia A, Kileng B, Kim B, Kim C, Kim DJ, Kim EJ, Kim J, Kim JS, Kim J, Kim J, Kim M, Kim S, Kim T, Kimura K, Kirsch S, Kisel I, Kiselev S, Kisiel A, Kitowski JP, Klay JL, Klein J, Klein S, Klein-Bösing C, Kleiner M, Klemenz T, Kluge A, Knospe AG, Kobdaj C, Kollegger T, Kondratyev A, Kondratyuk E, Konig J, Konigstorfer SA, Konopka PJ, Kornakov G, Koryciak SD, Kotliarov A, Kovalenko O, Kovalenko V, Kowalski M, Králik I, Kravčáková A, Kreis L, Krivda M, Krizek F, Krizkova Gajdosova K, Kroesen M, Krüger M, Krupova DM, Kryshen E, Kučera V, Kuhn C, Kuijer PG, Kumaoka T, Kumar D, Kumar L, Kumar N, Kumar S, Kundu S, Kurashvili P, Kurepin A, Kurepin AB, Kushpil S, Kvapil J, Kweon MJ, Kwon JY, Kwon Y, La Pointe SL, La Rocca P, Lai YS, Lakrathok A, Lamanna M, Langoy R, Larionov P, Laudi E, Lautner L, Lavicka R, Lazareva T, Lea R, Legras G, Lehrbach J, Lemmon RC, León Monzón I, Lesch MM, Lesser ED, Lettrich M, Lévai P, Li X, Li XL, Lien J, Lietava R, Lim B, Lim SH, Lindenstruth V, Lindner A, Lippmann C, Liu A, Liu DH, Liu J, Lofnes IM, Loizides C, Loncar P, Lopez JA, Lopez X, López Torres E, Lu P, Luhder JR, Lunardon M, Luparello G, Ma YG, Maevskaya A, Mager M, Mahmoud T, Maire A, Malaev M, Malfattore G, Malik NM, Malik QW, Malik SK, Malinina L, Mal'Kevich D, Mallick D, Mallick N, Mandaglio G, Manko V, Manso F, Manzari V, Mao Y, Margagliotti GV, Margotti A, Marín A, Markert C, Martinengo P, Martinez JL, Martínez MI, Martínez García G, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastroserio A, Mathis AM, Matonoha O, Matuoka PFT, Matyja A, Mayer C, Mazuecos AL, Mazzaschi F, Mazzilli M, Mdhluli JE, Mechler AF, Melikyan Y, Menchaca-Rocha A, Meninno E, Menon AS, Meres M, Mhlanga S, Miake Y, Micheletti L, Migliorin LC, Mihaylov DL, Mikhaylov K, Mishra AN, Miśkowiec D, Modak A, Mohanty AP, Mohanty B, Khan MM, Molander MA, Moravcova Z, Mordasini C, Moreira De Godoy DA, Morozov I, Morsch A, Mrnjavac T, Muccifora V, Muhuri S, Mulligan JD, Mulliri A, Munhoz MG, Munzer RH, Murakami H, Murray S, Musa L, Musinsky J, Myrcha JW, Naik B, Nair R, Nambrath AI, Nandi BK, Nania R, Nappi E, Nassirpour AF, Nath A, Nattrass C, Neagu A, Negru A, Nellen L, Nesbo SV, Neskovic G, Nesterov D, Nielsen BS, Nielsen EG, Nikolaev S, Nikulin S, Nikulin V, Noferini F, Noh S, Nomokonov P, Norman J, Novitzky N, Nowakowski P, Nyanin A, Nystrand J, Ogino M, Ohlson A, Okorokov VA, Oleniacz J, Oliveira Da Silva AC, Oliver MH, Onnerstad A, Oppedisano C, Ortiz Velasquez A, Oskarsson A, Otwinowski J, Oya M, Oyama K, Pachmayer Y, Padhan S, Pagano D, Paić G, Palasciano A, Panebianco S, Park H, Park J, Parkkila JE, Patra RN, Paul B, Pei H, Peitzmann T, Peng X, Pennisi M, Pereira LG, Pereira Da Costa H, Peresunko D, Perez GM, Perrin S, Pestov Y, Petráček V, Petrov V, Petrovici M, Pezzi RP, Piano S, Pikna M, Pillot P, Pinazza O, Pinsky L, Pinto C, Pisano S, Płoskoń M, Planinic M, Pliquett F, Poghosyan MG, Politano S, Poljak N, Pop A, Porteboeuf-Houssais S, Porter J, Pozdniakov V, Prasad SK, Prasad S, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puccio M, Pucillo S, Pugelova Z, Qiu S, Quaglia L, Quishpe RE, Ragoni S, Rakotozafindrabe A, Ramello L, Rami F, Ramirez SAR, Rancien TA, Raniwala R, Raniwala S, Rasa M, Räsänen SS, Rath R, Ravasenga I, Read KF, Reckziegel C, Redelbach AR, Redlich K, Rehman A, Reidt F, Reme-Ness HA, Rescakova Z, Reygers K, Riabov A, Riabov V, Ricci R, Richert T, Richter M, Riedel AA, Riegler W, Riggi F, Ristea C, Rodríguez Cahuantzi M, Røed K, Rogalev R, Rogochaya E, Rogoschinski TS, Rohr D, Röhrich D, Rojas PF, Rojas Torres S, Rokita PS, Romanenko G, Ronchetti F, Rosano A, Rosas ED, Rossi A, Roy A, Roy P, Roy S, Rubini N, Rueda OV, Ruggiano D, Rui R, Rumyantsev B, Russek PG, Russo R, Rustamov A, Ryabinkin E, Ryabov Y, Rybicki A, Rytkonen H, Rzesa W, Saarimaki OAM, Sadek R, Sadhu S, Sadovsky S, Saetre J, Šafařík K, Saha SK, Saha S, Sahoo B, Sahoo R, Sahoo S, Sahu D, Sahu PK, Saini J, Sajdakova K, Sakai S, Salvan MP, Sambyal S, Saramela TB, Sarkar D, Sarkar N, Sarma P, Sarritzu V, Sarti VM, Sas MHP, Schambach J, Scheid HS, Schiaua C, Schicker R, Schmah A, Schmidt C, Schmidt HR, Schmidt MO, Schmidt M, Schmidt NV, Schmier AR, Schotter R, Schukraft J, Schwarz K, Schweda K, Scioli G, Scomparin E, Seger JE, Sekiguchi Y, Sekihata D, Selyuzhenkov I, Senyukov S, Seo JJ, Serebryakov D, Šerkšnytė L, Sevcenco A, Shaba TJ, Shabetai A, Shahoyan R, Shangaraev A, Sharma A, Sharma D, Sharma H, Sharma M, Sharma N, Sharma S, Sharma S, Sharma U, Shatat A, Sheibani O, Shigaki K, Shimomura M, Shirinkin S, Shou Q, Sibiriak Y, Siddhanta S, Siemiarczuk T, Silva TF, Silvermyr D, Simantathammakul T, Simeonov R, Singh B, Singh B, Singh R, Singh R, Singh R, Singh S, Singh VK, Singhal V, Sinha T, Sitar B, Sitta M, Skaali TB, Skorodumovs G, Slupecki M, Smirnov N, Snellings RJM, Solheim EH, Song J, Songmoolnak A, Soramel F, Sorensen S, Spijkers R, Sputowska I, Staa J, Stachel J, Stan I, Steffanic PJ, Stiefelmaier SF, Stocco D, Storehaug I, Storetvedt MM, Stratmann P, Strazzi S, Stylianidis CP, Suaide AAP, Suire C, Sukhanov M, Suljic M, Sumberia V, Sumowidagdo S, Swain S, Szarka I, Tabassam U, Taghavi SF, Taillepied G, Takahashi J, Tambave GJ, Tang S, Tang Z, Tapia Takaki JD, Tapus N, Tarasovicova LA, Tarzila MG, Tassielli GF, Tauro A, Telesca A, Terlizzi L, Terrevoli C, Tersimonov G, Thakur S, Thomas D, Tikhonov A, Timmins AR, Tkacik M, Tkacik T, Toia A, Tokumoto R, Topilskaya N, Toppi M, Torales-Acosta F, Tork T, Torres Ramos AG, Trifiró A, Triolo AS, Tripathy S, Tripathy T, Trogolo S, Trubnikov V, Trzaska WH, Trzcinski TP, Turrisi R, Tveter TS, Ullaland K, Ulukutlu B, Uras A, Urioni M, Usai GL, Vala M, Valle N, Vallero S, van Doremalen LVR, van Leeuwen M, van Veen CA, van Weelden RJG, Vande Vyvre P, Varga D, Varga Z, Varga-Kofarago M, Vasileiou M, Vasiliev A, Vázquez Doce O, Vechernin V, Vercellin E, Vergara Limón S, Vermunt L, Vértesi R, Verweij M, Vickovic L, Vilakazi Z, Villalobos Baillie O, Vino G, Vinogradov A, Virgili T, Vislavicius V, Vodopyanov A, Volkel B, Völkl MA, Voloshin K, Voloshin SA, Volpe G, von Haller B, Vorobyev I, Vozniuk N, Vrláková J, Wagner B, Wang C, Wang D, Wegrzynek A, Weiglhofer FT, Wenzel SC, Wessels JP, Weyhmiller SL, Wiechula J, Wikne J, Wilk G, Wilkinson J, Willems GA, Windelband B, Winn M, Wright JR, Wu W, Wu Y, Xu R, Yadav A, Yadav AK, Yalcin S, Yamaguchi Y, Yamakawa K, Yang S, Yano S, Yin Z, Yoo IK, Yoon JH, Yuan S, Yuncu A, Zaccolo V, Zampolli C, Zanoli HJC, Zanone F, Zardoshti N, Zarochentsev A, Závada P, Zaviyalov N, Zhalov M, Zhang B, Zhang S, Zhang X, Zhang Y, Zhang Z, Zhao M, Zherebchevskii V, Zhi Y, Zhigareva N, Zhou D, Zhou Y, Zhu J, Zhu Y, Zinovjev G, Zurlo N. Measurements of Groomed-Jet Substructure of Charm Jets Tagged by D^{0} Mesons in Proton-Proton Collisions at sqrt[s]=13 TeV. Phys Rev Lett 2023; 131:192301. [PMID: 38000395 DOI: 10.1103/physrevlett.131.192301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Revised: 01/13/2023] [Accepted: 07/19/2023] [Indexed: 11/26/2023]
Abstract
Understanding the role of parton mass and Casimir color factors in the quantum chromodynamics parton shower represents an important step in characterizing the emission properties of heavy quarks. Recent experimental advances in jet substructure techniques have provided the opportunity to isolate and characterize gluon emissions from heavy quarks. In this Letter, the first direct experimental constraint on the charm-quark splitting function is presented, obtained via the measurement of the groomed shared momentum fraction of the first splitting in charm jets, tagged by a reconstructed D^{0} meson. The measurement is made in proton-proton collisions at sqrt[s]=13 TeV, in the low jet transverse-momentum interval of 15≤p_{T}^{jet ch}<30 GeV/c where the emission properties are sensitive to parton mass effects. In addition, the opening angle of the first perturbative emission of the charm quark, as well as the number of perturbative emissions it undergoes, is reported. Comparisons to measurements of an inclusive-jet sample show a steeper splitting function for charm quarks compared with gluons and light quarks. Charm quarks also undergo fewer perturbative emissions in the parton shower, with a reduced probability of large-angle emissions.
Collapse
Affiliation(s)
- S Acharya
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - D Adamová
- Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
| | - A Adler
- Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
| | - G Aglieri Rinella
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Agnello
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - N Agrawal
- INFN, Sezione di Bologna, Bologna, Italy
| | - Z Ahammed
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Ahmad
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - S U Ahn
- Korea Institute of Science and Technology Information, Daejeon, Republic of Korea
| | - I Ahuja
- Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
| | - A Akindinov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Al-Turany
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - D Aleksandrov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - H M Alfanda
- Central China Normal University, Wuhan, China
| | - R Alfaro Molina
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - B Ali
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - Y Ali
- COMSATS University Islamabad, Islamabad, Pakistan
| | - A Alici
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | | | - A Alkin
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Alme
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - G Alocco
- INFN, Sezione di Cagliari, Cagliari, Italy
| | - T Alt
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - I Altsybeev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M N Anaam
- Central China Normal University, Wuhan, China
| | - C Andrei
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - A Andronic
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - V Anguelov
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | | | | | - C Anuj
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - N Apadula
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - L Aphecetche
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - H Appelshäuser
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - C Arata
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - S Arcelli
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - M Aresti
- INFN, Sezione di Cagliari, Cagliari, Italy
| | - R Arnaldi
- INFN, Sezione di Torino, Turin, Italy
| | - I C Arsene
- Department of Physics, University of Oslo, Oslo, Norway
| | - M Arslandok
- Yale University, New Haven, Connecticut, USA
| | - A Augustinus
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Averbeck
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M D Azmi
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - A Badalà
- INFN, Sezione di Catania, Catania, Italy
| | - Y W Baek
- Gangneung-Wonju National University, Gangneung, Republic of Korea
| | - X Bai
- University of Science and Technology of China, Hefei, China
| | - R Bailhache
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - Y Bailung
- Indian Institute of Technology Indore, Indore, India
| | - R Bala
- Physics Department, University of Jammu, Jammu, India
| | - A Balbino
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - A Baldisseri
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - B Balis
- AGH University of Science and Technology, Cracow, Poland
| | - D Banerjee
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - Z Banoo
- Physics Department, University of Jammu, Jammu, India
| | - R Barbera
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Catania, Italy
| | - F Barile
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
| | - L Barioglio
- Physik Department, Technische Universität München, Munich, Germany
| | - M Barlou
- National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
| | | | - L S Barnby
- Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
| | - V Barret
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - L Barreto
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - C Bartels
- University of Liverpool, Liverpool, United Kingdom
| | - K Barth
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Bartsch
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - F Baruffaldi
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
| | - N Bastid
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S Basu
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - G Batigne
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - D Battistini
- Physik Department, Technische Universität München, Munich, Germany
| | - B Batyunya
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - D Bauri
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - J L Bazo Alba
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
| | - I G Bearden
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - C Beattie
- Yale University, New Haven, Connecticut, USA
| | - P Becht
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - D Behera
- Indian Institute of Technology Indore, Indore, India
| | - I Belikov
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | | | - F Bellini
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - R Bellwied
- University of Houston, Houston, Texas, USA
| | - S Belokurova
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Belyaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Bencedi
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
- Wigner Research Centre for Physics, Budapest, Hungary
| | - S Beole
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - A Bercuci
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - Y Berdnikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Berdnikova
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - L Bergmann
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - M G Besoiu
- Institute of Space Science (ISS), Bucharest, Romania
| | - L Betev
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P P Bhaduri
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - A Bhasin
- Physics Department, University of Jammu, Jammu, India
| | - M A Bhat
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | | | - L Bianchi
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - N Bianchi
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - J Bielčík
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - J Bielčíková
- Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
| | - J Biernat
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - A P Bigot
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - A Bilandzic
- Physik Department, Technische Universität München, Munich, Germany
| | - G Biro
- Wigner Research Centre for Physics, Budapest, Hungary
| | - S Biswas
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - N Bize
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - J T Blair
- The University of Texas at Austin, Austin, Texas, USA
| | - D Blau
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M B Blidaru
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - N Bluhme
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - C Blume
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - G Boca
- Dipartimento di Fisica, Università di Pavia, Pavia, Italy
- INFN, Sezione di Pavia, Pavia, Italy
| | - F Bock
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - T Bodova
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - A Bogdanov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Boi
- Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
| | - J Bok
- Inha University, Incheon, Republic of Korea
| | - L Boldizsár
- Wigner Research Centre for Physics, Budapest, Hungary
| | - A Bolozdynya
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Bombara
- Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
| | - P M Bond
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Bonomi
- INFN, Sezione di Pavia, Pavia, Italy
- Università di Brescia, Brescia, Italy
| | - H Borel
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - A Borissov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - H Bossi
- Yale University, New Haven, Connecticut, USA
| | - E Botta
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - Y E M Bouziani
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - L Bratrud
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - P Braun-Munzinger
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M Bregant
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - M Broz
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - G E Bruno
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
- Politecnico di Bari and Sezione INFN, Bari, Italy
| | - M D Buckland
- University of Liverpool, Liverpool, United Kingdom
| | - D Budnikov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - H Buesching
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S Bufalino
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - O Bugnon
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - P Buhler
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - Z Buthelezi
- iThemba LABS, National Research Foundation, Somerset West, South Africa
- University of the Witwatersrand, Johannesburg, South Africa
| | - J B Butt
- COMSATS University Islamabad, Islamabad, Pakistan
| | - S A Bysiak
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - M Cai
- Central China Normal University, Wuhan, China
| | - H Caines
- Yale University, New Haven, Connecticut, USA
| | - A Caliva
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - E Calvo Villar
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
| | | | - P Camerini
- Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
| | - F D M Canedo
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - M Carabas
- University Politehnica of Bucharest, Bucharest, Romania
| | - F Carnesecchi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Caron
- Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
| | - J Castillo Castellanos
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - F Catalano
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - C Ceballos Sanchez
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - I Chakaberia
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - P Chakraborty
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - S Chandra
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Chapeland
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Chartier
- University of Liverpool, Liverpool, United Kingdom
| | - S Chattopadhyay
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Chattopadhyay
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - T G Chavez
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - T Cheng
- Central China Normal University, Wuhan, China
| | - C Cheshkov
- Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
| | - B Cheynis
- Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
| | | | - D D Chinellato
- Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
| | - E S Chizzali
- Physik Department, Technische Universität München, Munich, Germany
| | - J Cho
- Inha University, Incheon, Republic of Korea
| | - S Cho
- Inha University, Incheon, Republic of Korea
| | - P Chochula
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Christakoglou
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - C H Christensen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - P Christiansen
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - T Chujo
- University of Tsukuba, Tsukuba, Japan
| | - M Ciacco
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - C Cicalo
- INFN, Sezione di Cagliari, Cagliari, Italy
| | - L Cifarelli
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - F Cindolo
- INFN, Sezione di Bologna, Bologna, Italy
| | - M R Ciupek
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - G Clai
- INFN, Sezione di Bologna, Bologna, Italy
| | | | - J S Colburn
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - D Colella
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
- Politecnico di Bari and Sezione INFN, Bari, Italy
| | - M Colocci
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Concas
- INFN, Sezione di Torino, Turin, Italy
| | - G Conesa Balbastre
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - Z Conesa Del Valle
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | - G Contin
- Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
| | - J G Contreras
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - M L Coquet
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - T M Cormier
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - P Cortese
- INFN, Sezione di Torino, Turin, Italy
- Università del Piemonte Orientale, Vercelli, Italy
| | | | - F Costa
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Costanza
- Dipartimento di Fisica, Università di Pavia, Pavia, Italy
- INFN, Sezione di Pavia, Pavia, Italy
| | - J Crkovská
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - P Crochet
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - R Cruz-Torres
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - E Cuautle
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - P Cui
- Central China Normal University, Wuhan, China
| | - L Cunqueiro
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - A Dainese
- INFN, Sezione di Padova, Padova, Italy
| | - M C Danisch
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Danu
- Institute of Space Science (ISS), Bucharest, Romania
| | - P Das
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - P Das
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - S Das
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - A R Dash
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - S Dash
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - R M H David
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - A De Caro
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
| | | | - J de Cuveland
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - A De Falco
- Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
| | - D De Gruttola
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
| | | | - C De Martin
- Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
| | - S De Pasquale
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
| | - S Deb
- Indian Institute of Technology Indore, Indore, India
| | - R J Debski
- AGH University of Science and Technology, Cracow, Poland
| | - K R Deja
- Warsaw University of Technology, Warsaw, Poland
| | - R Del Grande
- Physik Department, Technische Universität München, Munich, Germany
| | - L Dello Stritto
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
| | - W Deng
- Central China Normal University, Wuhan, China
| | - P Dhankher
- Department of Physics, University of California, Berkeley, California, USA
| | - D Di Bari
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
| | - A Di Mauro
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R A Diaz
- Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - T Dietel
- University of Cape Town, Cape Town, South Africa
| | - Y Ding
- Central China Normal University, Wuhan, China
- Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
| | - R Divià
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D U Dixit
- Department of Physics, University of California, Berkeley, California, USA
| | - Ø Djuvsland
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - U Dmitrieva
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Dobrin
- Institute of Space Science (ISS), Bucharest, Romania
| | - B Dönigus
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - A K Dubey
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | | | - A Dubla
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - S Dudi
- Physics Department, Panjab University, Chandigarh, India
| | - P Dupieux
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - M Durkac
- Technical University of Košice, Košice, Slovak Republic
| | - N Dzalaiova
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
| | - T M Eder
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - R J Ehlers
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - V N Eikeland
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - F Eisenhut
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - D Elia
- INFN, Sezione di Bari, Bari, Italy
| | - B Erazmus
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - F Ercolessi
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - F Erhardt
- Physics Department, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - M R Ersdal
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - B Espagnon
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | - G Eulisse
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Evans
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - S Evdokimov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Fabbietti
- Physik Department, Technische Universität München, Munich, Germany
| | - M Faggin
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
| | - J Faivre
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - F Fan
- Central China Normal University, Wuhan, China
| | - W Fan
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - A Fantoni
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - M Fasel
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - P Fecchio
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | | | - G Feofilov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Fernández Téllez
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - M B Ferrer
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Ferrero
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - C Ferrero
- INFN, Sezione di Torino, Turin, Italy
| | - A Ferretti
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - V J G Feuillard
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - V Filova
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - D Finogeev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - F M Fionda
- INFN, Sezione di Cagliari, Cagliari, Italy
| | - F Flor
- University of Houston, Houston, Texas, USA
| | - A N Flores
- The University of Texas at Austin, Austin, Texas, USA
| | - S Foertsch
- iThemba LABS, National Research Foundation, Somerset West, South Africa
| | - I Fokin
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Fokin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - E Frajna
- Wigner Research Centre for Physics, Budapest, Hungary
| | - U Fuchs
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - N Funicello
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
| | - C Furget
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - A Furs
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - J J Gaardhøje
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - M Gagliardi
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - A M Gago
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
| | - C D Galvan
- Universidad Autónoma de Sinaloa, Culiacán, Mexico
| | | | - P Ganoti
- National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
| | - C Garabatos
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - J R A Garcia
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | | | - K Garg
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - C Gargiulo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Garibli
- National Nuclear Research Center, Baku, Azerbaijan
| | - K Garner
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - A Gautam
- University of Kansas, Lawrence, Kansas, USA
| | - M B Gay Ducati
- Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
| | - M Germain
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - C Ghosh
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S K Ghosh
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - M Giacalone
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - P Gianotti
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - P Giubellino
- INFN, Sezione di Torino, Turin, Italy
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - P Giubilato
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
| | - A M C Glaenzer
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - P Glässel
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - E Glimos
- University of Tennessee, Knoxville, Tennessee, USA
| | - D J Q Goh
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - V Gonzalez
- Wayne State University, Detroit, Michigan, USA
| | - L H González-Trueba
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M Gorgon
- AGH University of Science and Technology, Cracow, Poland
| | - S Gotovac
- Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
| | - V Grabski
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | | | - E Grecka
- Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
| | - A Grelli
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - C Grigoras
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Grigoriev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Grigoryan
- A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - F Grosa
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - R Grosso
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - D Grund
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - G G Guardiano
- Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
| | - R Guernane
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - M Guilbaud
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - K Gulbrandsen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - T Gundem
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - T Gunji
- University of Tokyo, Tokyo, Japan
| | - W Guo
- Central China Normal University, Wuhan, China
| | - A Gupta
- Physics Department, University of Jammu, Jammu, India
| | - R Gupta
- Physics Department, University of Jammu, Jammu, India
| | - S P Guzman
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - L Gyulai
- Wigner Research Centre for Physics, Budapest, Hungary
| | - M K Habib
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - C Hadjidakis
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | - H Hamagaki
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - M Hamid
- Central China Normal University, Wuhan, China
| | - Y Han
- Yonsei University, Seoul, Republic of Korea
| | - R Hannigan
- The University of Texas at Austin, Austin, Texas, USA
| | - M R Haque
- Warsaw University of Technology, Warsaw, Poland
| | - J W Harris
- Yale University, New Haven, Connecticut, USA
| | - A Harton
- Chicago State University, Chicago, Illinois, USA
| | - H Hassan
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | | | - P Hauer
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - L B Havener
- Yale University, New Haven, Connecticut, USA
| | - S T Heckel
- Physik Department, Technische Universität München, Munich, Germany
| | - E Hellbär
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - H Helstrup
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - M Hemmer
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - T Herman
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - G Herrera Corral
- Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
| | - F Herrmann
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - S Herrmann
- Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
| | - K F Hetland
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - B Heybeck
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - H Hillemanns
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Hills
- University of Liverpool, Liverpool, United Kingdom
| | - B Hippolyte
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - B Hofman
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - B Hohlweger
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - J Honermann
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - G H Hong
- Yonsei University, Seoul, Republic of Korea
| | - A Horzyk
- AGH University of Science and Technology, Cracow, Poland
| | - R Hosokawa
- Creighton University, Omaha, Nebraska, USA
| | - Y Hou
- Central China Normal University, Wuhan, China
| | - P Hristov
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Hughes
- University of Tennessee, Knoxville, Tennessee, USA
| | - P Huhn
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - L M Huhta
- University of Jyväskylä, Jyväskylä, Finland
| | - C V Hulse
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | | | - H Hushnud
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - A Hutson
- University of Houston, Houston, Texas, USA
| | - D Hutter
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - J P Iddon
- University of Liverpool, Liverpool, United Kingdom
| | - R Ilkaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - H Ilyas
- COMSATS University Islamabad, Islamabad, Pakistan
| | - M Inaba
- University of Tsukuba, Tsukuba, Japan
| | - G M Innocenti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Ippolitov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Isakov
- Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
| | - T Isidori
- University of Kansas, Lawrence, Kansas, USA
| | - M S Islam
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - M Ivanov
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
| | - M Ivanov
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - V Ivanov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Izucheev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Jablonski
- AGH University of Science and Technology, Cracow, Poland
| | - B Jacak
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - N Jacazio
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P M Jacobs
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - S Jadlovska
- Technical University of Košice, Košice, Slovak Republic
| | - J Jadlovsky
- Technical University of Košice, Košice, Slovak Republic
| | - S Jaelani
- National Research and Innovation Agency - BRIN, Jakarta, Indonesia
| | - L Jaffe
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - C Jahnke
- Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
| | | | - M A Janik
- Warsaw University of Technology, Warsaw, Poland
| | - T Janson
- Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
| | - M Jercic
- Physics Department, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - O Jevons
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - A A P Jimenez
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - F Jonas
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - P G Jones
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - J M Jowett
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - J Jung
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - M Jung
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - A Junique
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Jusko
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - M J Kabus
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Warsaw University of Technology, Warsaw, Poland
| | - J Kaewjai
- Suranaree University of Technology, Nakhon Ratchasima, Thailand
| | - P Kalinak
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic
| | - A S Kalteyer
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - A Kalweit
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Kaplin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - D Karatovic
- Physics Department, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - O Karavichev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Karavicheva
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - E Karpechev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Kashyap
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - U Kebschull
- Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
| | - R Keidel
- Zentrum für Technologie und Transfer (ZTT), Worms, Germany
| | - D L D Keijdener
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - M Keil
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Ketzer
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - A M Khan
- Central China Normal University, Wuhan, China
| | - S Khan
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - A Khanzadeev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Y Kharlov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Khatun
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - A Khuntia
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - B Kileng
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - B Kim
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - C Kim
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - D J Kim
- University of Jyväskylä, Jyväskylä, Finland
| | - E J Kim
- Jeonbuk National University, Jeonju, Republic of Korea
| | - J Kim
- Yonsei University, Seoul, Republic of Korea
| | - J S Kim
- Gangneung-Wonju National University, Gangneung, Republic of Korea
| | - J Kim
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Kim
- Jeonbuk National University, Jeonju, Republic of Korea
| | - M Kim
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Kim
- Department of Physics, Sejong University, Seoul, Republic of Korea
| | - T Kim
- Yonsei University, Seoul, Republic of Korea
| | - K Kimura
- Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
| | - S Kirsch
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - I Kisel
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S Kiselev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Kisiel
- Warsaw University of Technology, Warsaw, Poland
| | - J P Kitowski
- AGH University of Science and Technology, Cracow, Poland
| | - J L Klay
- California Polytechnic State University, San Luis Obispo, California, USA
| | - J Klein
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Klein
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - C Klein-Bösing
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - M Kleiner
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - T Klemenz
- Physik Department, Technische Universität München, Munich, Germany
| | - A Kluge
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A G Knospe
- University of Houston, Houston, Texas, USA
| | - C Kobdaj
- Suranaree University of Technology, Nakhon Ratchasima, Thailand
| | - T Kollegger
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - A Kondratyev
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - E Kondratyuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J Konig
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S A Konigstorfer
- Physik Department, Technische Universität München, Munich, Germany
| | - P J Konopka
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Kornakov
- Warsaw University of Technology, Warsaw, Poland
| | - S D Koryciak
- AGH University of Science and Technology, Cracow, Poland
| | - A Kotliarov
- Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
| | - O Kovalenko
- National Centre for Nuclear Research, Warsaw, Poland
| | - V Kovalenko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Kowalski
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - I Králik
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic
| | - A Kravčáková
- Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
| | - L Kreis
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M Krivda
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - F Krizek
- Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
| | - K Krizkova Gajdosova
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - M Kroesen
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - M Krüger
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - D M Krupova
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - E Kryshen
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Kučera
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Kuhn
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - P G Kuijer
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - T Kumaoka
- University of Tsukuba, Tsukuba, Japan
| | - D Kumar
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - L Kumar
- Physics Department, Panjab University, Chandigarh, India
| | - N Kumar
- Physics Department, Panjab University, Chandigarh, India
| | - S Kumar
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
| | - S Kundu
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Kurashvili
- National Centre for Nuclear Research, Warsaw, Poland
| | - A Kurepin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A B Kurepin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Kushpil
- Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
| | - J Kvapil
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - M J Kweon
- Inha University, Incheon, Republic of Korea
| | - J Y Kwon
- Inha University, Incheon, Republic of Korea
| | - Y Kwon
- Yonsei University, Seoul, Republic of Korea
| | - S L La Pointe
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - P La Rocca
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Catania, Italy
| | - Y S Lai
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - A Lakrathok
- Suranaree University of Technology, Nakhon Ratchasima, Thailand
| | - M Lamanna
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Langoy
- University of South-Eastern Norway, Kongsberg, Norway
| | - P Larionov
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Laudi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - L Lautner
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Physik Department, Technische Universität München, Munich, Germany
| | - R Lavicka
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - T Lazareva
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Lea
- INFN, Sezione di Pavia, Pavia, Italy
- Università di Brescia, Brescia, Italy
| | - G Legras
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - J Lehrbach
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - R C Lemmon
- Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
| | | | - M M Lesch
- Physik Department, Technische Universität München, Munich, Germany
| | - E D Lesser
- Department of Physics, University of California, Berkeley, California, USA
| | - M Lettrich
- Physik Department, Technische Universität München, Munich, Germany
| | - P Lévai
- Wigner Research Centre for Physics, Budapest, Hungary
| | - X Li
- China Institute of Atomic Energy, Beijing, China
| | - X L Li
- Central China Normal University, Wuhan, China
| | - J Lien
- University of South-Eastern Norway, Kongsberg, Norway
| | - R Lietava
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - B Lim
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - S H Lim
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - V Lindenstruth
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - A Lindner
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - C Lippmann
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - A Liu
- Department of Physics, University of California, Berkeley, California, USA
| | - D H Liu
- Central China Normal University, Wuhan, China
| | - J Liu
- University of Liverpool, Liverpool, United Kingdom
| | - I M Lofnes
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - C Loizides
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - P Loncar
- Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
| | - J A Lopez
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - X Lopez
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - E López Torres
- Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
| | - P Lu
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
- University of Science and Technology of China, Hefei, China
| | - J R Luhder
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - M Lunardon
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
| | | | - Y G Ma
- Fudan University, Shanghai, China
| | - A Maevskaya
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Mager
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Mahmoud
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - A Maire
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - M Malaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G Malfattore
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - N M Malik
- Physics Department, University of Jammu, Jammu, India
| | - Q W Malik
- Department of Physics, University of Oslo, Oslo, Norway
| | - S K Malik
- Physics Department, University of Jammu, Jammu, India
| | - L Malinina
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - D Mal'Kevich
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - D Mallick
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - N Mallick
- Indian Institute of Technology Indore, Indore, India
| | - G Mandaglio
- Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - V Manko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - F Manso
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | | | - Y Mao
- Central China Normal University, Wuhan, China
| | - G V Margagliotti
- Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
| | - A Margotti
- INFN, Sezione di Bologna, Bologna, Italy
| | - A Marín
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - C Markert
- The University of Texas at Austin, Austin, Texas, USA
| | - P Martinengo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - M I Martínez
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - G Martínez García
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - S Masciocchi
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M Masera
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - A Masoni
- INFN, Sezione di Cagliari, Cagliari, Italy
| | - L Massacrier
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | - A Mastroserio
- INFN, Sezione di Bari, Bari, Italy
- Università degli Studi di Foggia, Foggia, Italy
| | - A M Mathis
- Physik Department, Technische Universität München, Munich, Germany
| | - O Matonoha
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | | | - A Matyja
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - C Mayer
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - A L Mazuecos
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F Mazzaschi
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - M Mazzilli
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J E Mdhluli
- University of the Witwatersrand, Johannesburg, South Africa
| | - A F Mechler
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - Y Melikyan
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Menchaca-Rocha
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - E Meninno
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - A S Menon
- University of Houston, Houston, Texas, USA
| | - M Meres
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
| | - S Mhlanga
- iThemba LABS, National Research Foundation, Somerset West, South Africa
- University of Cape Town, Cape Town, South Africa
| | - Y Miake
- University of Tsukuba, Tsukuba, Japan
| | | | - L C Migliorin
- Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
| | - D L Mihaylov
- Physik Department, Technische Universität München, Munich, Germany
| | - K Mikhaylov
- Affiliated with an institute covered by a cooperation agreement with CERN
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - A N Mishra
- Wigner Research Centre for Physics, Budapest, Hungary
| | - D Miśkowiec
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - A Modak
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - A P Mohanty
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - B Mohanty
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - M Mohisin Khan
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - M A Molander
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - Z Moravcova
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - C Mordasini
- Physik Department, Technische Universität München, Munich, Germany
| | - D A Moreira De Godoy
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - I Morozov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Morsch
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Mrnjavac
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Muccifora
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - S Muhuri
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - J D Mulligan
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - A Mulliri
- Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
| | - M G Munhoz
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - R H Munzer
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | | | - S Murray
- University of Cape Town, Cape Town, South Africa
| | - L Musa
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Musinsky
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic
| | - J W Myrcha
- Warsaw University of Technology, Warsaw, Poland
| | - B Naik
- University of the Witwatersrand, Johannesburg, South Africa
| | - R Nair
- National Centre for Nuclear Research, Warsaw, Poland
| | - A I Nambrath
- Department of Physics, University of California, Berkeley, California, USA
| | - B K Nandi
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - R Nania
- INFN, Sezione di Bologna, Bologna, Italy
| | - E Nappi
- INFN, Sezione di Bari, Bari, Italy
| | - A F Nassirpour
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - A Nath
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Nattrass
- University of Tennessee, Knoxville, Tennessee, USA
| | - A Neagu
- Department of Physics, University of Oslo, Oslo, Norway
| | - A Negru
- University Politehnica of Bucharest, Bucharest, Romania
| | - L Nellen
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - S V Nesbo
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - G Neskovic
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - D Nesterov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - B S Nielsen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - E G Nielsen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - S Nikolaev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Nikulin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Nikulin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - F Noferini
- INFN, Sezione di Bologna, Bologna, Italy
| | - S Noh
- Chungbuk National University, Cheongju, Republic of Korea
| | - P Nomokonov
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - J Norman
- University of Liverpool, Liverpool, United Kingdom
| | | | | | - A Nyanin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J Nystrand
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - M Ogino
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - A Ohlson
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - V A Okorokov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J Oleniacz
- Warsaw University of Technology, Warsaw, Poland
| | | | - M H Oliver
- Yale University, New Haven, Connecticut, USA
| | | | | | - A Ortiz Velasquez
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Oskarsson
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - J Otwinowski
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - M Oya
- Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
| | - K Oyama
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - Y Pachmayer
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Padhan
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - D Pagano
- INFN, Sezione di Pavia, Pavia, Italy
- Università di Brescia, Brescia, Italy
| | - G Paić
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | | | - S Panebianco
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - H Park
- University of Tsukuba, Tsukuba, Japan
| | - J Park
- Inha University, Incheon, Republic of Korea
| | - J E Parkkila
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R N Patra
- Physics Department, University of Jammu, Jammu, India
| | - B Paul
- Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
| | - H Pei
- Central China Normal University, Wuhan, China
| | - T Peitzmann
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - X Peng
- Central China Normal University, Wuhan, China
| | - M Pennisi
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - L G Pereira
- Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
| | - H Pereira Da Costa
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - D Peresunko
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - G M Perez
- Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
| | - S Perrin
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - Y Pestov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Petráček
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - V Petrov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Petrovici
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - R P Pezzi
- Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - S Piano
- INFN, Sezione di Trieste, Trieste, Italy
| | - M Pikna
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
| | - P Pillot
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - O Pinazza
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- INFN, Sezione di Bologna, Bologna, Italy
| | - L Pinsky
- University of Houston, Houston, Texas, USA
| | - C Pinto
- Physik Department, Technische Universität München, Munich, Germany
| | - S Pisano
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - M Płoskoń
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - M Planinic
- Physics Department, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - F Pliquett
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - M G Poghosyan
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - S Politano
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - N Poljak
- Physics Department, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - A Pop
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | | | - J Porter
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - V Pozdniakov
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - S K Prasad
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - S Prasad
- Indian Institute of Technology Indore, Indore, India
| | | | - F Prino
- INFN, Sezione di Torino, Turin, Italy
| | - C A Pruneau
- Wayne State University, Detroit, Michigan, USA
| | - I Pshenichnov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Puccio
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Pucillo
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - Z Pugelova
- Technical University of Košice, Košice, Slovak Republic
| | - S Qiu
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - L Quaglia
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | | | - S Ragoni
- Creighton University, Omaha, Nebraska, USA
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - A Rakotozafindrabe
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - L Ramello
- INFN, Sezione di Torino, Turin, Italy
- Università del Piemonte Orientale, Vercelli, Italy
| | - F Rami
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - S A R Ramirez
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - T A Rancien
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - R Raniwala
- Physics Department, University of Rajasthan, Jaipur, India
| | - S Raniwala
- Physics Department, University of Rajasthan, Jaipur, India
| | - M Rasa
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Catania, Italy
| | - S S Räsänen
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - R Rath
- Indian Institute of Technology Indore, Indore, India
- INFN, Sezione di Bologna, Bologna, Italy
| | - I Ravasenga
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - K F Read
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
- University of Tennessee, Knoxville, Tennessee, USA
| | - C Reckziegel
- Universidade Federal do ABC, Santo Andre, Brazil
| | - A R Redelbach
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - K Redlich
- National Centre for Nuclear Research, Warsaw, Poland
| | - A Rehman
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - F Reidt
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H A Reme-Ness
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - Z Rescakova
- Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
| | - K Reygers
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Riabov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - V Riabov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - R Ricci
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
| | - T Richert
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - M Richter
- Department of Physics, University of Oslo, Oslo, Norway
| | - A A Riedel
- Physik Department, Technische Universität München, Munich, Germany
| | - W Riegler
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F Riggi
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Catania, Italy
| | - C Ristea
- Institute of Space Science (ISS), Bucharest, Romania
| | | | - K Røed
- Department of Physics, University of Oslo, Oslo, Norway
| | - R Rogalev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - E Rogochaya
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - T S Rogoschinski
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - D Rohr
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Röhrich
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - P F Rojas
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - S Rojas Torres
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - P S Rokita
- Warsaw University of Technology, Warsaw, Poland
| | - G Romanenko
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - F Ronchetti
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - A Rosano
- Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - E D Rosas
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Rossi
- INFN, Sezione di Padova, Padova, Italy
| | - A Roy
- Indian Institute of Technology Indore, Indore, India
| | - P Roy
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - S Roy
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - N Rubini
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - O V Rueda
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - D Ruggiano
- Warsaw University of Technology, Warsaw, Poland
| | - R Rui
- Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
| | - B Rumyantsev
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - P G Russek
- AGH University of Science and Technology, Cracow, Poland
| | - R Russo
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - A Rustamov
- National Nuclear Research Center, Baku, Azerbaijan
| | - E Ryabinkin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Y Ryabov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Rybicki
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - H Rytkonen
- University of Jyväskylä, Jyväskylä, Finland
| | - W Rzesa
- Warsaw University of Technology, Warsaw, Poland
| | | | - R Sadek
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - S Sadhu
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
| | - S Sadovsky
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J Saetre
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - K Šafařík
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech
| | - S K Saha
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - S Saha
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - B Sahoo
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - R Sahoo
- Indian Institute of Technology Indore, Indore, India
| | - S Sahoo
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - D Sahu
- Indian Institute of Technology Indore, Indore, India
| | - P K Sahu
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - J Saini
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - K Sajdakova
- Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
| | - S Sakai
- University of Tsukuba, Tsukuba, Japan
| | - M P Salvan
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - S Sambyal
- Physics Department, University of Jammu, Jammu, India
| | - T B Saramela
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - D Sarkar
- Wayne State University, Detroit, Michigan, USA
| | - N Sarkar
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - P Sarma
- Gauhati University, Department of Physics, Guwahati, India
| | - V Sarritzu
- Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
| | - V M Sarti
- Physik Department, Technische Universität München, Munich, Germany
| | - M H P Sas
- Yale University, New Haven, Connecticut, USA
| | - J Schambach
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - H S Scheid
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - C Schiaua
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - R Schicker
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Schmah
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Schmidt
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - H R Schmidt
- Physikalisches Institut, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - M O Schmidt
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Schmidt
- Physikalisches Institut, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - N V Schmidt
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - A R Schmier
- University of Tennessee, Knoxville, Tennessee, USA
| | - R Schotter
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - J Schukraft
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - K Schwarz
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - K Schweda
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - G Scioli
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | | | - J E Seger
- Creighton University, Omaha, Nebraska, USA
| | | | | | - I Selyuzhenkov
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - S Senyukov
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - J J Seo
- Inha University, Incheon, Republic of Korea
| | - D Serebryakov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - L Šerkšnytė
- Physik Department, Technische Universität München, Munich, Germany
| | - A Sevcenco
- Institute of Space Science (ISS), Bucharest, Romania
| | - T J Shaba
- iThemba LABS, National Research Foundation, Somerset West, South Africa
| | - A Shabetai
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - R Shahoyan
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Shangaraev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - A Sharma
- Physics Department, Panjab University, Chandigarh, India
| | - D Sharma
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - H Sharma
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - M Sharma
- Physics Department, University of Jammu, Jammu, India
| | - N Sharma
- Physics Department, Panjab University, Chandigarh, India
| | - S Sharma
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - S Sharma
- Physics Department, University of Jammu, Jammu, India
| | - U Sharma
- Physics Department, University of Jammu, Jammu, India
| | - A Shatat
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | - O Sheibani
- University of Houston, Houston, Texas, USA
| | - K Shigaki
- Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
| | | | - S Shirinkin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Q Shou
- Fudan University, Shanghai, China
| | - Y Sibiriak
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - T Siemiarczuk
- National Centre for Nuclear Research, Warsaw, Poland
| | - T F Silva
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - D Silvermyr
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | | | - R Simeonov
- Faculty of Physics, Sofia University, Sofia, Bulgaria
| | - B Singh
- Physics Department, University of Jammu, Jammu, India
| | - B Singh
- Physik Department, Technische Universität München, Munich, Germany
| | - R Singh
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - R Singh
- Physics Department, University of Jammu, Jammu, India
| | - R Singh
- Indian Institute of Technology Indore, Indore, India
| | - S Singh
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - V K Singh
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - V Singhal
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - T Sinha
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - B Sitar
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
| | - M Sitta
- INFN, Sezione di Torino, Turin, Italy
- Università del Piemonte Orientale, Vercelli, Italy
| | - T B Skaali
- Department of Physics, University of Oslo, Oslo, Norway
| | - G Skorodumovs
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - M Slupecki
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - N Smirnov
- Yale University, New Haven, Connecticut, USA
| | - R J M Snellings
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - E H Solheim
- Department of Physics, University of Oslo, Oslo, Norway
| | - J Song
- University of Houston, Houston, Texas, USA
| | - A Songmoolnak
- Suranaree University of Technology, Nakhon Ratchasima, Thailand
| | - F Soramel
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
| | - S Sorensen
- University of Tennessee, Knoxville, Tennessee, USA
| | - R Spijkers
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - I Sputowska
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - J Staa
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - J Stachel
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - I Stan
- Institute of Space Science (ISS), Bucharest, Romania
| | | | - S F Stiefelmaier
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - D Stocco
- SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
| | - I Storehaug
- Department of Physics, University of Oslo, Oslo, Norway
| | - M M Storetvedt
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - P Stratmann
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - S Strazzi
- Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
| | - C P Stylianidis
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - A A P Suaide
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - C Suire
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | - M Sukhanov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Suljic
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Sumberia
- Physics Department, University of Jammu, Jammu, India
| | - S Sumowidagdo
- National Research and Innovation Agency - BRIN, Jakarta, Indonesia
| | - S Swain
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - I Szarka
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
| | - U Tabassam
- COMSATS University Islamabad, Islamabad, Pakistan
| | - S F Taghavi
- Physik Department, Technische Universität München, Munich, Germany
| | - G Taillepied
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - J Takahashi
- Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
| | - G J Tambave
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - S Tang
- Central China Normal University, Wuhan, China
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - Z Tang
- University of Science and Technology of China, Hefei, China
| | | | - N Tapus
- University Politehnica of Bucharest, Bucharest, Romania
| | - L A Tarasovicova
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - M G Tarzila
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - G F Tassielli
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
| | - A Tauro
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Telesca
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - L Terlizzi
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | | | - G Tersimonov
- Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
| | - S Thakur
- Bose Institute, Department of Physics and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - D Thomas
- The University of Texas at Austin, Austin, Texas, USA
| | - A Tikhonov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - M Tkacik
- Technical University of Košice, Košice, Slovak Republic
| | - T Tkacik
- Technical University of Košice, Košice, Slovak Republic
| | - A Toia
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - R Tokumoto
- Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
| | - N Topilskaya
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Toppi
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - F Torales-Acosta
- Department of Physics, University of California, Berkeley, California, USA
| | - T Tork
- Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
| | - A G Torres Ramos
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
| | - A Trifiró
- Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - A S Triolo
- Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy
- INFN, Sezione di Catania, Catania, Italy
| | - S Tripathy
- INFN, Sezione di Bologna, Bologna, Italy
| | - T Tripathy
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - S Trogolo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Trubnikov
- Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
| | | | | | - R Turrisi
- INFN, Sezione di Padova, Padova, Italy
| | - T S Tveter
- Department of Physics, University of Oslo, Oslo, Norway
| | - K Ullaland
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - B Ulukutlu
- Physik Department, Technische Universität München, Munich, Germany
| | - A Uras
- Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
| | - M Urioni
- INFN, Sezione di Pavia, Pavia, Italy
- Università di Brescia, Brescia, Italy
| | - G L Usai
- Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
| | - M Vala
- Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
| | - N Valle
- Dipartimento di Fisica, Università di Pavia, Pavia, Italy
| | - S Vallero
- INFN, Sezione di Torino, Turin, Italy
| | - L V R van Doremalen
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - M van Leeuwen
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - C A van Veen
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - R J G van Weelden
- Nikhef, National Institute for Subatomic Physics, Amsterdam, Netherlands
| | - P Vande Vyvre
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Varga
- Wigner Research Centre for Physics, Budapest, Hungary
| | - Z Varga
- Wigner Research Centre for Physics, Budapest, Hungary
| | | | - M Vasileiou
- National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
| | - A Vasiliev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - V Vechernin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - E Vercellin
- Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
| | - S Vergara Limón
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - L Vermunt
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - R Vértesi
- Wigner Research Centre for Physics, Budapest, Hungary
| | - M Verweij
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - L Vickovic
- Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
| | - Z Vilakazi
- University of the Witwatersrand, Johannesburg, South Africa
| | - O Villalobos Baillie
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - G Vino
- INFN, Sezione di Bari, Bari, Italy
| | - A Vinogradov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - T Virgili
- Dipartimento di Fisica "E.R. Caianiello" dell'Università and Gruppo Collegato INFN, Salerno, Italy
| | - V Vislavicius
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - A Vodopyanov
- Affiliated with an international laboratory covered by a cooperation agreement with CERN
| | - B Volkel
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M A Völkl
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - K Voloshin
- Affiliated with an institute covered by a cooperation agreement with CERN
| | | | - G Volpe
- Dipartimento Interateneo di Fisica "M. Merlin" and Sezione INFN, Bari, Italy
| | - B von Haller
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - I Vorobyev
- Physik Department, Technische Universität München, Munich, Germany
| | - N Vozniuk
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - J Vrláková
- Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
| | - B Wagner
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - C Wang
- Fudan University, Shanghai, China
| | - D Wang
- Fudan University, Shanghai, China
| | - A Wegrzynek
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F T Weiglhofer
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S C Wenzel
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J P Wessels
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | | | - J Wiechula
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - J Wikne
- Department of Physics, University of Oslo, Oslo, Norway
| | - G Wilk
- National Centre for Nuclear Research, Warsaw, Poland
| | - J Wilkinson
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - G A Willems
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - B Windelband
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - M Winn
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - J R Wright
- The University of Texas at Austin, Austin, Texas, USA
| | - W Wu
- Fudan University, Shanghai, China
| | - Y Wu
- University of Science and Technology of China, Hefei, China
| | - R Xu
- Central China Normal University, Wuhan, China
| | - A Yadav
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - A K Yadav
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Yalcin
- KTO Karatay University, Konya, Turkey
| | - Y Yamaguchi
- Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
| | - K Yamakawa
- Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
| | - S Yang
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - S Yano
- Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
| | - Z Yin
- Central China Normal University, Wuhan, China
| | - I-K Yoo
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - J H Yoon
- Inha University, Incheon, Republic of Korea
| | - S Yuan
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - A Yuncu
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - V Zaccolo
- Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
| | - C Zampolli
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H J C Zanoli
- Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
| | - F Zanone
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - N Zardoshti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - A Zarochentsev
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - P Závada
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - N Zaviyalov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - M Zhalov
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - B Zhang
- Central China Normal University, Wuhan, China
| | - S Zhang
- Fudan University, Shanghai, China
| | - X Zhang
- Central China Normal University, Wuhan, China
| | - Y Zhang
- University of Science and Technology of China, Hefei, China
| | - Z Zhang
- Central China Normal University, Wuhan, China
| | - M Zhao
- China Institute of Atomic Energy, Beijing, China
| | - V Zherebchevskii
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - Y Zhi
- China Institute of Atomic Energy, Beijing, China
| | - N Zhigareva
- Affiliated with an institute covered by a cooperation agreement with CERN
| | - D Zhou
- Central China Normal University, Wuhan, China
| | - Y Zhou
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - J Zhu
- Central China Normal University, Wuhan, China
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - Y Zhu
- Central China Normal University, Wuhan, China
| | - G Zinovjev
- Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
| | - N Zurlo
- INFN, Sezione di Pavia, Pavia, Italy
- Università di Brescia, Brescia, Italy
| |
Collapse
|
121
|
Zhao Y, Fan R, Wang C, Xu S, Xie L, Hou J, Lei W, Liu J. Quantification and isotope abundance determination of 13C labeled intracellular sugar metabolites with hydrophilic interaction liquid chromatography. Anal Methods 2023; 15:5666-5673. [PMID: 37855701 DOI: 10.1039/d3ay01178j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2023]
Abstract
Metabolic flux analysis (MFA) using stable isotope labeled tracers is a powerful tool to estimate fluxes through metabolic pathways. It finds applications in studying metabolic changes in diseases, regulation of cellular energetics, and novel strategies for metabolic engineering. Accurate and precise quantification of the concentration of metabolites and their labeling states is critical for correct MFA results. Utilizing an ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) system, an analytical method for simultaneously quantifying the concentration of sugar metabolites and their mass isotopologue distribution (MID) was developed. The method performs with good linearity and coefficient of determination (R2) > 0.99, while the detection limit ranged from 0.1 to 50 mg L-1. Seven sugar metabolites were detected in a labeled Brevibacterium flavum sample using the method. The detected quantities ranged from 6.15 to 3704.21 mg L-1, and 13C abundance was between 12.77% and 66.67% in the fermentation fluid and 16.28% and 91.93% in the bacterial body. Overall, the method is efficient, accurate, and suitable for analysis of labeled sugar metabolites in 13C MFA studies.
Collapse
Affiliation(s)
- Yameng Zhao
- Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Shanghai Research Institute of Chemical Industry Co., Ltd, Shanghai, China
| | - Ruoning Fan
- Shanghai Research Institute of Chemical Industry Co., Ltd, Shanghai, China
| | - Chuyao Wang
- Shanghai Research Institute of Chemical Industry Co., Ltd, Shanghai, China
| | - Sen Xu
- Shanghai Research Institute of Chemical Industry Co., Ltd, Shanghai, China
| | - Long Xie
- Shanghai Research Institute of Chemical Industry Co., Ltd, Shanghai, China
| | - Jinghua Hou
- Shanghai Research Institute of Chemical Industry Co., Ltd, Shanghai, China
| | - Wen Lei
- Shanghai Research Institute of Chemical Industry Co., Ltd, Shanghai, China
| | - Jianjun Liu
- Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
| |
Collapse
|
122
|
de Las Fuentes L, Schwander KL, Brown MR, Bentley AR, Winkler TW, Sung YJ, Munroe PB, Miller CL, Aschard H, Aslibekyan S, Bartz TM, Bielak LF, Chai JF, Cheng CY, Dorajoo R, Feitosa MF, Guo X, Hartwig FP, Horimoto A, Kolčić I, Lim E, Liu Y, Manning AK, Marten J, Musani SK, Noordam R, Padmanabhan S, Rankinen T, Richard MA, Ridker PM, Smith AV, Vojinovic D, Zonderman AB, Alver M, Boissel M, Christensen K, Freedman BI, Gao C, Giulianini F, Harris SE, He M, Hsu FC, Kühnel B, Laguzzi F, Li X, Lyytikäinen LP, Nolte IM, Poveda A, Rauramaa R, Riaz M, Robino A, Sofer T, Takeuchi F, Tayo BO, van der Most PJ, Verweij N, Ware EB, Weiss S, Wen W, Yanek LR, Zhan Y, Amin N, Arking DE, Ballantyne C, Boerwinkle E, Brody JA, Broeckel U, Campbell A, Canouil M, Chai X, Chen YDI, Chen X, Chitrala KN, Concas MP, de Faire U, de Mutsert R, de Silva HJ, de Vries PS, Do A, Faul JD, Fisher V, Floyd JS, Forrester T, Friedlander Y, Girotto G, Gu CC, Hallmans G, Heikkinen S, Heng CK, Homuth G, Hunt S, Ikram MA, Jacobs DR, Kavousi M, Khor CC, Kilpeläinen TO, Koh WP, Komulainen P, Langefeld CD, Liang J, Liu K, Liu J, Lohman K, Mägi R, Manichaikul AW, McKenzie CA, Meitinger T, Milaneschi Y, Nauck M, Nelson CP, O'Connell JR, Palmer ND, Pereira AC, Perls T, Peters A, Polašek O, Raitakari OT, Rice K, Rice TK, Rich SS, Sabanayagam C, Schreiner PJ, Shu XO, Sidney S, Sims M, Smith JA, Starr JM, Strauch K, Tai ES, Taylor KD, Tsai MY, Uitterlinden AG, van Heemst D, Waldenberger M, Wang YX, Wei WB, Wilson G, Xuan D, Yao J, Yu C, Yuan JM, Zhao W, Becker DM, Bonnefond A, Bowden DW, Cooper RS, Deary IJ, Divers J, Esko T, Franks PW, Froguel P, Gieger C, Jonas JB, Kato N, Lakka TA, Leander K, Lehtimäki T, Magnusson PKE, North KE, Ntalla I, Penninx B, Samani NJ, Snieder H, Spedicati B, van der Harst P, Völzke H, Wagenknecht LE, Weir DR, Wojczynski MK, Wu T, Zheng W, Zhu X, Bouchard C, Chasman DI, Evans MK, Fox ER, Gudnason V, Hayward C, Horta BL, Kardia SLR, Krieger JE, Mook-Kanamori DO, Peyser PA, Province MM, Psaty BM, Rudan I, Sim X, Smith BH, van Dam RM, van Duijn CM, Wong TY, Arnett DK, Rao DC, Gauderman J, Liu CT, Morrison AC, Rotter JI, Fornage M. Gene-educational attainment interactions in a multi-population genome-wide meta-analysis identify novel lipid loci. Front Genet 2023; 14:1235337. [PMID: 38028628 PMCID: PMC10651736 DOI: 10.3389/fgene.2023.1235337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Accepted: 09/27/2023] [Indexed: 12/01/2023] Open
Abstract
Introduction: Educational attainment, widely used in epidemiologic studies as a surrogate for socioeconomic status, is a predictor of cardiovascular health outcomes. Methods: A two-stage genome-wide meta-analysis of low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), and triglyceride (TG) levels was performed while accounting for gene-educational attainment interactions in up to 226,315 individuals from five population groups. We considered two educational attainment variables: "Some College" (yes/no, for any education beyond high school) and "Graduated College" (yes/no, for completing a 4-year college degree). Genome-wide significant (p < 5 × 10-8) and suggestive (p < 1 × 10-6) variants were identified in Stage 1 (in up to 108,784 individuals) through genome-wide analysis, and those variants were followed up in Stage 2 studies (in up to 117,531 individuals). Results: In combined analysis of Stages 1 and 2, we identified 18 novel lipid loci (nine for LDL, seven for HDL, and two for TG) by two degree-of-freedom (2 DF) joint tests of main and interaction effects. Four loci showed significant interaction with educational attainment. Two loci were significant only in cross-population analyses. Several loci include genes with known or suggested roles in adipose (FOXP1, MBOAT4, SKP2, STIM1, STX4), brain (BRI3, FILIP1, FOXP1, LINC00290, LMTK2, MBOAT4, MYO6, SENP6, SRGAP3, STIM1, TMEM167A, TMEM30A), and liver (BRI3, FOXP1) biology, highlighting the potential importance of brain-adipose-liver communication in the regulation of lipid metabolism. An investigation of the potential druggability of genes in identified loci resulted in five gene targets shown to interact with drugs approved by the Food and Drug Administration, including genes with roles in adipose and brain tissue. Discussion: Genome-wide interaction analysis of educational attainment identified novel lipid loci not previously detected by analyses limited to main genetic effects.
Collapse
Affiliation(s)
- Lisa de Las Fuentes
- Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States
- Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States
| | - Karen L Schwander
- Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States
- Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States
| | - Michael R Brown
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Amy R Bentley
- Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States
| | - Thomas W Winkler
- Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany
| | - Yun Ju Sung
- Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States
| | - Patricia B Munroe
- Clinical Pharmacology, Queen Mary University of London, London, United Kingdom
- National Institute for Health Research Barts Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, United Kingdom
| | - Clint L Miller
- Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States
- Biochemistry and Molecular Genetics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States
- Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, United States
| | - Hugo Aschard
- Department of Epidemiology, Harvard School of Public Health, Boston, MA, United States
- Département de Génomes et Génétique, Institut Pasteur de Lille, Université de Lille, Lille, France
| | - Stella Aslibekyan
- School of Public Health, Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Traci M Bartz
- Cardiovascular Health Research Unit, University of Washington, Seattle, WA, United States
- Department of Biostatistics, University of Washington, Seattle, WA, United States
| | - Lawrence F Bielak
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States
| | - Jin Fang Chai
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore
| | - Ching-Yu Cheng
- Ocular Epidemiology, Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
- Ophthalmology and Visual Sciences Academic Clinical Program, Medical School, Duke-National University of Singapore, Singapore, Singapore
| | - Rajkumar Dorajoo
- Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore
| | - Mary F Feitosa
- Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States
| | - Xiuqing Guo
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Los Angeles, CA, United States
| | - Fernando P Hartwig
- Postgraduate Programme in Epidemiology, Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil
- Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom
| | - Andrea Horimoto
- Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, SP, Brazil
| | - Ivana Kolčić
- University of Split School of Medicine, Split, Croatia
- Algebra University College, Zagreb, Croatia
| | - Elise Lim
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States
| | - Yongmei Liu
- Division of Cardiology, Department of Medicine, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, United States
| | - Alisa K Manning
- Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, United States
- Department of Medicine, Harvard Medical School, Boston, MA, United States
| | - Jonathan Marten
- Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom
| | - Solomon K Musani
- Jackson Heart Study, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States
| | - Raymond Noordam
- Section of Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands
| | - Sandosh Padmanabhan
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
| | - Tuomo Rankinen
- Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, United States
| | - Melissa A Richard
- Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Paul M Ridker
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, United States
- Harvard Medical School, Boston, MA, United States
| | - Albert V Smith
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, United States
- Icelandic Heart Association, Kopavogur, Iceland
| | - Dina Vojinovic
- Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
- Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
| | - Alan B Zonderman
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States
- National Institutes of Health, Baltimore, MD, United States
| | - Maris Alver
- Estonian Genome Center, Insititute of Genomics, University of Tartu, Tartu, Estonia
| | - Mathilde Boissel
- European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France
- University of Lille, Lille University Hospital, Lille, France
| | - Kaare Christensen
- Unit of Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark
| | - Barry I Freedman
- Nephrology Division, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States
| | - Chuan Gao
- Molecular Genetics and Genomics Program, Wake Forest School of Medicine, Winston-Salem, NC, United States
| | - Franco Giulianini
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, United States
| | - Sarah E Harris
- Department of Psychology, The University of Edinburgh, Edinburgh, United Kingdom
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, United Kingdom
| | - Meian He
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Fang-Chi Hsu
- Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
| | - Brigitte Kühnel
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
| | - Federica Laguzzi
- Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Xiaoyin Li
- Department of Population and Quantitative Health Sciences, Cleveland, OH, United States
- Department of Mathematics and Statistics, St. Cloud State University, St. Cloud, MN, United States
| | - Leo-Pekka Lyytikäinen
- Department of Clinical Chemistry, University of Tampere, Tampere, Finland
- Finnish Cardiovascular Research Center, University of Tampere, Tampere, Finland
| | - Ilja M Nolte
- Unit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
| | - Alaitz Poveda
- Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Rainer Rauramaa
- Kuopio Research Institute of Exercise Medicine, Kuopio, Finland
| | - Muhammad Riaz
- Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom
| | - Antonietta Robino
- Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy
| | - Tamar Sofer
- Biostatistics, Department of Medicine, Brigham and Women's Hospital, Harvard University, Boston, MA, United States
| | - Fumihiko Takeuchi
- Department of Gene Diagnostics and Therapeutics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
| | - Bamidele O Tayo
- Department of Public Health Sciences, Loyola University Chicago, Maywood, IL, United States
| | - Peter J van der Most
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
| | - Niek Verweij
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
| | - Erin B Ware
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, United States
| | - Stefan Weiss
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald and University of Greifswald, Greifswald, Germany
- German Center for Cardiovascular Research, Greifswald, Germany
| | - Wanqing Wen
- Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States
| | - Lisa R Yanek
- Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States
| | - Yiqiang Zhan
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Najaf Amin
- Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
| | - Dan E Arking
- Department of Genetic Medicine, McKusick-Nathans Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States
| | - Christie Ballantyne
- Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, United States
- Houston Methodist Debakey Heart and Vascular Center, Houston, TX, United States
| | - Eric Boerwinkle
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, United States
| | - Jennifer A Brody
- Cardiovascular Health Research Unit, University of Washington, Seattle, WA, United States
| | - Ulrich Broeckel
- Section on Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States
| | - Archie Campbell
- Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, United Kingdom
- Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom
| | - Mickaël Canouil
- European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France
- University of Lille, Lille University Hospital, Lille, France
| | - Xiaoran Chai
- Data Science Unit, Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
| | - Yii-Der Ida Chen
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Los Angeles, CA, United States
| | - Xu Chen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Kumaraswamy Naidu Chitrala
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States
| | - Maria Pina Concas
- Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy
| | - Ulf de Faire
- Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Renée de Mutsert
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands
| | - H Janaka de Silva
- Department of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
| | - Paul S de Vries
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Ahn Do
- Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States
- Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States
| | - Jessica D Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, United States
| | - Virginia Fisher
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States
| | - James S Floyd
- Cardiovascular Health Research Unit, University of Washington, Seattle, WA, United States
| | - Terrence Forrester
- Tropical Medicine Research Institute, University of the West Indies, Mona, Jamaica
| | - Yechiel Friedlander
- Braun School of Public Health, Hadassah Medical Center, Hebrew University, Jerusalem, Israel
| | - Giorgia Girotto
- Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy
| | - C Charles Gu
- Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States
| | - Göran Hallmans
- Section for Nutritional Research, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
| | - Sami Heikkinen
- Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland
| | - Chew-Kiat Heng
- Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Khoo Teck Puat National University Children's Medical Institute, National University Health System, Singapore, Singapore
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald and University of Greifswald, Greifswald, Germany
| | - Steven Hunt
- Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States
- Department of Genetic Medicine, Weill Cornell Medicine in Qatar, Doha, Qatar
| | - M Arfan Ikram
- Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
| | - David R Jacobs
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States
| | - Maryam Kavousi
- Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
| | - Chiea Chuen Khor
- Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore
| | - Tuomas O Kilpeläinen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Department of Environmental Medicine and Public Health, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Woon-Puay Koh
- Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore, Singapore
| | | | - Carl D Langefeld
- Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
| | - Jingjing Liang
- Department of Population and Quantitative Health Sciences, Cleveland, OH, United States
| | - Kiang Liu
- Epidemiology, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
| | - Jianjun Liu
- Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore
| | - Kurt Lohman
- Division of Cardiology, Department of Medicine, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, United States
| | - Reedik Mägi
- Estonian Genome Center, Insititute of Genomics, University of Tartu, Tartu, Estonia
| | - Ani W Manichaikul
- Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States
| | - Colin A McKenzie
- Tropical Medicine Research Institute, University of the West Indies, Mona, Jamaica
| | - Thomas Meitinger
- Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Human Genetics, Technische Universität München, Munich, Germany
| | | | - Matthias Nauck
- German Center for Cardiovascular Research, Greifswald, Germany
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Christopher P Nelson
- Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom
| | - Jeffrey R O'Connell
- Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, United States
- Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
| | - Nicholette D Palmer
- Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, United States
| | - Alexandre C Pereira
- Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, SP, Brazil
| | - Thomas Perls
- Geriatrics Section, Department of Medicine, Boston University School of Medicine, Boston, MA, United States
| | - Annette Peters
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- German Center for Cardiovascular Research, Neuherberg, Germany
| | - Ozren Polašek
- University of Split School of Medicine, Split, Croatia
- Algebra University College, Zagreb, Croatia
| | - Olli T Raitakari
- Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland
- Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
- Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland
| | - Kenneth Rice
- Department of Biostatistics, University of Washington, Seattle, WA, United States
| | - Treva K Rice
- Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States
| | - Stephen S Rich
- Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States
| | - Charumathi Sabanayagam
- Ocular Epidemiology, Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
- Ophthalmology and Visual Sciences Academic Clinical Program, Medical School, Duke-National University of Singapore, Singapore, Singapore
| | - Pamela J Schreiner
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States
| | - Xiao-Ou Shu
- Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States
| | - Stephen Sidney
- Division of Research, Kaiser Permanente of Northern California, Oakland, CA, United States
| | - Mario Sims
- Jackson Heart Study, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States
| | - Jennifer A Smith
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, United States
| | - John M Starr
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, United Kingdom
- Alzheimer Scotland Dementia Research Centre, The University of Edinburgh, Edinburgh, United Kingdom
| | - Konstantin Strauch
- German Research Center for Environmental Health, Helmholtz Zentrum München, Institute of Genetic Epidemiology, Neuherberg, Germany
- Institute of Medical Informatics Biometry and Epidemiology, Ludwig-Maximilians-Universität München, Munich, Germany
| | - E Shyong Tai
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore
- Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore
- Duke-National University of Singapore Medical School, Singapore, Singapore
| | - Kent D Taylor
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Los Angeles, CA, United States
| | - Michael Y Tsai
- Department of Laboratory Medicine and Pathology, Minneapolis, MN, United States
| | - André G Uitterlinden
- Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
- Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands
| | - Diana van Heemst
- Section of Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands
| | - Melanie Waldenberger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
| | - Ya-Xing Wang
- Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Institute of Ophthalmology, Capital Medical University, Beijing, China
| | - Wen-Bin Wei
- Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Institute of Ophthalmology, Capital Medical University, Beijing, China
| | - Gregory Wilson
- Jackson Heart Study Graduate Training Center, School of Public, Jackson State University, Jackson, MS, United States
| | - Deng Xuan
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States
| | - Jie Yao
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Los Angeles, CA, United States
| | - Caizheng Yu
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jian-Min Yuan
- Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States
- Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States
| | - Wei Zhao
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States
| | - Diane M Becker
- Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States
| | - Amélie Bonnefond
- European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France
- University of Lille, Lille University Hospital, Lille, France
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
| | - Donald W Bowden
- Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, United States
| | - Richard S Cooper
- Department of Public Health Sciences, Loyola University Chicago, Maywood, IL, United States
| | - Ian J Deary
- Department of Psychology, The University of Edinburgh, Edinburgh, United Kingdom
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, United Kingdom
| | - Jasmin Divers
- Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
| | - Tõnu Esko
- Estonian Genome Center, Insititute of Genomics, University of Tartu, Tartu, Estonia
- Broad Institute, Massachusetts Institute of Technology and Harvard University, Boston, MA, United States
| | - Paul W Franks
- Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden
- Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
- Department of Nutrition, Harvard Chan School of Public Health, Boston, MA, United States
| | - Philippe Froguel
- European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France
- University of Lille, Lille University Hospital, Lille, France
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
| | - Christian Gieger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- German Center for Diabetes Research, Neuherberg, Germany
| | - Jost B Jonas
- Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Institute of Ophthalmology, Capital Medical University, Beijing, China
- Department of Ophthalmology, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
- Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland
| | - Norihiro Kato
- Department of Gene Diagnostics and Therapeutics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
| | - Timo A Lakka
- Kuopio Research Institute of Exercise Medicine, Kuopio, Finland
- Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland
- Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland
| | - Karin Leander
- Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Terho Lehtimäki
- Department of Clinical Chemistry, University of Tampere, Tampere, Finland
- Finnish Cardiovascular Research Center, University of Tampere, Tampere, Finland
| | - Patrik K E Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Kari E North
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
| | - Ioanna Ntalla
- Clinical Pharmacology, Queen Mary University of London, London, United Kingdom
- Celgene, Bristol Myers Squibb, Mississauga, ON, Canada
| | | | - Nilesh J Samani
- Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom
| | - Harold Snieder
- Unit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
| | - Beatrice Spedicati
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
| | - Pim van der Harst
- Division Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands
| | - Henry Völzke
- German Center for Cardiovascular Research, Greifswald, Germany
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Lynne E Wagenknecht
- Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
| | - David R Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, United States
| | - Mary K Wojczynski
- Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States
| | - Tangchun Wu
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Wei Zheng
- Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States
| | - Xiaofeng Zhu
- Department of Population and Quantitative Health Sciences, Cleveland, OH, United States
| | - Claude Bouchard
- Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, United States
| | - Daniel I Chasman
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, United States
- Harvard Medical School, Boston, MA, United States
| | - Michele K Evans
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States
- National Institute on Aging, National Institutes of Health, Bethesda, MD, United States
| | - Ervin R Fox
- Division of Cardiology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Caroline Hayward
- Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom
| | - Bernardo L Horta
- Postgraduate Programme in Epidemiology, Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Sharon L R Kardia
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States
| | - Jose Eduardo Krieger
- Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, SP, Brazil
| | - Dennis O Mook-Kanamori
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands
- Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands
| | - Patricia A Peyser
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States
| | - Michael M Province
- Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States
| | - Bruce M Psaty
- Cardiovascular Health Research Unit, University of Washington, Seattle, WA, United States
- Department of Epidemiology, University of Washington, Seattle, WA, United States
- Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States
| | - Igor Rudan
- Centre for Global Health, The Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom
| | - Xueling Sim
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore
| | - Blair H Smith
- Division of Population Health and Genomics, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom
| | - Rob M van Dam
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore
- Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States
| | - Cornelia M van Duijn
- Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
- Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
| | - Tien Yin Wong
- Ocular Epidemiology, Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
- Ophthalmology and Visual Sciences Academic Clinical Program, Medical School, Duke-National University of Singapore, Singapore, Singapore
| | - Donna K Arnett
- College of Public Health, Dean's Office, University of Kentucky, Lexington, KY, United States
| | - Dabeeru C Rao
- Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States
| | - James Gauderman
- Division of Biostatistics, Population and Public Health Sciences, University of Southern California, Los Angeles, CA, United States
| | - Ching-Ti Liu
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States
| | - Alanna C Morrison
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Jerome I Rotter
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Los Angeles, CA, United States
| | - Myriam Fornage
- Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States
- Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, United States
| |
Collapse
|
123
|
Li X, Wu Y, Li G, Shen W, Xiao W, Liu J, Hu W, Lu H, Huang F. The combined effects of exposure to multiple PM 2.5 components on overweight and obesity in middle-aged and older adults: a nationwide cohort study from 125 cities in China. Environ Geochem Health 2023; 45:8749-8760. [PMID: 37726540 DOI: 10.1007/s10653-023-01741-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Accepted: 08/21/2023] [Indexed: 09/21/2023]
Abstract
The prevalence of overweight or obesity increased rapidly over the past decades in most countries, including China. However, little evidence exists about the effects of long-term exposure to PM2.5 components on overweight or obesity, particularly in developing countries. We measured different weight stages according to body mass index (BMI), and investigated the effects of exposure to PM2.5 components (ammonium [[Formula: see text]], sulfate [[Formula: see text]], nitrate [[Formula: see text]], black carbon and organic matter) on different BMI levels in middle-aged and elderly people of China. Our study explored the effects of single and multiple air pollution exposures on overweight and obesity by using the Generalized Linear Model and Quantile g-Computation model (QgC). This study found a significantly positive association between five PM2.5 components and overweight/obesity. In the QgC model, there was still a positive association between multiple exposure to PM2.5 components and overweight when all PM2.5 components were considered as a whole. In addition, males, the elderly, and urban residents were also more sensitive to five PM2.5 components.
Collapse
Affiliation(s)
- Xue Li
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Yueyang Wu
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Guoao Li
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Wenbin Shen
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Wei Xiao
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Jianjun Liu
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Wenlei Hu
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Huanhuan Lu
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China
| | - Fen Huang
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Shushan District, Hefei, 230032, Anhui, China.
| |
Collapse
|
124
|
Zeng Q, Liu J, Mu J, Yang J, Gao Q, Wu F, Zhou H. Optimal biopsy site for the diagnosis of oral pemphigus vulgaris and mucous membrane pemphigoid: a systematic review and meta-analysis. Int J Oral Maxillofac Surg 2023; 52:1162-1172. [PMID: 37268547 DOI: 10.1016/j.ijom.2023.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2022] [Revised: 05/07/2023] [Accepted: 05/11/2023] [Indexed: 06/04/2023]
Abstract
The aim of this study was to critically evaluate the diagnostic yields of direct immunofluorescence (DIF) analysis on perilesional and normal-appearing mucosa biopsy samples, to determine the optimal biopsy site for patients presenting with oral pemphigus vulgaris (PV) or mucous membrane pemphigoid (MMP). Electronic databases and article bibliographies were searched in December 2022. The primary outcome was the rate of DIF positivity. Of 374 records identified after the elimination of duplicates, 21 studies with 1027 samples were ultimately included. Meta-analysis revealed a pooled DIF positivity rate of 99.6% (95% confidence interval (CI) 97.4-100.0%, I2 = 0%) for PV and 92.6% (95% CI 87.9-96.5%, I2 = 44%) for MMP for biopsies from perilesional sites, and of 95.4% (95% CI 88.6-99.5%, I2 = 0%) for PV and 94.1% (95% CI 86.5-99.2%, I2 = 42%) for MMP for biopsies from normal-appearing sites. For MMP, there was no significant difference in the rate of DIF positivity between the two biopsy sites (odds ratio 1.91, 95% CI 0.91-4.01, I2 = 0%). The results suggest that the perilesional mucosa remains the optimal biopsy site for DIF diagnosis of oral PV, while the normal-appearing mucosa biopsy is optimal for oral MMP.
Collapse
Affiliation(s)
- Q Zeng
- State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - J Liu
- State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - J Mu
- State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - J Yang
- State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Q Gao
- Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - F Wu
- State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
| | - H Zhou
- State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| |
Collapse
|
125
|
Zeng M, Issotina Zibrila A, Li X, Liu X, Wang X, Zeng Z, Wang Z, He Y, Meng L, Liu J. Pyridostigmine ameliorates pristane-induced arthritis symptoms in Dark Agouti rats. Scand J Rheumatol 2023; 52:627-636. [PMID: 37339380 DOI: 10.1080/03009742.2023.2196783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Accepted: 03/27/2023] [Indexed: 06/22/2023]
Abstract
OBJECTIVE Rheumatoid arthritis (RA) is a chronic inflammatory disorder. Pyridostigmine (PYR), an acetylcholinesterase (AChE) inhibitor, has been shown to reduce inflammation and oxidative stress in several animal models for inflammation-associated conditions. The present study aimed to investigate the effects of PYR on pristane-induced (PIA) in Dark Agouti (DA) rats. METHOD DA rats were intradermally infused with pristane to establish the PIA model, which was treated with PYR (10 mg/kg/day) for 27 days. The effects of PYR on synovial inflammation, oxidative stress, and gut microbiota were evaluated by determining arthritis scores, H&E staining, quantitative polymerase chain reaction, and biochemical assays, as well as 16S rDNA sequencing. RESULTS Pristane induced arthritis, with swollen paws and body weight loss, increased arthritis scores, synovium hyperplasia, and bone or cartilage erosion. The expression of pro-inflammatory cytokines in synovium was higher in the PIA group than in the control group. PIA rats also displayed elevated levels of malondialdehyde, nitric oxide, superoxide dismutase, and catalase in plasma. Moreover, sequencing results showed that the richness, diversity, and composition of the gut microbiota dramatically changed in PIA rats. PYR abolished pristane-induced inflammation and oxidative stress, and corrected the gut microbiota dysbiosis. CONCLUSION The results of this study support the protective role of PYR in PIA in DA rats, associated with the attenuation of inflammation and correction of gut microbiota dysbiosis. These findings open new perspectives for pharmacological interventions in animal models of RA.
Collapse
Affiliation(s)
- M Zeng
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, PR China
| | - A Issotina Zibrila
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, PR China
| | - X Li
- National Joint Engineering Research Center of Biodiagnostics and Biotherapy, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, PR China
| | - X Liu
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, PR China
| | - X Wang
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, PR China
| | - Z Zeng
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, PR China
| | - Z Wang
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, PR China
| | - Y He
- Department of Traditional Chinese Medicine, Shaanxi University of Chinese Medicine, Xianyang, PR China
| | - L Meng
- Institute of Molecular and Translational Medicine, and Department of Biochemistry and Molecular Biology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an, PR China
| | - J Liu
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, PR China
| |
Collapse
|
126
|
Liu J, Ma R, He Y, Luo XY, Han W, Han TT, Wang Y, Zhang XH, Xu LP, Liu KY, Huang XJ, Sun YQ. [Prognostic analysis of patients with acute leukemia and central nervous system involvement undergoing allogeneic hematopoietic stem cell transplantation]. Zhonghua Nei Ke Za Zhi 2023; 62:1295-1302. [PMID: 37935495 DOI: 10.3760/cma.j.cn112138-20230601-00285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/09/2023]
Abstract
Objective: To investigate the potential of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in mitigating the adverse prognosis associated with central nervous system leukemia (CNSL) and to assess the significance of prophylactic intrathecal injection. Methods: A retrospective cohort analysis was conducted involving 30 patients with acute leukemia who had a history of CNSL who underwent allo-HSCT at Peking University People's Hospital between September 2012 and March 2018 (referred to as the CNSL-positive group). In addition, 90 patients with acute leukemia were selected from the same period who underwent allo-HSCT without a history of CNSL (referred to as the CNSL-negative group) and a rigorous 1∶3 matching was performed based on disease type, disease status, and transplantation type to form the control group. The prognosis between the two groups was compared using Kaplan-Meier analysis and the high-risk factors for CNSL relapse post-transplant were identified through Cox proportional-hazards model. Results: The median age of patients in the CNSL-negative group was significantly higher than that of patients in the CNSL-positive group (32 years vs. 24 years, P=0.014). No significant differences were observed in baseline data, including sex, disease type, disease status at transplantation, donor-recipient relationship, and human leukocyte antigen consistency between the two groups. The median follow-up time was 568 days (range: 21-1 852 days). The 4-year cumulative incidence of relapse (71.4%±20.9% vs. 29.3%±11.5%, P=0.005) and the cumulative incidence of CNSL post-transplant (33.6%±9.2% vs. 1.2%±1.2%, P<0.001) were significantly higher in the CNSL-positive group than in the CNSL-negative group. Furthermore, the 4-year leukemia-free survival rate in the CNSL-positive group was significantly lower than that in the CNSL-negative group (23.1%±17.0% vs. 71.5%±11.6%, P<0.001). However, no significant differences were observed in the 4-year cumulative transplant-related mortality and overall survival rates between the two groups (both P>0.05). Multivariate analysis revealed that a history of CNSL before transplantation (HR=25.050, 95%CI 3.072-204.300, P=0.003) was identified as high-risk factors for CNSL relapse post-transplant. Conversely, haploidentical transplantation was associated with a reduced risk of CNSL relapse post-transplant (HR=0.260, 95%CI 0.073-0.900, P=0.034). Within the CNSL-positive group, seven patients received prophylactic intrathecal therapy after transplantation, and their CNSL relapse rate was significantly lower than that of the 23 patients who did not receive intrathecal therapy after transplantation (0/7 vs. 9/23, P=0.048). Conclusions: Patients with a history of CNSL have a higher risk of relapse and experience poorer leukemia-free survival following transplantation. The use of prophylactic intrathecal injection shows promise in mitigating CNSL relapse rates, although further validation through prospective studies is necessary to substantiate these observations.
Collapse
Affiliation(s)
- J Liu
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - R Ma
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - Y He
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - X Y Luo
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - W Han
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - T T Han
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - Y Wang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - X H Zhang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - L P Xu
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - K Y Liu
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - X J Huang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| | - Y Q Sun
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China
| |
Collapse
|
127
|
Wang Y, Chen Z, Zhu Y, Zhao H, Li L, Huang G, Xue W, Chen R, Liu J. Total-body [ 68 Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [ 68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer. Eur J Nucl Med Mol Imaging 2023; 50:4096-4106. [PMID: 37578502 DOI: 10.1007/s00259-023-06355-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 07/22/2023] [Indexed: 08/15/2023]
Abstract
PURPOSE The purpose of this study was to assess whether total-body [68 Ga]Ga-PSMA-11 PET/CT could improve the detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer. METHODS Two hundred biochemical recurrent prostate cancer patients with similar clinicopathological characteristics were included, of whom 100 patients underwent early total-body [68 Ga]Ga-PSMA-11 PET/CT and diuretic-delayed total-body [68 Ga]Ga-PSMA-11 PET/CT, and the other 100 patients received early conventional [68 Ga]Ga-PSMA-11 PET/CT and diuretic-delayed conventional [68 Ga]Ga-PSMA-11 PET/CT. The detection rates of total-body [68 Ga]Ga-PSMA-11 PET/CT and conventional [68 Ga]Ga-PSMA-11 PET/CT were compared using a chi-square test and stratified analysis. The image quality of total-body [68 Ga]Ga-PSMA PET/CT and conventional [68 Ga]Ga-PSMA-11 PET/CT was compared based on subjective scoring and objective parameters. Subjective scoring was conducted from background noise and lesion prominence using a 5-point scale. Objective parameters were evaluated by SUVmax, SUVmean, the standard deviation (SD) of SUV, and the signal-to-noise ratio (SNR) of liver and gluteus maximus. The SUVmax of the recurrent lesions was also measured. RESULTS The liver SD of the total-body [68 Ga]Ga-PSMA-11 PET/CT was significantly lower than that of conventional [68 Ga]Ga-PSMA-11 PET/CT, the SNR was significantly higher than that of conventional [68 Ga]Ga-PSMA-11 PET/CT, and the subjective evaluation was significantly better than that of conventional [68 Ga]Ga-PSMA-11 PET/CT. The detection rate of total-body [68 Ga]Ga-PSMA PET/CT for biochemical recurrence of prostate cancer was significantly higher than that of conventional [68 Ga]Ga-PSMA-11 PET/CT (91.0% vs. 74.0%, P = 0.003). Total-body [68 Ga]Ga-PSMA-11 PET/CT had better detection efficiency for patients with a Gleason score ≤ 8 or PSA ≤ 2 ng/ml. The advantages of diuretic-delayed total-body [68 Ga]Ga-PSMA-11 PET/CT were more obvious. CONCLUSION Total-body [68 Ga]Ga-PSMA-11 PET/CT could significantly improve the detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer.
Collapse
Affiliation(s)
- Yining Wang
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Zijun Chen
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Yinjie Zhu
- Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Haitao Zhao
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Lianghua Li
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Gang Huang
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Wei Xue
- Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Ruohua Chen
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
| | - Jianjun Liu
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
| |
Collapse
|
128
|
Le QF, Liu J, Chen L. The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study. Eur Rev Med Pharmacol Sci 2023; 27:10730-10735. [PMID: 37975398 DOI: 10.26355/eurrev_202311_34353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
Abstract
OBJECTIVE This study aims to explore the value of serum lipoprotein-associated phospholipase A2 (Lp-PLA2), ischemia-modified albumin (IMA), and cystatin C (Cys-C) in predicting the risk of coronary heart disease (CHD). PATIENTS AND METHODS Clinical data from 104 CHD patients admitted to our hospital from January 2020 to December 2022 were analyzed. Of them, 31 patients had stable angina (Group-S), 36 patients were diagnosed with unstable angina (Group-U), and 37 patients had acute myocardial infarction (Group-A). Additionally, clinical data from 35 healthy individuals undergoing physical examination during the same time period were selected as the control group. Levels of blood lipid indicators and serum Lp-PLA2, IMA, and Cys-C levels were compared between the groups. RESULTS The rates of diabetes, hypertension, and smoking in Group-S, Group-U, and Group-A were significantly higher than those in the control group (p<0.05). Levels of Lp-PLA2, IMA, and Cys-C in Group-S, Group-U, and Group-A were significantly higher than those in the control group (p<0.05). Levels of Lp-PLA2, IMA, and Cys-C in Group-U and Group-A were significantly higher than those in Group-S, and Group-A had the highest value of these indexes (p<0.05). Multivariate logistic regression analysis showed that Lp-PLA2, Cys-C, and IMA were important risk factors for the onset of CHD (p<0.05). Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) of Lp-PLA2, IMA, and Cys-C predicting the occurrence of CHD was 0.775, 0.835, and 0.735, respectively. The combined prediction of the three factors has an AUC of 0.920, which is higher than the individual prediction. CONCLUSIONS Lp-PLA2, IMA, and Cys-C are closely related to the onset and progression of CHD. These indicators, therefore, can be used in clinical practice to predict and evaluate CHD.
Collapse
Affiliation(s)
- Q-F Le
- Department of Clinical Laboratory, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China.
| | | | | |
Collapse
|
129
|
Zhu X, Li Z, Liu J, Guo J, Xian J, Wu J. MRI features for prediction of the intravenous chemotherapy effect in patients with retinoblastoma. Clin Radiol 2023; 78:e864-e871. [PMID: 37596180 DOI: 10.1016/j.crad.2023.07.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2023] [Revised: 07/07/2023] [Accepted: 07/17/2023] [Indexed: 08/20/2023]
Abstract
AIM To investigate the value of orbital magnetic resonance imaging (MRI) features in predicting the efficacy of intravenous chemotherapy (IVC) for patients with retinoblastoma (RB). MATERIALS AND METHODS The pretreatment clinical and MRI data of 100 eyes from 80 RB patients who underwent IVC were collected retrospectively. There were 59 eyes in the effective group and 41 eyes in the ineffective group, and the baseline data of the two groups were compared statistically. Three radiologists reviewed and evaluated each lesion independently based on 25 MRI features. The predictive values of the MRI features for IVC efficacy were assessed by multi-factor logistic regression analysis, and their odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Receiver operating characteristic curves (ROCs) with the area under the curve (AUC) were used to determine the predictive abilities. A predictive model was constructed by integrating all independent predictors visualised by the nomogram. RESULTS There were no statistically significant differences in sex or age between the effective and ineffective groups. The results of multivariate regression analysis showed that laterality, margin, and anterior eye segment enhancement were identified as independent factors that could predict IVC efficacy. The predictive model combining these three features was constructed, and it had an AUC of 0.732 (95% CI: 0.633, 0.831, p<0.01), a sensitivity of 71.2%, and a specificity of 70.7%. CONCLUSION The data demonstrate that the orbital MRI features can be used to predict IVC efficiency before RB patients are treated.
Collapse
Affiliation(s)
- X Zhu
- Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Department of Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China
| | - Z Li
- Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
| | - J Liu
- Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
| | - J Guo
- Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
| | - J Xian
- Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
| | - J Wu
- Department of Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
| |
Collapse
|
130
|
Zhuang M, Chen H, Li Y, Mei S, Liu J, Du B, Wang X, Wang X, Tang J. Laparoscopic posterior pelvic exenteration is safe and feasible for locally advanced primary rectal cancer in female patients: a comparative study from China PelvEx collaborative. Tech Coloproctol 2023; 27:1109-1117. [PMID: 37243857 DOI: 10.1007/s10151-023-02824-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Accepted: 05/08/2023] [Indexed: 05/29/2023]
Abstract
PURPOSE Posterior pelvic exenteration (PPE) for locally advanced rectal cancer is a technical and challenging procedure. The safety and feasibility of laparoscopic PPE remain to be determined. This study aims to compare short-term and survival outcomes of laparoscopic PPE (LPPE) with open PPE (OPPE) in female patients. METHOD From January 2015 to December 2020, data from 105 female patients who underwent PPE at three institutions were retrospectively analyzed. The short-term and oncological outcomes between LPPE and OPPE were compared. RESULTS A total of 54 cases with LPPE and 51 cases with OPPE were enrolled. The operative time (240 vs. 295 min, p = 0.009), blood loss (100 vs. 300 ml, p < 0.001), surgical site infection (SSI) rate (20.4% vs. 58.8%, p = 0.003), urinary retention rate (3.7% vs. 17.6%, p = 0.020), and postoperative hospital stay (10 vs. 13 days, p = 0.009) were significantly lower in the LPPE group. The two groups showed no significant differences in the local recurrence rate (p = 0.296), 3-year overall survival (p = 0.129), or 3-year disease-free survival (p = 0.082). A higher CEA level (HR 1.02, p = 0.002), poor tumor differentiation (HR 3.05, p = 0.004), and (y)pT4b stage (HR 2.35, p = 0.035) were independent risk factors for disease-free survival. CONCLUSION LPPE is safe and feasible for locally advanced rectal cancers and shows lower operative time and blood loss, fewer SSI complications, and better preservation of bladder function without compromising oncological outcomes.
Collapse
Affiliation(s)
- M Zhuang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - H Chen
- Department of General Surgery, Tianjin Fifth Central Hospital, Tianjin, 300450, China
| | - Y Li
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - S Mei
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - J Liu
- Department of General Surgery, Peking University First Hospital, Beijing, 100034, China
| | - B Du
- Department of Colorectal Surgery, Gansu Provincial Hospital, Lanzhou, 730000, China
| | - X Wang
- Department of General Surgery, Peking University First Hospital, Beijing, 100034, China
| | - Xishan Wang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
| | - J Tang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
| |
Collapse
|
131
|
Shi Y, Tang L, Fei M, Liu J, Wang Z. 68 Ga-FAPI-Avid Submental Ectopic Papillary Thyroid Carcinoma and Lateral Neck Lymphadenopathy With Low 18 F-FDG Uptake. Clin Nucl Med 2023; 48:974-975. [PMID: 37703468 DOI: 10.1097/rlu.0000000000004810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/15/2023]
Abstract
ABSTRACT Ectopic thyroid tissue is rare and generally occurs along the thyroglossal duct or in lateral cervical region. We reported 18 F-FDG and 68 Ga-FAPI findings of a 28-year-old woman with previously diagnosed BRAF -mutated lateral lymph node metastasis of unknown primary site. Low 18 F-FDG but increased 68 Ga-FAPI uptake was seen in a submental pretracheal nodular lesion. Postsurgical pathologic report verified the diagnosis of ectopic papillary thyroid carcinoma. High FAP expression in the tumor sample corresponded to its imaging manifestations.
Collapse
Affiliation(s)
- Yuan Shi
- From the Departments of Head and Neck Surgery
| | - Linglin Tang
- Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Mengjia Fei
- From the Departments of Head and Neck Surgery
| | - Jianjun Liu
- Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | | |
Collapse
|
132
|
Chen Z, Wang Y, Yang X, Li L, Huo Y, Yu X, Xiao X, Zhang C, Chen Y, Zhao H, Zhou Y, Huang G, Liu J, Chen R. Feasibility of acquisitions using total-body PET/CT with a half-dose [ 68Ga]Ga-FAPI-04 activity in oncology patients. Eur J Nucl Med Mol Imaging 2023; 50:3961-3969. [PMID: 37535107 DOI: 10.1007/s00259-023-06354-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2023] [Revised: 06/20/2023] [Accepted: 07/23/2023] [Indexed: 08/04/2023]
Abstract
BACKGROUND [68Ga]Ga-FAPI-04 (gallium-68-labeled fibroblast activation protein inhibitor-04) PET/CT has been widely used in diagnosing malignant tumors. Total-body PET/CT has a long axial field of view and provides higher sensitivity compared to traditional PET/CT. However, whether the reduced injected dose of [68Ga]Ga-FAPI-04 could obtain qualified imaging has not been evaluated. PURPOSE To explore the effect of half-dose [68Ga]Ga-FAPI-04 on image quality and tumor detectability in oncology patients. METHODS A total of twenty-seven patients with tumors or clinically suspected tumors were included, and all patients were scanned with total-body PET/CT after an injected dose of 0.84-1.14 MBq/kg [68Ga]Ga-FAPI-04. All patients obtained superior image quality with 300 s original acquisition time. Images were reconstructed using 180 s, 120 s, 60 s, 40 s, 30 s, 20 s scanning duration by ordered subset expectation maximization algorithm. The subjective image quality of all patients in each time group was scored using 5-point Likert scale. Mediastinal blood pool, liver, spleen, and muscle were analyzed as background using semi-quantitative parameters maximum standardized uptake values (SUVmax), mean standardized uptake values (SUVmean), standard deviation (SD), and signal to noise ratio (SNR). The lesion detection rate, SUVmax, and tumor-to-background ratio (TBR) were calculated for tumors confirmed by pathology. RESULTS The subjective image quality score decreased with the shortening of scanning time; however, both 180 s and 120 s images met the diagnostic requirements in terms of overall quality, lesion conspicuity, and image noise. The SUVmax of background increased with the reduction of scanning time, while the SUVmean was relatively stable. With the shortening of scanning time, the SD gradually increased, and the SNR gradually decreased, which was consistent with subjective image quality scores. In 180 s and 120 s images, all 11 primary lesions and 79 metastatic lesions were detected. The SUVmax of tumor focus showed an increasing trend as same as the background. Compared with 300 s, the TBR muscle had no statistical difference in 180 s and 120 s. CONCLUSIONS Half-dose [68Ga]Ga-FAPI-04 in total-body PET/CT imaging can shorten the acquisition time to 120 s with acceptable subjective image quality and 100% tumor detection rate. Total-body PET/CT imaging with a half-dose [68Ga]Ga-FAPI-04 and reduced acquisition time can be used in radiation-sensitive and poor tolerant to prolong horizontal positioning and waiting time populations such as children and gravidas.
Collapse
Affiliation(s)
- Zijun Chen
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China
| | - Yining Wang
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China
| | - Xinlan Yang
- Central Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, China
| | - Lianghua Li
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China
| | - Yanmiao Huo
- Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Xiaofeng Yu
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China
| | - Xiuying Xiao
- Department of Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
| | - Chenpeng Zhang
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China
| | - Yumei Chen
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China
| | - Haitao Zhao
- Central Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, China
| | - Yun Zhou
- Central Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, China
| | - Gang Huang
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
| | - Jianjun Liu
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
| | - Ruohua Chen
- Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
- Institute of Clinical Nuclear Medicine, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
| |
Collapse
|
133
|
Dong HJ, Wang R, Wang X, Liu J, Pu BZX, Li J, Mo YJ, Fu M, Li G, Luo JF. [Simultaneous transcatheter aortic valve replacement and mitral balloon dilatation in patients with severe aortic stenosis and mitral stenosis: two case reports]. Zhonghua Xin Xue Guan Bing Za Zhi 2023; 51:1082-1086. [PMID: 37859362 DOI: 10.3760/cma.j.cn112148-20230808-00062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/21/2023]
Affiliation(s)
- H J Dong
- Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| | - R Wang
- Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| | - X Wang
- Department of Cardiology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
| | - J Liu
- Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| | - B Z X Pu
- Nyingchi People's Hospital, Nyingchi 850400, China
| | - J Li
- Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| | - Y J Mo
- Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| | - M Fu
- Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| | - G Li
- Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| | - J F Luo
- Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China
| |
Collapse
|
134
|
Zeng Q, Wei WB, Liu J, Liu BF, Liu HL. [Construction of Tianjin occupational disease prevention and control ability assessment system based on Delphi method]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2023; 41:871-875. [PMID: 37935558 DOI: 10.3760/cma.j.cn121094-20220606-00300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/09/2023]
Abstract
Objective: To establish a systematic, scientific, reasonable, feasible and reliable evaluation system for occupational disease prevention and control capability, in order to provide reference for occupational disease prevention and control work in Tianjin City. Methods: In August 2022, literature review was conducted to propose indicators for the evaluation system. Two rounds of anonymous consultation with occupational health experts were conducted using the Delphi method to form expert opinions. According to the boundary value method and expert opinions, eliminate, screen, and modify the evaluation system indicators to ultimately determine the system indicators. Use Cronbach's alpha to test the reliability of the system indicators and form a Tianjin occupational disease prevention and control capability evaluation system. Results: It showed that the effective response rates of the two rounds of consultation conducted by experts in this study were 92.3% and 100.0%, respectively. The expert authority coefficients were 0.84 and 0.82, respectively. The Kendall coordination coefficient was tested for differences, and the differences were statistically significant (P<0.05). The Tianjin occupational disease prevention and control capability evaluation system includes 7 primary indicators, 17 secondary indicators, and 54 tertiary indicators. The Cronbach's alpha of the primary, second, third level indicators and all indicators were 0.91, 0.98, 0.98, 0.98 (>0.7) . Conclusion: The preliminary evaluation system for occupational disease prevention and control capacity in Tianjin City has been established, providing a reference basis for the investigation of occupational disease prevention and control capacity in Tianjin City.
Collapse
Affiliation(s)
- Q Zeng
- Institute for Occupational Health, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China School of Public Health, Tianjin Medical University, Tianjin 300070, China
| | - W B Wei
- School of Public Health, Tianjin Medical University, Tianjin 300070, China Medical Record Statistics Department of Shaoxing People's Hospital, Shaoxing 312000, China
| | - J Liu
- Institute for Occupational Health, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China
| | - B F Liu
- Institute for Occupational Health, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China
| | - H L Liu
- School of Public Health, Tianjin Medical University, Tianjin 300070, China Tianjin Municipal Health Commission Science and Education Office, Tianjin 300070, China
| |
Collapse
|
135
|
Xu XZ, Liu R, Zhao WH, Yang Y, Liu J, Zhang WG, Bai J, He AL. [Alteration and significance of serum lipid levels and nutritional status during BCMA-CAR-T-cell therapy in patients with refractory or relapsed multiple myeloma: a retrospective study based on LEGEND-2]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:838-844. [PMID: 38049336 PMCID: PMC10694087 DOI: 10.3760/cma.j.issn.0253-2727.2023.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Indexed: 12/06/2023]
Abstract
Objective: To explore the dynamic changes in serum lipid levels and nutritional status during BCMA-CAR-T-cell therapy in patients with refractory or relapsed multiple myeloma (R/R MM) based on LEGEND-2. Methods: The data of patients with R/R MM who underwent BCMA-CAR-T therapy at our hospital between March 30, 2016, and February 6, 2018, were retrospectively collected. Serum lipid levels, controlled nutritional status (CONUT) score, and other clinical indicators at different time points before and after CAR-T-cell infusion were compared and analyzed. The best cut-off value was determined by using the receiver operator characteristic (ROC) curve. The patients were divided into high-CONUT score (>6.5 points, malnutrition group) and low-CONUT score groups (≤6.5 points, good nutrition group), comparing the progression-free survival (PFS) and total survival (OS) of the two groups using Kaplan-Meier survival analysis. Results: Before the infusion of CAR-T-cells, excluding triglycerides (TG), patients' serum lipid levels were lower than normal on average. At 8-14 d after CAR-T-cell infusion, serum albumin (ALB), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and apolipoprotein A1 (Apo A1) levels dropped to the minimum, whereas CONUT scores reached the maximum. In addition to TG, apolipoprotein B (Apo B) levels increased compared with baseline. After CAR-T-cell therapy, the patients' serum lipid levels significantly increased with well-improved nutritional status. Spearman's related analysis showed that TC, HDL, and ApoA1 levels after CAR-T-cell injection were significantly negatively correlated with the grade of cytokine-release syndrome (CRS) (r=-0.548, P=0.003; r=-0.444, P=0.020; r=-0.589, P=0.001). Furthermore, survival analysis indicated that the CONUT score was unrelated to PFS, and the median OS of patients with R/R MM in the high-CONUT score group was shorter than that in the low-CONUT score group (P=0.046) . Conclusions: During CAR-T-cell therapy, hypolipidemia and poor nutritional status were aggravated, which is possibly related to CRS. The patients' serum lipid levels and nutritional status were significantly improved after CAR-T-cell treatment. The CONUT score affected the median OS in patients treated with CAR-T-cells. Therefore, specific screening and intervention for nutritional status in patients receiving CAR-T-cell therapy are required.
Collapse
Affiliation(s)
- X Z Xu
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| | - R Liu
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| | - W H Zhao
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| | - Y Yang
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| | - J Liu
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| | - W G Zhang
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| | - J Bai
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| | - A L He
- Department of Hematopathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
| |
Collapse
|
136
|
Cao Z, Aharonian F, An Q, Axikegu, Bai YX, Bao YW, Bastieri D, Bi XJ, Bi YJ, Cai JT, Cao Q, Cao WY, Cao Z, Chang J, Chang JF, Chen AM, Chen ES, Chen L, Chen L, Chen L, Chen MJ, Chen ML, Chen QH, Chen SH, Chen SZ, Chen TL, Chen Y, Cheng N, Cheng YD, Cui MY, Cui SW, Cui XH, Cui YD, Dai BZ, Dai HL, Dai ZG, Danzengluobu, Della Volpe D, Dong XQ, Duan KK, Fan JH, Fan YZ, Fang J, Fang K, Feng CF, Feng L, Feng SH, Feng XT, Feng YL, Gabici S, Gao B, Gao CD, Gao LQ, Gao Q, Gao W, Gao WK, Ge MM, Geng LS, Giacinti G, Gong GH, Gou QB, Gu MH, Guo FL, Guo XL, Guo YQ, Guo YY, Han YA, He HH, He HN, He JY, He XB, He Y, Heller M, Hor YK, Hou BW, Hou C, Hou X, Hu HB, Hu Q, Hu SC, Huang DH, Huang TQ, Huang WJ, Huang XT, Huang XY, Huang Y, Huang ZC, Ji XL, Jia HY, Jia K, Jiang K, Jiang XW, Jiang ZJ, Jin M, Kang MM, Ke T, Kuleshov D, Kurinov K, Li BB, Li C, Li C, Li D, Li F, Li HB, Li HC, Li HY, Li J, Li J, Li J, Li K, Li WL, Li WL, Li XR, Li X, Li YZ, Li Z, Li Z, Liang EW, Liang YF, Lin SJ, Liu B, Liu C, Liu D, Liu H, Liu HD, Liu J, Liu JL, Liu JY, Liu MY, Liu RY, Liu SM, Liu W, Liu Y, Liu YN, Lu R, Luo Q, Lv HK, Ma BQ, Ma LL, Ma XH, Mao JR, Min Z, Mitthumsiri W, Mu HJ, Nan YC, Neronov A, Ou ZW, Pang BY, Pattarakijwanich P, Pei ZY, Qi MY, Qi YQ, Qiao BQ, Qin JJ, Ruffolo D, Sáiz A, Semikoz D, Shao CY, Shao L, Shchegolev O, Sheng XD, Shu FW, Song HC, Stenkin YV, Stepanov V, Su Y, Sun QN, Sun XN, Sun ZB, Tam PHT, Tang QW, Tang ZB, Tian WW, Wang C, Wang CB, Wang GW, Wang HG, Wang HH, Wang JC, Wang K, Wang LP, Wang LY, Wang PH, Wang R, Wang W, Wang XG, Wang XY, Wang Y, Wang YD, Wang YJ, Wang ZH, Wang ZX, Wang Z, Wang Z, Wei DM, Wei JJ, Wei YJ, Wen T, Wu CY, Wu HR, Wu S, Wu XF, Wu YS, Xi SQ, Xia J, Xia JJ, Xiang GM, Xiao DX, Xiao G, Xin GG, Xin YL, Xing Y, Xiong Z, Xu DL, Xu RF, Xu RX, Xu WL, Xue L, Yan DH, Yan JZ, Yan T, Yang CW, Yang F, Yang FF, Yang HW, Yang JY, Yang LL, Yang MJ, Yang RZ, Yang SB, Yao YH, Yao ZG, Ye YM, Yin LQ, Yin N, You XH, You ZY, Yu YH, Yuan Q, Yue H, Zeng HD, Zeng TX, Zeng W, Zha M, Zhang BB, Zhang F, Zhang HM, Zhang HY, Zhang JL, Zhang LX, Zhang L, Zhang PF, Zhang PP, Zhang R, Zhang SB, Zhang SR, Zhang SS, Zhang X, Zhang XP, Zhang YF, Zhang Y, Zhang Y, Zhao B, Zhao J, Zhao L, Zhao LZ, Zhao SP, Zheng F, Zhou B, Zhou H, Zhou JN, Zhou M, Zhou P, Zhou R, Zhou XX, Zhu CG, Zhu FR, Zhu H, Zhu KJ, Zuo X. Measurement of Ultra-High-Energy Diffuse Gamma-Ray Emission of the Galactic Plane from 10 TeV to 1 PeV with LHAASO-KM2A. Phys Rev Lett 2023; 131:151001. [PMID: 37897763 DOI: 10.1103/physrevlett.131.151001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 07/08/2023] [Accepted: 08/18/2023] [Indexed: 10/30/2023]
Abstract
The diffuse Galactic γ-ray emission, mainly produced via interactions between cosmic rays and the interstellar medium and/or radiation field, is a very important probe of the distribution, propagation, and interaction of cosmic rays in the Milky Way. In this Letter, we report the measurements of diffuse γ rays from the Galactic plane between 10 TeV and 1 PeV energies, with the square kilometer array of the Large High Altitude Air Shower Observatory (LHAASO). Diffuse emissions from the inner (15°10 TeV). The energy spectrum in the inner Galaxy regions can be described by a power-law function with an index of -2.99±0.04, which is different from the curved spectrum as expected from hadronic interactions between locally measured cosmic rays and the line-of-sight integrated gas content. Furthermore, the measured flux is higher by a factor of ∼3 than the prediction. A similar spectrum with an index of -2.99±0.07 is found in the outer Galaxy region, and the absolute flux for 10≲E≲60 TeV is again higher than the prediction for hadronic cosmic ray interactions. The latitude distributions of the diffuse emission are consistent with the gas distribution, while the longitude distributions show clear deviation from the gas distribution. The LHAASO measurements imply that either additional emission sources exist or cosmic ray intensities have spatial variations.
Collapse
Affiliation(s)
- Zhen Cao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Aharonian
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, 2 Dublin, Ireland
- Max-Planck-Institut for Nuclear Physics, P.O. Box 103980, 69029 Heidelberg, Germany
| | - Q An
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Axikegu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y X Bai
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - D Bastieri
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X J Bi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Bi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J T Cai
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Q Cao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - W Y Cao
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Zhe Cao
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - J Chang
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J F Chang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - A M Chen
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - E S Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Liang Chen
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Lin Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Long Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M J Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M L Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - Q H Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - S H Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S Z Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T L Chen
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - N Cheng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y D Cheng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Cui
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S W Cui
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - X H Cui
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - Y D Cui
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Z Dai
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - H L Dai
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - Z G Dai
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Danzengluobu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - D Della Volpe
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - X Q Dong
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - K K Duan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J H Fan
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y Z Fan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Fang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - K Fang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Feng
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S H Feng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X T Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Y L Feng
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - S Gabici
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - B Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C D Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Q Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q Gao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - W Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W K Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M M Ge
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - L S Geng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - G Giacinti
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - G H Gong
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - Q B Gou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M H Gu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - F L Guo
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - X L Guo
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Y Guo
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y A Han
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - H H He
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H N He
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Y He
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - X B He
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Y He
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M Heller
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - Y K Hor
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B W Hou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C Hou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Hou
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - H B Hu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q Hu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S C Hu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D H Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - T Q Huang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W J Huang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X T Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X Y Huang
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y Huang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z C Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X L Ji
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - H Y Jia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - K Jia
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - K Jiang
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - X W Jiang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z J Jiang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Jin
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M M Kang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - T Ke
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Kuleshov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - K Kurinov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - B B Li
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - Cheng Li
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Cong Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - H B Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H C Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H Y Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Jian Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Jie Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - K Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W L Li
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W L Li
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - X R Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Xin Li
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Y Z Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhe Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhuo Li
- School of Physics, Peking University, 100871 Beijing, China
| | - E W Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Y F Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - S J Lin
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Liu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - C Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Liu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - H Liu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H D Liu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - J Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J Y Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Liu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - R Y Liu
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - S M Liu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Liu
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y N Liu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - R Lu
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Q Luo
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - H K Lv
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Q Ma
- School of Physics, Peking University, 100871 Beijing, China
| | - L L Ma
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X H Ma
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J R Mao
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - Z Min
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - H J Mu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - Y C Nan
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - A Neronov
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - Z W Ou
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Y Pang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - P Pattarakijwanich
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - Z Y Pei
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - M Y Qi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Q Qi
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - B Q Qiao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J J Qin
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Ruffolo
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - A Sáiz
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - D Semikoz
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - C Y Shao
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L Shao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - O Shchegolev
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - X D Sheng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F W Shu
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science & Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - H C Song
- School of Physics, Peking University, 100871 Beijing, China
| | - Yu V Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - V Stepanov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - Y Su
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Q N Sun
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X N Sun
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Z B Sun
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - P H T Tam
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Q W Tang
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science & Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - Z B Tang
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - W W Tian
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - C Wang
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - C B Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G W Wang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - H G Wang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - H H Wang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J C Wang
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - K Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - L P Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Y Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - P H Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - R Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W Wang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X G Wang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - X Y Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - Y Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y D Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z H Wang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z X Wang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Zhen Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - Zheng Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - D M Wei
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Wei
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y J Wei
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T Wen
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - C Y Wu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H R Wu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S Wu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X F Wu
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y S Wu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S Q Xi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J Xia
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Xia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G M Xiang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - D X Xiao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - G Xiao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - G G Xin
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y L Xin
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Xing
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Z Xiong
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D L Xu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - R F Xu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R X Xu
- School of Physics, Peking University, 100871 Beijing, China
| | - W L Xu
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - D H Yan
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - J Z Yan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T Yan
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C W Yang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - F Yang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - F F Yang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - H W Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L L Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - M J Yang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R Z Yang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S B Yang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Y H Yao
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z G Yao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y M Ye
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - L Q Yin
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - N Yin
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X H You
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z Y You
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y H Yu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Q Yuan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - H Yue
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H D Zeng
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T X Zeng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - W Zeng
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Zha
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B B Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - F Zhang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H M Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - H Y Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Zhang
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - L X Zhang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Li Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P F Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P P Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - R Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S B Zhang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - S R Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S S Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - X P Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y F Zhang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Yi Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Yong Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Zhao
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - J Zhao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - L Zhao
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L Z Zhao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S P Zhao
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F Zheng
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - B Zhou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H Zhou
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J N Zhou
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - M Zhou
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science & Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - P Zhou
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - R Zhou
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - X X Zhou
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - C G Zhu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F R Zhu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - K J Zhu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - X Zuo
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| |
Collapse
|
137
|
Liu J, Shen D, Sun XY, Zhou K, Wang YN, Wei W. [Short term clinical observation of keratoconus treated with stromal lenticule addition keratoplasty combined with corneal collagen cross-linking]. Zhonghua Yan Ke Za Zhi 2023; 59:832-837. [PMID: 37805417 DOI: 10.3760/cma.j.cn112142-20221204-00621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 10/09/2023]
Abstract
Objective: To investigate the efficacy of Femtosecond laser-assisted stromal lenticule addition keratoplasty (SLAK) combined with corneal collagen cross-linking (CXL) in the treatment of middle and advanced Keratoconus. Methods: It was a retrospective case series study. Data of 23 cases (24 eyes) of keratoconus treated with femtosecond laser-assisted SLAK combined with CXL in Laser Vision Centre of Xi'an No.1 Hospital from September 2020 to June 2022 were collected, including 16 males and 7 females, aged (23.69±5.18) years. The thickness, diopter number and diameter of the donor corneal stromal lens were assessed. uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), and diopter were recorded before and 1, 3, and 6 months after surgery. Sirius 3D fault corneal topography instrument to measure flat simulated keratometry (Kf), steep simulated keratometry (Ks) and the difference between them (ΔK), as well as central corneal thickness (CCT) and corneal high-order aberration. Results: Six months after surgery, CCT (454.83±50.01) μm were significantly higher than before (384.92±35.45) μm (P<0.05). Six months after surgery, UCVA (1.41±0.32) was significantly lower than before (1.11±0.33)(P<0.05). Six months after surgery, spherical diopter [(-15.73±7.89) D], Kf [(56.82±4.76) D] and Ks [(61.00±4.70) D] were significantly higher than before [(-12.08±5.99) D, (53.55±4.95) D, (58.65±5.10) D] (P<0.05). There was no significant difference in BCVA, column mirror degree and higher order aberrations before and 6 months after surgery(P>0.05). No corneal stromal lens folds, melting and displacement were observed in all eyes during the follow-up period, and no corneal opacity or immune rejection was observed. Conclusions: femtosecond laser-assisted SLAK combined with CXL can significantly increase the corneal thickness of keratoconus and has good effectiveness. In addition, six months of postoperative follow-up of patients showed no significant changes in BCVA and high-order aberrations in the 6 mm central diameter of the cornea, and no postoperative adverse reaction were found in all eyes, indicating that the operation has certain safety.
Collapse
Affiliation(s)
- J Liu
- Ophthalmological Department of the First Affiliated Hospital of Northwestern University and Xi'an No.1 Hospital, Shaanxi Ophthalmological Institute, Shaanxi Key Laboratory of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, China
| | - D Shen
- Ophthalmological Department of the First Affiliated Hospital of Northwestern University and Xi'an No.1 Hospital, Shaanxi Ophthalmological Institute, Shaanxi Key Laboratory of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, China
| | - X Y Sun
- Ophthalmological Department of the First Affiliated Hospital of Northwestern University and Xi'an No.1 Hospital, Shaanxi Ophthalmological Institute, Shaanxi Key Laboratory of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, China
| | - K Zhou
- Ophthalmological Department of the First Affiliated Hospital of Northwestern University and Xi'an No.1 Hospital, Shaanxi Ophthalmological Institute, Shaanxi Key Laboratory of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, China
| | - Y N Wang
- Ophthalmological Department of the First Affiliated Hospital of Northwestern University and Xi'an No.1 Hospital, Shaanxi Ophthalmological Institute, Shaanxi Key Laboratory of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, China
| | - W Wei
- Ophthalmological Department of the First Affiliated Hospital of Northwestern University and Xi'an No.1 Hospital, Shaanxi Ophthalmological Institute, Shaanxi Key Laboratory of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, China
| |
Collapse
|
138
|
Lu WL, Sun Q, Yin ZC, Yu Y, Zhang SN, Xu B, Liu J. [Investigation and analysis of oral health resources allocation status in Yunnan Province]. Zhonghua Kou Qiang Yi Xue Za Zhi 2023; 58:1034-1040. [PMID: 37818539 DOI: 10.3760/cma.j.cn112144-20230814-00075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 10/12/2023]
Abstract
Objective: To investigate and analyze the allocation status of oral health resources in Yunnan Province at the end of the 13th Five-Year Plan, providing a scientific basis for the rational resource allocation and formulation regional oral health plan for government health administrative departments. Methods: With the method of general survey, a cross-sectional study was conducted to investigate the allocation of material and human resources of all kinds of stomatological medical institutions registered in the health administrative departments in Yunnan before January 1, 2020. The general situation of oral health resources was analyzed by descriptive statistical analysis. Results: There were 2 712 stomatological medical institutions in Yunnan, 634 public and 2 078 non-public included. The largest number was in Kunming (1 167) and the least in Diqing (19). There were 9 018 dental chairs in total, among which 2 584 in public and 6 434 in non-public. Kunming had the largest number of chairs (3 612) and Nujiang had the least (57). There were 702 oral and maxillofacial surgical beds, all of which were distributed in public. There were 15 148 stomatological personnel, including 3 667 in public and 11 481 in non-public. The average ratio of stomatologist to population was 1∶6 615. Dehong (1∶6 620) was close to this average level, while Kunming (1∶2 283) and Yuxi (1∶4 936) were lower than the average and the other 13 states (cities) were higher. The population ratio of licensed stomatologist was only 1∶9 110. The average ratio of stomatologist to nurses was 1∶0.94. Honghe (1∶1.05), Kunming (1∶1.00), Yuxi (1∶1.18) and Qujing (1∶0.94) was better than or reached the average level, while the other 13 states (cities) were lower than this average. And this ratio in public comprehensive medical institutions was only 1∶0.38. Conclusions: The distribution of oral health resources in Yunnan was unbalanced between public and non-public institutions and among states (cities), mainly distributed in economically developed states (cities) and non-public institutions. For the oral health in Yunnan Province, the workforce was insufficient and the structure was unreasonable, and the proportion of nurses was seriously insufficient in public comprehensive medical institutions.
Collapse
Affiliation(s)
- W L Lu
- Department of Second Outpatient, Kunming Medical University School and Hospital of Stomatology, Yunnan Key Laboratory of Stomatology, Kunming 650106, China
| | - Q Sun
- Department of Preventive Dentistry, Kunming Medical University School and Hospital of Stomatology, Yunnan Key Laboratory of Stomatology, Kunming 650106, China
| | - Z C Yin
- Department of Integrated Office, Kunming Medical University School and Hospital of Stomatology, Yunnan Key Laboratory of Stomatology, Kunming 650106, China
| | - Y Yu
- Department of Stomatology, Kunming Maternal and Child Health Hospital, Kunming 650106, China
| | - S N Zhang
- Department of Preventive Dentistry, Kunming Medical University School and Hospital of Stomatology, Yunnan Key Laboratory of Stomatology, Kunming 650106, China
| | - B Xu
- Department of Oral and Maxillofacial Surgery, Kunming Medical University School and Hospital of Stomatology, Yunnan Key Laboratory of Stomatology, Kunming 650106, China
| | - J Liu
- Department of Preventive Dentistry, Kunming Medical University School and Hospital of Stomatology, Yunnan Key Laboratory of Stomatology, Kunming 650106, China
| |
Collapse
|
139
|
Li Y, Fu Y, Hu XN, Liu J, Ding P, Hou JX, Xu L. [Clinical and radiographic effect of simultaneously labial and lingual augmented corticotomy: a prospective case series study]. Zhonghua Kou Qiang Yi Xue Za Zhi 2023; 58:1010-1018. [PMID: 37818536 DOI: 10.3760/cma.j.cn112144-20230816-00083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/12/2023]
Abstract
Objective: To investigate soft-and hard-tissue changes after simultaneously labial and lingual augmented corticotomy in patients with insufficient alveolar bone thickness of lower anterior teeth both in labial and lingual side during orthodontic treatment. Methods: From January 2021 to June 2022, 10 patients [2 males and 8 females, (26.2±3.1) years old] who received orthodontic and orthognathic combined treatment from the Fourth Clinical Division, Peking University School and Hospital of Stomatology were selected. The alveolar bone thickness of lower anterior teeth both in labial and lingual side in these patients was less than 0.5 mm according to cone-beam CT examination before or during treatment, and 60 lower anterior teeth were included. The 10 patients were treated with simultaneously labial and lingual augmented corticotomy. The differences in gingival recession, papilla index and the differences in labial and lingual alveolar bone thickness of lower anterior teeth were compared. Results: Six months after surgery, the alveolar bone thicknesses at the 4 mm under cemento-enamel junction (CEJ), 8 mm under CEJ and at the apical level [labial side: (1.02±0.39), (2.22±0.89) and (4.87±1.35) mm; lingual side: (1.07±0.46), (2.31±1.04) and (3.91±1.29) mm] were significantly higher than that before surgery [labial side: (0.02±0.09), (0.06±0.21) and (2.71±1.33) mm]; lingual side: (0.14±0.29), (0.40±0.52) and (2.13±1.02) mm] (P<0.001), respectively. The increases in alveolar bone thickness of central incisors [apical level on labial side: (2.53±1.20) mm, 8 mm under CEJ on lingual side: (2.27±1.24) mm, apical level on lingual side: (2.66±1.49) mm] and lateral incisors [apical level on labial side: (2.42±1.30) mm, 8 mm under CEJ on lingual side: (2.28±0.92) mm, apical level on lingual side: (1.94±1.15) mm] were significantly higher than that of canines [apical level on labial side: (1.52±1.47) mm, 8 mm under CEJ on lingual side: (1.17±1.09) mm,apical level on lingual side: (0.74±1.37) mm] (P<0.01). There were no significant differences in the degree of gingival recession [labial side before surgery: (0.72±0.88) mm, lingual side before surgery: (0.80±1.09) mm; labial side 6 months after surgery: (0.72±0.81) mm,lingual side 6 months after surgery: (0.89±0.21) mm] and gingival papilla index [before surgery: 1.00(0.75, 2.00); 6 months after surgery: 1.00(1.00, 2.00) ] between pre-operation and 6 months after surgery (P>0.05). No serious complications occurred. Conclusions: The method used in this article for simultaneously labial and lingual augmented corticotomy was safe and feasible. This surgery has positive clinical significance for the stability of the periodontal tissue in orthodontic treatment for patients with alveolar bone thickness less than 0.5 mm of lower anterior teeth both in labial and lingual side.
Collapse
Affiliation(s)
- Y Li
- Fourth Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100025, China
| | - Y Fu
- Fourth Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100025, China
| | - X N Hu
- Fourth Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100025, China
| | - J Liu
- Department of Periodontology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - P Ding
- PrettySmile Dental Clinic, Beijing 100031, China
| | - J X Hou
- Department of Periodontology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - L Xu
- Department of Periodontology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| |
Collapse
|
140
|
Zhang D, Chen X, Huang K, Zheng Q, Fu Y, Ma J, Ren X, Xu B, Liu P, Liu J, Lu S. Urinary essential and toxic metal mixtures, and type 2 diabetes mellitus: Telomere shortening as an intermediary factor? J Hazard Mater 2023; 459:132329. [PMID: 37598517 DOI: 10.1016/j.jhazmat.2023.132329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 08/13/2023] [Accepted: 08/15/2023] [Indexed: 08/22/2023]
Abstract
The joint effect of metal mixtures on telomere function and type 2 diabetes mellitus (T2DM) is unclear. This large-scale cross-sectional study sought to assess the role of telomere length (TL) in the relationship between urinary essential and toxic metal mixtures, and T2DM in 7410 Chinese adults ≥ 60 years of age. Essential (Cr, Cu, Zn, Se) and non-essential metals (V, Al, Sb, Sn, Cd, Pb) in urine samples were quantified, while leukocyte TL was measured from blood samples. Restricted cubic splines regression showed nonlinear relationships between single metal and T2DM, and between TL and T2DM. Bayesian kernel machine regression and quantile-based g-computation showed that the overall status of urinary metals was positively associated with risk of developing T2DM, which was mainly explained by exposure to Pb, Cd, and Sb, excessive Se intake, and high excretion of Zn. Mediation analyses showed that shortened TL mediated 27.9% of the overall positive effect of metal exposure on T2DM, and this mediation was mainly explained by toxic metal exposure and excessive Se intake. Tobacco smoke exposure, extensive cooking at home, and black tea consumption were found to be important contributors of toxic metal exposures. Further studies are needed to explore the recommended Zn dosage for T2DM patients at different stages, which may ameliorate pancreatic senescence and glycemic progression.
Collapse
Affiliation(s)
- Duo Zhang
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China
| | - Xiao Chen
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China
| | - Ke Huang
- Food Inspection and Quarantine Center, Shenzhen Customs, Shenzhen, China
| | - Quanzhi Zheng
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China
| | - Ying Fu
- Community Health Service Management Center, Shenzhen Luohu Hospital Group, Shenzhen, China
| | - Jiaojiao Ma
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China
| | - Xiaohu Ren
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China
| | - Benhong Xu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China
| | - Peiyi Liu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China
| | - Jianjun Liu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China
| | - Shaoyou Lu
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
| |
Collapse
|
141
|
Huang C, Ren X, Xu B, Liu P, Li T, Zhu Q, Huang J, Chen X, Wu D, Yang X, Zhu F, Liu J. Urinary nicotine metabolites are associated with cognitive impairment among the elderly in southern China. Tob Induc Dis 2023; 21:123. [PMID: 37799805 PMCID: PMC10548790 DOI: 10.18332/tid/170423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2023] [Revised: 08/03/2023] [Accepted: 08/05/2023] [Indexed: 10/07/2023] Open
Abstract
INTRODUCTION This study comprehensively assessed the association between eight metabolites of urinary nicotine and cognitive impairment. METHODS This cross-sectional study was based on the data of Shenzhen Aging Related Disorder Cohort (SADC), including 51 elderly community data variables such as demographic characteristics, neuropsychological assessment and environmental factors, from July 2017 to November 2018. Participant's cognitive function was assessed by Mini-Mental State Examination (MMSE) scale and urinary nicotine metabolite [including cotinine N-β-D-glucuronide (CotGluc), rac 4-hydroxy-4-(3-pyridyl) butanoic acid dicyclohexylamine salt (HyPyBut), trans-3'-hydroxy cotinine O-β-D-glucuronide (OHCotGluc), and cotinine (Cot), etc.] concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). Generalized linear models and restricted cubic spline models were used to explore the relationships between the urinary levels of nicotine metabolite and cognitive function. RESULTS A total of 296 individuals aged >60 years were included. Individuals in the third quartile of CotGluc had a 0.786 point (95% CI: -1.244 - -0.329) decrease or in the highest quartile of OHCotGluc had a 0.804 point (95% CI: -1.330 - -0.278) decreased in attention and calculation compared to those in the lowest quartile (all p for trend <0.05). Compared with those in the lowest quartile, individuals in the highest quartile of CotGluc, HyPyBut, OHCotGluc and Cot, respectively, corresponded to a 1.043 point (95% CI: -2.269-0.182), 1.101 points (95% CI: -2.391-0.188), 2.318 points (95% CI: -3.615 - -1.020), and 1.460 points (95% CI: -2.726 - -0.194) decreased in MMSE total score (all p for trend <0.05). A non-linear dose-response relationship between urinary levels of CotGluc, HyPyBut, OHCotGluc or Cot and cognitive function (all overall p<0.05, non-linear p<0.05). Subgroup analysis showed that urinary levels of CotGluc, OHCotGluc or Cot were significantly negatively associated with cognitive function (all p for trend <0.05) among females and non-smokers. CONCLUSIONS The findings highlight the public health implications of environmental tobacco smoke exposure, and effective interventions need to be performed for vulnerable populations.
Collapse
Affiliation(s)
- Chao Huang
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Xiaohu Ren
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Benhong Xu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Peiyi Liu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Tian Li
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Qinqin Zhu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Jia Huang
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Xiao Chen
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Desheng Wu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Xifei Yang
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| | - Feiqi Zhu
- Cognitive Impairment Ward of Neurology Department, The Third Affiliated Hospital of Shenzhen University Medical College, Shenzhen, People’s Republic of China
| | - Jianjun Liu
- Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China
| |
Collapse
|
142
|
Xie ZH, Li X, Xiao MJ, Liu J, Zhang Q, Zhang ZK, Yang YL, Wang HJ, Chen YX, Zhang YD, Li DX. [Hyperprolinemia type Ⅰ caused by PRODH gene variation: 2 cases report and literature review]. Zhonghua Er Ke Za Zhi 2023; 61:935-937. [PMID: 37803864 DOI: 10.3760/cma.j.cn112140-20230314-00178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/08/2023]
Affiliation(s)
- Z H Xie
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - X Li
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - M J Xiao
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - J Liu
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - Q Zhang
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - Z K Zhang
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - Y L Yang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H J Wang
- Department of Emergency, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - Y X Chen
- Department of Endocrinology, Genetics and metabolism, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - Y D Zhang
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| | - D X Li
- Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
| |
Collapse
|
143
|
Liu G, Qian SY, Liu J. [Progress in the application of targeted monoclonal antibodies in children with hemophagocytic syndrome]. Zhonghua Er Ke Za Zhi 2023; 61:945-948. [PMID: 37803867 DOI: 10.3760/cma.j.cn112140-20230515-00332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/08/2023]
Affiliation(s)
- G Liu
- Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - S Y Qian
- Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - J Liu
- Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| |
Collapse
|
144
|
Liu J, Pei J, Yu J. Molecular Imaging of Radiation-Induced Lung Injury Using [ 18F]AlF Labeled Polypeptide Targeting C-X-C-Chemokine-Receptor-Type-4. Int J Radiat Oncol Biol Phys 2023; 117:S10. [PMID: 37784264 DOI: 10.1016/j.ijrobp.2023.06.222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Radiation-induced lung injury (RILI) is a severe side effect of radiotherapy (RT) for thoracic malignancies and we currently lack established means for the early detection of RILI. In this study, we synthesized a new tracer, [18F]AlF-NOTA-QHY-04, targeting C-X-C-chemokine-receptor-type-4 (CXCR4) and investigated the feasibility of using this tracer in positron emission tomography combined with computed tomography (PET/CT) for detecting RILI. MATERIALS/METHODS An RILI model was established using a high-dose single RT (50 Gy/Fraction) to the right lung of female Wistar rats. Experimental animals were scanned with [18F]AlF-NOTA-QHY-04 PET/CT and [18F]FDG PET/CT at various time-points post-RT. MicroCT imaging was conducted weekly till 11 weeks post-RT. Dynamic, competition, autoradiography and histopathological studies were performed on day 14 post-RT. Biodistribution study was further performed on day 18 post-RT. Lung QHY-04 uptake was analyzed in twelve patients with radiation pneumonia, developed during or after thoracic RT. RESULTS The yield of [18F]AlF-NOTA-QHY-04 was 28.5-43.2%, and the specific activity was 27-33 GBq/μmol. Significantly increased [18F]AlF-NOTA-QHY-04 uptake in the damaged lung compared with that in the normal lung was observed in the experimental animal model on 6 post-RT and peaked on day 14 post-RT (0.96 ± 0.06 vs. 0.50 ± 0.05 %ID/mL, P<0.05), whereas no apparent uptake of [18F]FDG was shown on day 7 and 15 post-RT. Significant intense [18F]AlF-NOTA-QHY-04 uptake was confirmed by autoradiography. No significant difference in CT density was observed between the damaged and normal lung tissues until six weeks post-RT. Immunofluorescence staining demonstrated expression of CXCR4 was significantly increased in the damaged lung tissue, which correlated with results obtained from hematoxylin-eosin and Masson's trichrome staining. Maximum standardized uptake values (SUVmax) were significantly higher in the irradiated lung compared with that in the normal lung in 12 patients with radiation pneumonia (3.07 ± 0.86 vs. 0.585 ± 0.17, P<0.001). SUVmax of patients with grade 2 RILI was significantly higher than that of patients with grade 1 RILI (3.30 ± 0.65 vs. 1.64 ± 0.08, P<0.05). CONCLUSION This study indicated that [18F]AlF-NOTA-QHY-04 PET/CT imaging can detect RILI noninvasively and earlier than [18F]FDG PET/CT in a rat model. Clinical studies verified its' feasibility, suggesting the clinical potential of [18F]AlF-NOTA-QHY-04 as a PET/CT tracer for early monitoring of RILI.
Collapse
Affiliation(s)
- J Liu
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - J Pei
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
| | - J Yu
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
| |
Collapse
|
145
|
Zang J, Liu J, Zhang M, Zhao L, Shi M. Development and Validation of CT-Based Dose-Volume-Radiomics Nomogram for Radiation Induced Hypothyroidism in Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2023; 117:e275. [PMID: 37785035 DOI: 10.1016/j.ijrobp.2023.06.1248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Several studies reported hypothyroidism occurred in 40-50% of patients who were treated with neck irradiation. Post-radiation hypothyroidism impairs quality of life, increases the risk of cardiac complications, and requires lifelong thyroxine replacement in affected patients. At present, radiation dose-volume constraints of thyroid gland are used to predict thyroid function outcomes in patients with nasopharyngeal carcinoma (NPC). However, it is limited by (a) inferior predictive power, (b) a lack of analyzing individualized thyroid characteristics as a categoriad to predict radiation induced hypothyroidism (RIHT). In this study, we firstly developed and validated CT-based dose-volume-radiomics nomogram to predict RIHT in patients with NPC. MATERIALS/METHODS A total of 451 NPC patients who underwent definitive radiotherapy were randomly assigned into the training (n = 338) and validation set (n = 113) in a 3:1 ratio. Dose-volume parameters, including the thyroid volume, mean dose (Dmean), percentage of the volume that received xGy of radiation (Vx), and the absolute volume that was spared from xGy of radiation (Vsx), were collected from radiotherapy planning databases. We defined primary hypothyroidism as an elevated TSH serum level (> 4.94 mIU/L) in combination with a normal or low serum FT4 level, regardless of symptoms. 1316 CT radiomic features were extracted and selected to construct the radiomics signature (RS). A CT-based nomogram was established by integrating clinical factors, dose-volume parameters and radiomics signature in training set and was tested in validation set. RESULTS With a median follow-up period of 68 months, 301 (66.7%) patients developed RIHT. Compared with other dose-volume parameters including thyroid volume, V30, V50, Dmean, Vs45, Vs50, the thyroid volume spared from 60Gy (Vs60) had best power to predict RIHT. The radiomics signature constructed by 8 selected radiomic features showed better prognostic performance than Vs60 for predicting RIHT in training set (RIHT vs. Vs60, C-index: 0.69 vs. 0.58) and internal validation set (C-index: 0.65 vs. 0.55). Patients were stratified into high- and low-risk groups by median radiomic signature. Patients in high-risk group had higher rate of RIHT than patients in low-risk group (training set:61% vs.39%, P<0.05; validation set: 73% vs.32%, P<0.05). The nomogram established by integrating radiomics signature with Vs60 showed optimal prognostic performance with C-index of 0.71 in training, 0.66 in validation set. Calibration curves showed good agreement. CONCLUSION CT-based dose-volume-radiomics nomogram provided an excellent prognostic tool for predict incidence rate of RITH in patients with NPC received definitive radiotherapy.
Collapse
Affiliation(s)
- J Zang
- Department of Radiation Oncology, Xijing Hospital, Air Force Medical University, Xi'an, China
| | - J Liu
- Department of Radiation Oncology, Xijing hospital, Air Force Medical University, Xi'an, China
| | - M Zhang
- Department of Radiation Oncology, Xijing Hospital, Air Force Medical University, Xi'an, China
| | - L Zhao
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - M Shi
- Department of Radiation Oncology, Xijing Hospital, Air Force Medical University, Xi'an, China
| |
Collapse
|
146
|
Liu J, Islam MT, Xing L. A Self-Attention-Based Neural Network for Predicting Immune Checkpoint Inhibitors Response. Int J Radiat Oncol Biol Phys 2023; 117:e475-e476. [PMID: 37785508 DOI: 10.1016/j.ijrobp.2023.06.1688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Cancer cells evade immune system by negatively regulating T cells via immune checkpoints (e.g., PD-1). By blocking these checkpoints, the ability of immune system to recognize and kill cancer cells restores. Individual response rate of checkpoint blockade varies among patients, with 50%-80% in specific types of cancer such as melanoma, while only 15%-30% in most other tumors. Yet it is still an open question what is the set of biomarkers that are crucial to the response to immune checkpoint inhibitors (ICI). The overall goal of this study is to develop and validate a biologically-aware interpretable deep learning model to identify the biomarkers that can predict the survival outcome to ICI treatment. MATERIALS/METHODS The self-attention mechanism could yield interpretable results where important biomarkers may have more "attention". However, in classical self-attention mechanism, the prior biological knowledge of protein interactions (PPI) and gene pathways are not incorporated. In this study, we propose a weighted biologically-aware attention score, where it is weighted against the gene centrality and pathway length. The genes that are closely connected to mutated genes receive 'high attention', while the genes that are far away from mutated genes along the pathway receive "lower attention". We then train, validate and test our model using 1,660 patients of nine types of cancer. To validate the prediction, 1. We evaluate the accuracy via concordance index. 2. We identified the genes that receive high attention and verify their functions in existed literature. 3. We perform sanity check by removing these genes from the data, re-training and predicting again, and comparing the prediction accuracy. RESULTS Our framework has achieved an average accuracy (measured via c-index) of 0.60 ± 0.06 for NSCLC and 0.58 ± 0.07 for melanoma, which is superior to both the gold standard COX-PH model (0.57 ± 0.06 for NSCLC and 0.53 ± 0.03 for melanoma) and DeepSurv (0.54 ± 0.05 for NSCLC and 0.51 ± 0.10 for melanoma). Genes that receive high attention have been validated by supporting literature, which provides an additional means of verifying the prediction in comparison to "black box" deep learning models, where there is no way to comprehend the reason behind predictions. Removing the top 8% high-attention genes (∼25 genes) from the data while using the remaining 92% for making predictions resulted in a drop in accuracy to 0.55 ± 0.073 for NSCLC and 0.56 ± 0.03 for melanoma, underscoring the significance of these genes. Patient stratification is also performed by dividing patients into responders and non-responders based on prediction score. CONCLUSION In this study, we propose and validate a biologically-aware self-attention based deep learning model which outperforms commonly-used survival models. Additionally, this tool has the potential to identify key biomarkers while assist in clinical decision-making, which demonstrates a promising step for immunotherapy response prediction.
Collapse
Affiliation(s)
- J Liu
- Stanford University, Palo Alto, CA
| | - M T Islam
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| | - L Xing
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| |
Collapse
|
147
|
Liu J, Lavie CJ, Park YMM, Bagiella E. Geographic variation and trends in prevalence of obesity among US adolescents, 2016-2021. Public Health 2023; 223:128-130. [PMID: 37634452 DOI: 10.1016/j.puhe.2023.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Revised: 06/23/2023] [Accepted: 07/11/2023] [Indexed: 08/29/2023]
Abstract
OBJECTIVE Recent updates of geographic variations, trends, and sociodemographic disparities in obesity prevalence among US adolescents are limited. The study aimed to fill those research gaps. STUDY DESIGN Serial cross-sectional analysis of the US nationally representative study. METHODS Data from six cycles of the National Survey of Children's Health (2016, 2017, 2018, 2019, 2020, and 2021) with information on physical health at the national and state level were used. A total of 107,274 adolescents aged 10-17 years old were included with sociodemographic data (age, sex, race/ethnicity, parental education level, and family income) and state of residence. Logistic regression models were used to estimate the odds ratios (ORs) associated with obesity across sociodemographic groups. In addition, ORs were calculated to compare obesity rates between the pandemic period (2020-2021) and the pre-pandemic period (2018-2019) overall and by sociodemographic subgroups. Survey analysis procedures were used to account for complex survey designs to derive representative estimates. RESULTS From 2016 to 2021, obesity prevalence increased from 16.1% (95% confidence interval [CI], 14.9%-17.4%) to 17.6% (95% CI, 16.4%-18.9%) (P-trend = 0.04). The combined prevalence of obesity varies substantially by state, from 9.34% (95% CI, 6.96%-12.4%; Colorado) to 27.1% (95% CI, 23.1%-31.5%; Mississippi) for adolescents aged 10-13 years and ranged from 9.86% (95% CI, 7.63%-12.7%; Utah) to 22.4% (95% CI, 19.0%-26.1%; West Virginia) for adolescents aged 14-17 years. Except for subgroups male gender and parents with college degrees or above, the prevalence of obesity showed stable trends across sociodemographic subgroups. Compared to the pre-pandemic period, the multivariable-adjusted ORs of obesity were 1.18 (95% CI, 1.06-1.32) for male adolescents, 1.16 (95% CI, 1.04-1.28) for non-Hispanic White adolescents, 1.81 (95% CI, 1.15-2.84) for non-Hispanic Asian adolescents, 1.26 (95% CI, 1.05-1.52) for adolescents whose parents had a high school education, and 1.15 (95% CI, 1.0-1.33) for adolescents whose parents had a college degree or higher. CONCLUSIONS The prevalence of obesity among US adolescents increased significantly between 2016 and 2021. The prevalence of obesity was relatively high in southern states. Those with low household income, low parental education, or being non-Hispanic Black or Hispanic were also more likely to be obese. Compared to the pre-pandemic period, several groups of adolescents increased their likelihood of obesity during the pandemic period.
Collapse
Affiliation(s)
- J Liu
- Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| | - C J Lavie
- John Ochsner Heart and Vascular Institute, Ochsner Clinical School University of Queensland School of Medicine, New Orleans, LA, USA
| | - Y-M M Park
- Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - E Bagiella
- Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| |
Collapse
|
148
|
Guo Q, Liu J, Dou X, Zhu K, Shi P, Zhang Y, Li S, Feng R, Yue J. Camrelizumab with Chemoradiotherapy for Locally Advanced Biliary Tract Cancer: Preliminary Results from A Phase II Study. Int J Radiat Oncol Biol Phys 2023; 117:e355. [PMID: 37785226 DOI: 10.1016/j.ijrobp.2023.06.2434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) For locally advanced biliary tract cancer (BTC), capecitabine-based chemoradiotherapy (CRT) is commonly used but has limited benefits. Immunotherapy is potentially effective for BTC and may be synergized with CRT. Followed by gemcitabine and cisplatin (GP) consolidation chemotherapy (CT), we evaluated the safety and efficacy of combined camrelizumab and capecitabine-based CRT for locally advanced BTC. MATERIALS/METHODS Patients had stage II-III (T4N0M0, T1-4N+M0) BTC (per the 7th [2010] edition of the American Joint Committee on Cancer staging system) were eligible for CRT (capecitabine plus [50-60 Gy] radiotherapy), to be followed by GP CT. Camrelizumab was given concurrently with CRT. Safety was defined as the incidence and severity of adverse events (AEs), while efficacy was defined as overall survival (OS), progression-free survival (PFS), objective response rate (ORR) and disease control rate (DCR). RESULTS Ten patients completed the planned treatment. None experienced grade ≥3 treatment-related AEs during CRT. Grade ≥3 immune-related AEs occurred in 2 of 10 patients (20%) only during GP CT. The mean OS time was 18.2 months (95% confidence interval [CI] 12.9m-23.5m) while the median OS time was 14.1 months (95% CI 10.1m-18.1m). OS rates were 100%, 59%, 44% at 6 months, 1 year and 2 years, respectively. The ORR was 30% while the DCR was 90%. Two patients (20%) obtained OS over 2 years with partial response (25.9m, 29.1m). Median PFS time was 14.1 months (95% CI 9.3m-18.9m). CONCLUSION Camrelizumab in combination with concurrent CRT was well tolerated and did not impair delivery of CRT in patients with locally advanced BTC.
Collapse
Affiliation(s)
- Q Guo
- Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China; Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - J Liu
- Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - X Dou
- Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - K Zhu
- Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - P Shi
- Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - Y Zhang
- Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - S Li
- Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - R Feng
- Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - J Yue
- Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China; Shandong Cancer Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| |
Collapse
|
149
|
Pan X, Feng T, Liu J, Liu C, Qi X. An Adaptive Multi-Feature Fusion Network for Predicting Overall Survival of Patients with Head and Neck Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e611-e612. [PMID: 37785840 DOI: 10.1016/j.ijrobp.2023.06.1986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Accurate prognostic prediction could allow personalized treatment to achieve optimal clinical outcome. We aimed to develop a highly predictive overall survival model, considering the complementary relationships between clinical information, traditional radiomics and deep image information, to further improve the overall prediction accuracy by constructing a richer feature set and adaptive weighting. MATERIALS/METHODS A total of 427 patients with Oropharyngeal Cancer (OPC) patients from the TCIA database were included. 341 cases were used for training, 86 cases were used as an independent cohort. Patient characteristics, including TMN, age, gender, HPV status, smoking or drinking status, etc. were considered as potential predictors. Traditional radiomics features of gross tumor volume (GTV) was extracted from planning CT using open-source software. In addition, a two-dimensional convolutional network (2D_CNN) was designed to extract deep image features. An adaptive multi-feature fusion network was developed to predict overall survival of patients based on three types of features. The fusion network integrates an attention mechanism to the channel dimension to obtain proper weighting of each channel in the feature graph through the fully connected network by focusing on effective feature channels and automatic learning according to the loss, thus improving the utilization rate of effective features. The model performance was evaluated using the area-under-ROC-curve (AUC), accuracy, precision, recall, f1-score. RESULTS The AUCs of predictive models based on clinical features, traditional radiomics features and deep image features were 0.7, 0.61 and 0.72, respectively. Combining patient characteristics, radiomic features and deep imaging features, the AUCs of the prediction models was significantly improved to 0.85 and 0.86 (with attention mechanisms) for the independent test cohort (Table 1). CONCLUSION The proposed adaptive multi-channel network assigned effective weights to the potential predictors, selectively enhanced useful features while suppressed irrelevant features, enabling more accurate feature map weights. We demonstrated the improved predictive value, with a multi-channel fusion network integrated with an attention mechanism, for overall survival of OPC patients.
Collapse
Affiliation(s)
- X Pan
- School of Computer Science and Technology, Xi'an University of Posts & Telecommunications, Xi'an, Shaanxi, China
| | - T Feng
- School of Computer Science and Technology, Xi'an University of Posts & Telecommunications, Xi'an, Shaanxi, China
| | - J Liu
- School of Computer Science and Technology, Xi'an University of Posts & Telecommunications, Xi'an, Shaanxi, China
| | - C Liu
- School of Computer Science and Technology, Xi'an University of Posts & Telecommunications, Xi'an, Shaanxi, China
| | - X Qi
- Dept. of Radiation Oncology, UCLA, Los Angeles, CA
| |
Collapse
|
150
|
Wong JYC, Liu B, Dandapani SV, Li YR, Glaser SM, Liu J, Chen Q, Qing K, Chen HK, Simpson J, Da Silva A, Leung D, Feghali K, Dorff TB, Liu A, Williams TM. Pilot Study of a Novel Ring Gantry-Based PET/CT Linear Accelerator in Patients with Prostate Cancer Receiving [18F]-DCFPyL for PSMA PET Imaging. Int J Radiat Oncol Biol Phys 2023; 117:e451. [PMID: 37785452 DOI: 10.1016/j.ijrobp.2023.06.1636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The RefleXion X1® system is a hybrid PET imaging-radiotherapy system that uses real-time positron emissions from a PET tracer to deliver biologically guided radiotherapy (BgRT). This study (NCT05470699) evaluated the hypothesis that the X1 PET imaging subsystem would be able to detect [18F]-DCFPyL PSMA PET signal sufficient to generate a deliverable BgRT plan in patients with prostate cancer. MATERIALS/METHODS Patients with prostate cancer scheduled for a diagnostic [18F]-DCFPyL PSMA PET scan as part of standard of care were eligible. Upon completion of the diagnostic PSMA PET scan, images were transferred to the radiotherapy planning system for target identification and contouring. If at least one PET avid tumor lesion was identified, the patient was then scanned on the X1 unit. BgRT planning was performed on each X1 scanned patient. The target lesion volume, activity concentration (AC) and normalized target signal (NTS) were acquired. Successful and deliverable BgRT plans required that the target AC was ≥ 5 kBq/ml and NTS ≥ 2.7. RESULTS Twenty-six patients underwent [18F]-DCFPyL PET scans (13 with rising PSA after surgery or radiotherapy, 6 with known metastases and 7 with newly diagnosed high-risk prostate cancer). Median (range) PSA was 3.40 (0.04-122). In 16 patients a PET avid tumor was identified and contoured for planning (4 lymph nodes, 5 bone, 6 prostate gland, and 1 prostate bed). In 13 patients the target lesion was visualized on the X1 PET scan, while in 3 patients the target lesion was too close to the bladder to be clearly visualized. BgRT planning was feasible and met standard of care published SBRT organ dose constraints in 8 patients (3 prostate gland, 3 bone, 2 lymph nodes). BgRT planning was not feasible in 8 patients due to insufficient AC, low NTS or proximity of the target lesion to the PET avid bladder. The accompanying table compares median (range) target volume, AC and NTS for feasible versus not feasible plans. CONCLUSION This is the first study to investigate the feasibility of using [18F]-DCFPyL PET imaging for BgRT plan generation on the X1 system in patients with prostate cancer. Lesions that are relevant to radiotherapy of prostate cancer can be visualized including lymph node and bone metastases. A dedicated BgRT workflow with PSMA PET imaging on the X1 at 60 minutes post injection will result in higher target AC and will optimize BgRT planning. PET avid lesions < 1 cm or close to the bladder may make BgRT planning challenging. [18F]-DCFPyL-guided BgRT is technically feasible using the RefleXion X1. BgRT using targeted PET radiopharmaceuticals to biologically guide external beam radiotherapy represents a promising new dimension in radiation oncology and warrants further investigation.
Collapse
Affiliation(s)
- J Y C Wong
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - B Liu
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - S V Dandapani
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - Y R Li
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - S M Glaser
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - J Liu
- Clinical Trials Office, City of Hope National Medical Center, Duarte, CA
| | - Q Chen
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - K Qing
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - H K Chen
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - J Simpson
- Clinical Trials Office, City of Hope National Medical Center, Duarte, CA
| | | | - D Leung
- RefleXion Medical, Inc., Hayward, CA
| | - K Feghali
- RefleXion Medical, Inc., Hayward, CA
| | - T B Dorff
- Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA
| | - A Liu
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| | - T M Williams
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA
| |
Collapse
|